Seed	Sign	Gene_target	Ensembl	Repeated	N_repeated	Repeated2	N_repeated2	P-value	Ortholist2	Orthologs	TRRUST(+)	Phenotype	GO	GOterm	Keyword	Reactome	Reactome_terms
PDSS2	positive	SUCLG2	ENSG00000172340	PDSS2	1	PDSS2	1	0.000814449730993649	WBGene00016844;WBGene00009812	WBGene00016844(1)			GO:0046872;GO:0000166;GO:0005524;GO:0006099;GO:0005739;GO:0003824;GO:0005886;GO:0005525;GO:0016874;GO:0005515;GO:0000287;GO:0004774;GO:0004775;GO:0004776;GO:0006104;GO:0005759;GO:0019003;GO:0046982;GO:0006105;GO:0032991;GO:0042709;GO:0045244	ATP binding;catalytic activity;tricarboxylic acid cycle;succinate-CoA ligase (GDP-forming) activity;succinyl-CoA metabolic process;metal ion binding;nucleotide binding;plasma membrane;mitochondrion;GTP binding;ligase activity;protein binding;magnesium ion binding;succinate-CoA ligase (ADP-forming) activity;mitochondrial matrix;succinate-CoA ligase activity;GDP binding;protein-containing complex binding;succinate metabolic process;protein-containing complex;succinate-CoA ligase complex;succinate-CoA ligase complex (GDP-forming)	Acetylation;Alternative splicing;GTP-binding;Ligase;Magnesium;Metal-binding;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide;Tricarboxylic acid cycle	R-HSA-1430728;R-HSA-1428517;R-HSA-71406;R-HSA-71403	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Pyruvate metabolism and Citric Acid (TCA) cycle;Citric acid cycle (TCA cycle)
PDSS2	positive	ALDH6A1	ENSG00000119711	PDSS2	1	PDSS2	1	0.00115315500755953	WBGene00000114	WBGene00000114(1)		Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency;METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	GO:0003723;GO:0005654;GO:0016491;GO:0055114;GO:0005739;GO:0016620;GO:0004491;GO:0050873;GO:0005759;GO:0009083;GO:0000062;GO:0006574;GO:0018478;GO:0006210;GO:0006573;GO:0019859	oxidation-reduction process;oxidoreductase activity;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor;methylmalonate-semialdehyde dehydrogenase (acylating) activity;RNA binding;nucleoplasm;mitochondrion;brown fat cell differentiation;mitochondrial matrix;branched-chain amino acid catabolic process;fatty-acyl-CoA binding;valine catabolic process;malonate-semialdehyde dehydrogenase (acetylating) activity;thymine catabolic process;valine metabolic process;thymine metabolic process	Acetylation;Alternative splicing;Disease mutation;Mitochondrion;NAD;Oxidoreductase;Phosphoprotein;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-70895	Metabolism;Metabolism of amino acids and derivatives;Branched-chain amino acid catabolism
PDSS2	positive	MCCC1	ENSG00000078070	PDSS2	1	PDSS2	1	0.00161666557347317	WBGene00009319;WBGene00004258;WBGene00017864	WBGene00009319(1)		3-Methylcrotonyl-CoA Carboxylase Deficiency;3-Methylcrotonyl-CoA Carboxylase Deficiency;3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	GO:0000166;GO:0005524;GO:0005739;GO:0046872;GO:0005759;GO:0016874;GO:0005515;GO:0005829;GO:0009083;GO:0006768;GO:0006552;GO:0009374;GO:0004485;GO:0004075;GO:0002169;GO:1905202	nucleotide binding;ATP binding;metal ion binding;mitochondrion;mitochondrial matrix;ligase activity;protein binding;cytosol;branched-chain amino acid catabolic process;biotin metabolic process;leucine catabolic process;biotin binding;methylcrotonoyl-CoA carboxylase activity;biotin carboxylase activity;3-methylcrotonyl-CoA carboxylase complex, mitochondrial;methylcrotonoyl-CoA carboxylase complex	3D-structure;ATP-binding;Acetylation;Biotin;Direct protein sequencing;Disease mutation;Ligase;Mitochondrion;Nucleotide-binding;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-1643685;R-HSA-196854;R-HSA-196780;R-HSA-196849;R-HSA-3296482;R-HSA-5668914;R-HSA-70895;R-HSA-3323169;R-HSA-3371599	Metabolism;Metabolism of amino acids and derivatives;Disease;Metabolism of vitamins and cofactors;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Defects in vitamin and cofactor metabolism;Diseases of metabolism;Branched-chain amino acid catabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency
PDSS2	positive	HIBCH	ENSG00000198130	PDSS2	1	PDSS2	1	0.00190713746800197	WBGene00017301	WBGene00017301(1)		Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency;HIBCH deficiency;3-@HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY	GO:0016787;GO:0005739;GO:0006574;GO:0009083;GO:0003860;GO:0005759	3-hydroxyisobutyryl-CoA hydrolase activity;hydrolase activity;mitochondrion;valine catabolic process;branched-chain amino acid catabolic process;mitochondrial matrix	3D-structure;Acetylation;Alternative splicing;Branched-chain amino acid catabolism;Disease mutation;Hydrolase;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-70895	Metabolism;Metabolism of amino acids and derivatives;Branched-chain amino acid catabolism
PDSS2	positive	APOOL	ENSG00000155008	PDSS2	1	PDSS2	1	0.00263455059793727		WBGene00019333(0)			GO:0016020;GO:0016021;GO:0005739;GO:0005743;GO:0005576;GO:0061617;GO:0042407;GO:0005515;GO:0002576;GO:0031093	MICOS complex;cristae formation;membrane;integral component of membrane;mitochondrion;mitochondrial inner membrane;extracellular region;protein binding;inner mitochondrial membrane organization;platelet degranulation;platelet alpha granule lumen;SAM complex;MIB complex	Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-1852241;R-HSA-76002;R-HSA-76005;R-HSA-114608;R-HSA-1592230;R-HSA-8949613	Hemostasis;Organelle biogenesis and maintenance;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation ;Mitochondrial biogenesis;Cristae formation
PDSS2	positive	MIPEP	ENSG00000027001	PDSS2	1	PDSS2	1	0.00308512947742057	WBGene00013464	WBGene00013464(1)		Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	GO:0046872;GO:0016787;GO:0005739;GO:0005759;GO:0008233;GO:0006508;GO:0004222;GO:0008237;GO:0006627;GO:0006518	proteolysis;metalloendopeptidase activity;metallopeptidase activity;metal ion binding;hydrolase activity;mitochondrion;mitochondrial matrix;peptidase activity;protein processing involved in protein targeting to mitochondrion;peptide metabolic process	Acetylation;Calcium;Cobalt;Disease mutation;Hydrolase;Iron;Magnesium;Manganese;Metal-binding;Metalloprotease;Mitochondrion;Polymorphism;Primary mitochondrial disease;Protease;Reference proteome;Transit peptide;Zinc		
PDSS2	positive	GLG1	ENSG00000090863	PDSS2	1	PDSS2	1	0.00308512947742057	WBGene00008800	WBGene00008800(1)			GO:0016020;GO:0016021;GO:0005794;GO:0000139;GO:0050900;GO:0005886;GO:0070062;GO:0005102;GO:0017134;GO:0010955;GO:0030512;GO:0032330;GO:0060349;GO:0031012	membrane;Golgi membrane;cytoplasm;integral component of membrane;Golgi apparatus;cytoskeleton;cell junction;synapse;leukocyte migration;plasma membrane;extracellular exosome;postsynaptic Golgi apparatus;signaling receptor binding;fibroblast growth factor binding;negative regulation of protein processing;negative regulation of transforming growth factor beta receptor signaling pathway;regulation of chondrocyte differentiation;bone morphogenesis;extracellular matrix	Alternative splicing;Cell junction;Cytoplasm;Cytoskeleton;Glycoprotein;Golgi apparatus;Membrane;Phosphoprotein;Reference proteome;Repeat;Sialic acid;Signal;Synapse;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-202733	Hemostasis;Cell surface interactions at the vascular wall
PDSS2	positive	KIAA0100	ENSG00000007202	PDSS2	1	PDSS2	1	0.00360395605051056	WBGene00009285	WBGene00009285(0)			GO:0005576;GO:0005515	extracellular region;protein binding	Alternative splicing;Coiled coil;Glycoprotein;Phosphoprotein;Polymorphism;Reference proteome;Secreted;Signal		
PDSS2	positive	ABHD2	ENSG00000140526	PDSS2	1	PDSS2	1	0.00360395605051056	WBGene00013358;WBGene00016644				GO:0016020;GO:0016021;GO:0031514;GO:0016787;GO:0006629;GO:0016042;GO:0005886;GO:0042995;GO:0007340;GO:0009611;GO:0030336;GO:0001669;GO:0052689;GO:0005929;GO:0036126;GO:0048240;GO:0047372;GO:0097524;GO:0016298;GO:0003707;GO:0008126;GO:0033878;GO:0042562;GO:0032570;GO:0043401;GO:0044255;GO:0046464	membrane;integral component of membrane;motile cilium;hydrolase activity;lipid metabolic process;lipid catabolic process;plasma membrane;cell projection;acrosome reaction;response to wounding;negative regulation of cell migration;acrosomal vesicle;carboxylic ester hydrolase activity;cilium;sperm flagellum;sperm capacitation;acylglycerol lipase activity;sperm plasma membrane;acylglycerol catabolic process;hydrolase activity, acting on ester bonds;lipase activity;steroid hormone receptor activity;acetylesterase activity;hormone-sensitive lipase activity;short-chain carboxylesterase activity;hormone binding;response to progesterone;steroid hormone mediated signaling pathway;cellular lipid metabolic process	Cell membrane;Cell projection;Cilium;Flagellum;Glycoprotein;Hydrolase;Lipid degradation;Lipid metabolism;Membrane;Polymorphism;Reference proteome;Serine esterase;Signal-anchor;Transmembrane;Transmembrane helix		
PDSS2	positive	COX11	ENSG00000166260	PDSS2	1	PDSS2	1	0.00360395605051056	WBGene00010437	WBGene00010437(1)			GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:0031305;GO:0022900;GO:0005507;GO:0005515;GO:0032991;GO:0009055;GO:0055065;GO:0033132	membrane;integral component of membrane;mitochondrial inner membrane;mitochondrion;integral component of mitochondrial inner membrane;electron transport chain;copper ion binding;protein binding;protein-containing complex;electron transfer activity;metal ion homeostasis;negative regulation of glucokinase activity	Alternative splicing;Copper;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-5628897	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;TP53 Regulates Metabolic Genes
PDSS2	positive	ACAT1	ENSG00000075239	PDSS2	1	PDSS2	1	0.00419978485851646	WBGene00002183;WBGene00020166;WBGene00009952	WBGene00002183(1);WBGene00020166(1)		Beta-ketothiolase deficiency;ALPHA-METHYLACETOACETIC ACIDURIA;ALPHA-METHYLACETOACETIC ACIDURIA	GO:0003824;GO:0016747;GO:0046872;GO:0016740;GO:0005739;GO:0016746;GO:0006629;GO:0006631;GO:0070062;GO:0005759;GO:0015937;GO:0009083;GO:0006635;GO:0003988;GO:0003985;GO:0016453;GO:0006085;GO:0006550;GO:0015936;GO:0034435;GO:0046356;GO:0046951;GO:0046952;GO:1902224;GO:1902860;GO:0019899;GO:0042803;GO:0050662;GO:0001889;GO:0007420;GO:0009725;GO:0014070;GO:0042594;GO:0051260;GO:0060612;GO:0072229	catalytic activity;transferase activity, transferring acyl groups other than amino-acyl groups;metal ion binding;transferase activity;mitochondrion;transferase activity, transferring acyl groups;lipid metabolic process;fatty acid metabolic process;extracellular exosome;mitochondrial matrix;coenzyme A biosynthetic process;branched-chain amino acid catabolic process;fatty acid beta-oxidation;potassium ion binding;acetyl-CoA C-acyltransferase activity;acetyl-CoA C-acetyltransferase activity;C-acetyltransferase activity;acetyl-CoA biosynthetic process;isoleucine catabolic process;coenzyme A metabolic process;cholesterol esterification;acetyl-CoA catabolic process;ketone body biosynthetic process;ketone body catabolic process;ketone body metabolic process;propionyl-CoA biosynthetic process;enzyme binding;identical protein binding;coenzyme binding;liver development;brain development;response to hormone;response to organic cyclic compound;response to starvation;adipose tissue development;metanephric proximal convoluted tubule development	3D-structure;Acetylation;Acyltransferase;Alternative splicing;Direct protein sequencing;Disease mutation;Fatty acid metabolism;Lipid metabolism;Metal-binding;Mitochondrion;Polymorphism;Potassium;Reference proteome;Transferase;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-71291;R-HSA-70895;R-HSA-74182;R-HSA-77108;R-HSA-77111	Metabolism;Metabolism of lipids;Metabolism of amino acids and derivatives;Branched-chain amino acid catabolism;Ketone body metabolism;Utilization of Ketone Bodies;Synthesis of Ketone Bodies
PDSS2	positive	PCCB	ENSG00000114054	PDSS2	1	PDSS2	1	0.00419978485851646	WBGene00018701	WBGene00018701(1)		PROPIONIC ACIDEMIA;PROPIONIC ACIDEMIA;PROPIONIC ACIDEMIA	GO:0000166;GO:0005524;GO:0005739;GO:0005759;GO:0016874;GO:0005515;GO:0005829;GO:0004658;GO:0006768;GO:0019626;GO:0003989;GO:0006633;GO:0009317	ligase activity;nucleotide binding;ATP binding;mitochondrion;mitochondrial matrix;protein binding;cytosol;propionyl-CoA carboxylase activity;biotin metabolic process;short-chain fatty acid catabolic process;acetyl-CoA carboxylase activity;fatty acid biosynthetic process;acetyl-CoA carboxylase complex	ATP-binding;Acetylation;Alternative splicing;Direct protein sequencing;Disease mutation;Ligase;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-1643685;R-HSA-77289;R-HSA-196854;R-HSA-196780;R-HSA-196849;R-HSA-3296482;R-HSA-5668914;R-HSA-3323169;R-HSA-3371599;R-HSA-71032	Metabolism;Metabolism of lipids;Fatty acid metabolism;Disease;Mitochondrial Fatty Acid Beta-Oxidation;Metabolism of vitamins and cofactors;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Defects in vitamin and cofactor metabolism;Diseases of metabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency;Propionyl-CoA catabolism
PDSS2	positive	COMMD10	ENSG00000145781	PDSS2	1	PDSS2	1	0.00419978485851646					GO:0005634;GO:0005737;GO:0005515	nucleus;cytoplasm;nucleoplasm;protein binding	Acetylation;Cytoplasm;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-8951664	Metabolism of proteins;Post-translational protein modification;Neddylation
PDSS2	positive	PPP1R7	ENSG00000115685	PDSS2	1	PDSS2	1	0.00488223147978228	WBGene00011637;WBGene00015516;WBGene00189952				GO:0005515;GO:0005634;GO:0050790;GO:0043666;GO:0030234;GO:0070062;GO:0005737;GO:0019888;GO:0035307;GO:0005694	protein binding;nucleus;regulation of catalytic activity;regulation of phosphoprotein phosphatase activity;enzyme regulator activity;extracellular exosome;cytoplasm;protein phosphatase regulator activity;positive regulation of protein dephosphorylation;chromosome	3D-structure;Acetylation;Alternative splicing;Leucine-rich repeat;Nucleus;Phosphoprotein;Reference proteome;Repeat		
PDSS2	positive	HSDL2	ENSG00000119471	PDSS2	1	PDSS2	1	0.00488223147978228	WBGene00000981;WBGene00000970;WBGene00017123	WBGene00000975(0);WBGene00011424(0);WBGene00000981(0);WBGene00000970(0);WBGene00008986(0);WBGene00008985(0);WBGene00022809(0)			GO:0016020;GO:0016491;GO:0055114;GO:0005739;GO:0005777;GO:0003674;GO:0008150	oxidoreductase activity;membrane;oxidation-reduction process;mitochondrion;peroxisome;molecular_function;biological_process	3D-structure;Acetylation;Alternative splicing;NADP;Oxidoreductase;Peroxisome;Reference proteome		
PDSS2	positive	KCTD3	ENSG00000136636	PDSS2	1	PDSS2	1	0.00488223147978228	WBGene00020721	WBGene00020721(1)			GO:0016020;GO:0051260;GO:0005886;GO:0005515	protein binding;protein homooligomerization;membrane;plasma membrane	Alternative splicing;Cell membrane;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat		
PDSS2	positive	FTO	ENSG00000140718	PDSS2	1	PDSS2	1	0.00488223147978228				Lethal polymalformative syndrome Boissel type;GROWTH RETARDATION DEVELOPMENTAL DELAY COARSE FACIES AND EARLY DEATH;BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14;GROWTH RETARDATION DEVELOPMENTAL DELAY AND FACIAL DYSMORPHISM	GO:0035515;GO:0035516;GO:0006307;GO:0035552;GO:0035553;GO:0040014;GO:0042245;GO:0005634;GO:0005737;GO:0016607;GO:0046872;GO:0016740;GO:0016491;GO:0055114;GO:0051213;GO:0005654;GO:0008198;GO:0070989;GO:0090335;GO:0061157;GO:1990984;GO:0043734;GO:0080111;GO:1990931;GO:0010883;GO:0001659;GO:0044065;GO:0060612;GO:0070350;GO:0016020;GO:0016021	DNA dealkylation involved in DNA repair;oxidative single-stranded DNA demethylation;oxidative RNA demethylase activity;oxidative single-stranded RNA demethylation;oxidative DNA demethylase activity;regulation of multicellular organism growth;RNA repair;nucleus;cytoplasm;nuclear speck;metal ion binding;transferase activity;oxidoreductase activity;oxidation-reduction process;dioxygenase activity;nucleoplasm;ferrous iron binding;oxidative demethylation;regulation of brown fat cell differentiation;mRNA destabilization;tRNA demethylase activity;DNA-N1-methyladenine dioxygenase activity;DNA demethylation;RNA N6-methyladenosine dioxygenase activity;regulation of lipid storage;temperature homeostasis;regulation of respiratory system process;adipose tissue development;regulation of white fat cell proliferation;membrane;integral component of membrane	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Dioxygenase;Disease mutation;Iron;Metal-binding;Nucleus;Obesity;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome;Transferase	R-HSA-73894;R-HSA-73942;R-HSA-73943	DNA Repair;DNA Damage Reversal;Reversal of alkylation damage by DNA dioxygenases
PDSS2	positive	CWC27	ENSG00000153015	PDSS2	1	PDSS2	1	0.00488223147978228	WBGene00000892	WBGene00000892(1)		Retinitis pigmentosa skeletal anomalies and intellectual disability;RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	GO:0005634;GO:0005654;GO:0000413;GO:0006457;GO:0000398;GO:0071013;GO:0003755;GO:0071005	peptidyl-prolyl cis-trans isomerase activity;protein folding;protein peptidyl-prolyl isomerization;nucleus;nucleoplasm;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;U2-type precatalytic spliceosome	3D-structure;Acetylation;Alternative splicing;Coiled coil;Disease mutation;Dwarfism;Glycoprotein;Mental retardation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Retinitis pigmentosa	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
PDSS2	positive	RXRA	ENSG00000186350	PDSS2	1	PDSS2	1	0.00488223147978228	WBGene00006790;WBGene00003654	WBGene00017198(0);WBGene00016975(0);WBGene00007547(0);WBGene00003726(0);WBGene00011100(0);WBGene00011099(0);WBGene00011097(0);WBGene00011098(0);WBGene00003706(0);WBGene00003650(0);WBGene00008221(0);WBGene00017787(0);WBGene00003719(0);WBGene00015395(0);WBGene00015396(0);WBGene00015397(0);WBGene00020748(0);WBGene00003683(0);WBGene00015705(0);WBGene00022423(0);WBGene00003659(0);WBGene00044354(0);WBGene00003626(0);WBGene00021848(0)	ABCA1;CPT1B;CXCR5;HSD17B2;IL2RA;IL2RB;IL2RG;NOL7;SERPINC1		GO:0044212;GO:0005634;GO:0005737;GO:0008270;GO:0046872;GO:0006355;GO:0003677;GO:0003700;GO:0005739;GO:0043565;GO:0005515;GO:0003707;GO:0043401;GO:0030154;GO:0000977;GO:0006357;GO:0045944;GO:0000122;GO:0000981;GO:0000790;GO:0005654;GO:0090575;GO:0016032;GO:0048856;GO:0004879;GO:0008134;GO:0031490;GO:0001701;GO:0001890;GO:0001893;GO:0007507;GO:0007566;GO:0043010;GO:0045893;GO:0045994;GO:0048384;GO:0055010;GO:0055012;GO:0060038;GO:0060528;GO:0060687;GO:0003713;GO:0019899;GO:0046982;GO:0006367;GO:0032991;GO:0042802;GO:0043235;GO:0032526;GO:0019216;GO:0015721;GO:0035357;GO:0008203;GO:0019048;GO:0038023;GO:0044323;GO:0003690;GO:0070644;GO:0042277;GO:0001972;GO:0016922;GO:0042809;GO:0050692;GO:0050693;GO:0006766	DNA binding;steroid hormone receptor activity;zinc ion binding;regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;sequence-specific DNA binding;transcription regulatory region DNA binding;cytoplasm;metal ion binding;mitochondrion;protein binding;steroid hormone mediated signaling pathway;cell differentiation;regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;nucleoplasm;RNA polymerase II transcription factor complex;viral process;anatomical structure development;RNA polymerase II cis-regulatory region sequence-specific DNA binding;RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding;nuclear receptor activity;transcription factor binding;chromatin DNA binding;in utero embryonic development;placenta development;maternal placenta development;heart development;embryo implantation;camera-type eye development;positive regulation of transcription, DNA-templated;positive regulation of translational initiation by iron;retinoic acid receptor signaling pathway;ventricular cardiac muscle tissue morphogenesis;ventricular cardiac muscle cell differentiation;cardiac muscle cell proliferation;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;regulation of branching involved in prostate gland morphogenesis;transcription coactivator activity;enzyme binding;transcription initiation from RNA polymerase II promoter;protein-containing complex;identical protein binding;receptor complex;response to retinoic acid;regulation of lipid metabolic process;bile acid and bile salt transport;peroxisome proliferator activated receptor signaling pathway;cholesterol metabolic process;modulation by virus of host morphology or physiology;signaling receptor activity;retinoic acid-responsive element binding;double-stranded DNA binding;vitamin D response element binding;peptide binding;retinoic acid binding;nuclear receptor binding;vitamin D receptor binding;DNA binding domain binding;LBD domain binding;vitamin metabolic process	3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA-binding;Host-virus interaction;Isopeptide bond;Metal-binding;Mitochondrion;Nucleus;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-1266738;R-HSA-1852241;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206;R-HSA-162582;R-HSA-8978868;R-HSA-211859;R-HSA-2990846;R-HSA-3108232;R-HSA-9006931;R-HSA-211897;R-HSA-211945;R-HSA-211976;R-HSA-8957322;R-HSA-1428517;R-HSA-1368108;R-HSA-400253;R-HSA-204174;R-HSA-5362517;R-HSA-70268;R-HSA-71406;R-HSA-1592230;R-HSA-2151201;R-HSA-5617472;R-HSA-5619507;R-HSA-1655829;R-HSA-200425;R-HSA-2426168;R-HSA-192105;R-HSA-193368;R-HSA-194068;R-HSA-159418;R-HSA-9616222;R-HSA-1368082;R-HSA-383280;R-HSA-193807;R-HSA-4090294	Developmental Biology;Organelle biogenesis and maintenance;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Signal Transduction;Fatty acid metabolism;Biological oxidations;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Signaling by Nuclear Receptors;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of steroids;The citric acid (TCA) cycle and respiratory electron transport;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock;Regulation of pyruvate dehydrogenase (PDH) complex;Signaling by Retinoic Acid;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Regulation of cholesterol biosynthesis by SREBP (SREBF);Carnitine metabolism;Activation of gene expression by SREBF (SREBP);Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Bile acid and bile salt metabolism;Recycling of bile acids and salts;Transcriptional regulation of granulopoiesis;RORA activates gene expression;Nuclear Receptor transcription pathway;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;SUMOylation of intracellular receptors
PDSS2	positive	SYNJ2BP	ENSG00000213463	PDSS2	1	PDSS2	1	0.00488223147978228	WBGene00011890				GO:0016020;GO:0016021;GO:0005739;GO:0005515;GO:0005741;GO:0008022;GO:0006605;GO:0007266;GO:0030100;GO:0048312;GO:0031307;GO:0043113;GO:0007268;GO:0043005;GO:0098609;GO:0001937;GO:0010596;GO:0016525;GO:0008593;GO:0070373;GO:0031594;GO:0016323;GO:0098839;GO:0008328;GO:0045197;GO:0097120;GO:1903671;GO:0030054	protein binding;membrane;integral component of membrane;mitochondrion;mitochondrial outer membrane;receptor clustering;chemical synaptic transmission;neuron projection;cell-cell adhesion;negative regulation of endothelial cell proliferation;negative regulation of endothelial cell migration;negative regulation of angiogenesis;regulation of Notch signaling pathway;negative regulation of ERK1 and ERK2 cascade;neuromuscular junction;basolateral plasma membrane;postsynaptic density membrane;negative regulation of sprouting angiogenesis;cell junction;ionotropic glutamate receptor complex;establishment or maintenance of epithelial cell apical/basal polarity;receptor localization to synapse	3D-structure;Membrane;Mitochondrion;Mitochondrion outer membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
PDSS2	positive	GSTZ1	ENSG00000100577	PDSS2	1	PDSS2	1	0.0056618170349183	WBGene00001790;WBGene00021817;WBGene00001791	WBGene00001790(1)		MALEYLACETOACETATE ISOMERASE DEFICIENCY	GO:0005737;GO:0016740;GO:0016853;GO:0003824;GO:0009072;GO:0005515;GO:0005739;GO:0042803;GO:0008152;GO:0098869;GO:0042802;GO:0004364;GO:0006749;GO:0006559;GO:0006572;GO:0005829;GO:0005759;GO:1901687;GO:0004602;GO:0016034;GO:0010510	protein binding;cytoplasm;catalytic activity;aromatic amino acid family metabolic process;transferase activity;isomerase activity;mitochondrion;protein homodimerization activity;metabolic process;cellular oxidant detoxification;identical protein binding;glutathione transferase activity;L-phenylalanine catabolic process;glutathione metabolic process;tyrosine catabolic process;cytosol;mitochondrial matrix;glutathione derivative biosynthetic process;glutathione peroxidase activity;maleylacetoacetate isomerase activity;regulation of acetyl-CoA biosynthetic process from pyruvate	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Disease mutation;Isomerase;Multifunctional enzyme;Phenylalanine catabolism;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Tyrosine catabolism	R-HSA-1430728;R-HSA-71291;R-HSA-156580;R-HSA-156590;R-HSA-211859;R-HSA-1428517;R-HSA-204174;R-HSA-70268;R-HSA-71406;R-HSA-8963684;R-HSA-8963691	Metabolism;Metabolism of amino acids and derivatives;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations;The citric acid (TCA) cycle and respiratory electron transport;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Tyrosine catabolism;Phenylalanine and tyrosine metabolism
PDSS2	positive	ELP4	ENSG00000109911	PDSS2	1	PDSS2	1	0.0056618170349183	WBGene00016128	WBGene00016128(0)		ANIRIDIA 2	GO:0002098;GO:0033588;GO:0000993;GO:0005634;GO:0005737;GO:0005654;GO:0008033;GO:0005515;GO:0045859;GO:0006357;GO:0008023;GO:0008607;GO:0006368	tRNA wobble uridine modification;Elongator holoenzyme complex;nucleoplasm;RNA polymerase II complex binding;nucleus;cytoplasm;tRNA processing;protein binding;regulation of protein kinase activity;regulation of transcription by RNA polymerase II;transcription elongation factor complex;transcription elongation from RNA polymerase II promoter;phosphorylase kinase regulator activity	Alternative splicing;Cytoplasm;Nucleus;Polymorphism;Reference proteome;Transcription;Transcription regulation;tRNA processing	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
PDSS2	positive	SDHB	ENSG00000117118	PDSS2	1	PDSS2	1	0.0056618170349183	WBGene00006433	WBGene00006433(0)		Carney-Stratakis syndrome;COWDEN SYNDROME;Gastrointestinal stromal tumor;Hereditary pheochromocytoma-paraganglioma;Isolated succinate-CoQ reductase deficiency;Sporadic pheochromocytoma;Gastrointestinal stromal tumor;PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA;PARAGANGLIOMAS 4;Pheochromocytoma	GO:0016020;GO:0046872;GO:0005654;GO:0016491;GO:0055114;GO:0008177;GO:0006099;GO:0005739;GO:0005743;GO:0005886;GO:0051537;GO:0005515;GO:0051536;GO:0051539;GO:0009055;GO:0051538;GO:0009060;GO:0048039;GO:0005749;GO:0031966;GO:0006105;GO:0022904;GO:0045273;GO:0022900	electron transfer activity;oxidation-reduction process;oxidoreductase activity;iron-sulfur cluster binding;2 iron, 2 sulfur cluster binding;tricarboxylic acid cycle;membrane;metal ion binding;nucleoplasm;plasma membrane;succinate dehydrogenase (ubiquinone) activity;mitochondrion;mitochondrial inner membrane;protein binding;4 iron, 4 sulfur cluster binding;3 iron, 4 sulfur cluster binding;aerobic respiration;mitochondrial membrane;ubiquinone binding;mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone);respiratory electron transport chain;succinate metabolic process;respiratory chain complex II;electron transport chain	2Fe-2S;3Fe-4S;4Fe-4S;Acetylation;Disease mutation;Electron transport;Iron;Iron-sulfur;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Oxidoreductase;Polymorphism;Reference proteome;Transit peptide;Transport;Tricarboxylic acid cycle	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-71406;R-HSA-71403	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Pyruvate metabolism and Citric Acid (TCA) cycle;Citric acid cycle (TCA cycle)
PDSS2	positive	GLCE	ENSG00000138604	PDSS2	1	PDSS2	1	0.0056618170349183	WBGene00002003	WBGene00002003(1)			GO:0015012;GO:0047464;GO:0016020;GO:0016021;GO:0046872;GO:0016853;GO:0005794;GO:0042803;GO:0000139;GO:0005509;GO:0016857;GO:0030210	heparan sulfate proteoglycan biosynthetic process;heparosan-N-sulfate-glucuronate 5-epimerase activity;membrane;integral component of membrane;metal ion binding;isomerase activity;Golgi apparatus;protein homodimerization activity;Golgi membrane;calcium ion binding;racemase and epimerase activity, acting on carbohydrates and derivatives;heparin biosynthetic process	3D-structure;Calcium;Glycoprotein;Golgi apparatus;Isomerase;Membrane;Metal-binding;Polymorphism;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-71387;R-HSA-1630316;R-HSA-1638091;R-HSA-2022928	Metabolism;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis
PDSS2	positive	SUOX	ENSG00000139531	PDSS2	1	PDSS2	1	0.0056618170349183	WBGene00010397	WBGene00010397(1)		Isolated sulfite oxidase deficiency;SULFITE OXIDASE DEFICIENCY ISOLATED	GO:0046872;GO:0016491;GO:0055114;GO:0005739;GO:0005515;GO:0020037;GO:0030151;GO:0043546;GO:0042128;GO:0005758;GO:0005759;GO:0006790;GO:0070221;GO:0008482	oxidation-reduction process;oxidoreductase activity;nitrate assimilation;heme binding;molybdenum ion binding;molybdopterin cofactor binding;metal ion binding;mitochondrion;protein binding;mitochondrial intermembrane space;mitochondrial matrix;sulfur compound metabolic process;sulfide oxidation, using sulfide:quinone oxidoreductase;sulfite oxidase activity	3D-structure;Disease mutation;Epilepsy;Heme;Iron;Mental retardation;Metal-binding;Mitochondrion;Molybdenum;Oxidoreductase;Phosphoprotein;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-1614517;R-HSA-1614558;R-HSA-1614635	Metabolism;Metabolism of amino acids and derivatives;Sulfide oxidation to sulfate;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism
PDSS2	positive	ITGB3BP	ENSG00000142856	PDSS2	1	PDSS2	1	0.0056618170349183					GO:0005634;GO:0005737;GO:0005654;GO:0006355;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0006915;GO:0034080;GO:0000775;GO:0000776;GO:0000777;GO:0005829;GO:0007165;GO:0007155;GO:0016020;GO:0043065;GO:0008022	regulation of transcription, DNA-templated;CENP-A containing nucleosome assembly;nucleus;cytoplasm;nucleoplasm;cell division;chromosome;protein binding;cell cycle;apoptotic process;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;signal transduction;cell adhesion;membrane;positive regulation of apoptotic process;protein C-terminus binding	Activator;Alternative splicing;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Isopeptide bond;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-162582;R-HSA-194315;R-HSA-193704;R-HSA-204998;R-HSA-73887;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-205043	Signal Transduction;Signaling by Rho GTPases;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Death Receptor Signalling;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;NRIF signals cell death from the nucleus
PDSS2	positive	AUH	ENSG00000148090	PDSS2	1	PDSS2	1	0.0056618170349183	WBGene00001154	WBGene00007130(0);WBGene00001154(0)		3-methylglutaconic aciduria type 1;3-methylglutaconic aciduria type 1;3-@METHYLGLUTACONIC ACIDURIA TYPE I	GO:0003723;GO:0003824;GO:0016829;GO:0005739;GO:0009083;GO:0005759;GO:0003730;GO:0006635;GO:0006552;GO:0004300;GO:0004490;GO:0050011	catalytic activity;RNA binding;lyase activity;mitochondrion;branched-chain amino acid catabolic process;mitochondrial matrix;mRNA 3'-UTR binding;fatty acid beta-oxidation;leucine catabolic process;enoyl-CoA hydratase activity;methylglutaconyl-CoA hydratase activity;itaconyl-CoA hydratase activity	3D-structure;Acetylation;Alternative splicing;Branched-chain amino acid catabolism;Direct protein sequencing;Disease mutation;Lyase;Mitochondrion;RNA-binding;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-70895	Metabolism;Metabolism of amino acids and derivatives;Branched-chain amino acid catabolism
PDSS2	positive	PDIK1L	ENSG00000175087	PDSS2	1	PDSS2	1	0.0056618170349183					GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0006468;GO:0005634;GO:0016301;GO:0016740;GO:0016310;GO:0005654;GO:0005515	ATP binding;protein phosphorylation;protein kinase activity;nucleotide binding;protein serine/threonine kinase activity;nucleus;kinase activity;transferase activity;phosphorylation;nucleoplasm;protein binding	ATP-binding;Kinase;Nucleotide-binding;Nucleus;Reference proteome;Serine/threonine-protein kinase;Transferase		
PDSS2	positive	RTN4IP1	ENSG00000130347	PDSS2	1	PDSS2	1	0.00655000888535318	WBGene00044305	WBGene00044305(1)		Autosomal recessive isolated optic atrophy;EARLY-ONSET RECESSIVE OPTIC NEUROPATHY;OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA MENTAL RETARDATION AND SEIZURES	GO:0016020;GO:0008270;GO:0055114;GO:0016491;GO:0005739;GO:0005741;GO:0007399;GO:0050773	zinc ion binding;oxidation-reduction process;oxidoreductase activity;mitochondrion;membrane;protein binding;mitochondrial outer membrane;nervous system development;regulation of dendrite development	3D-structure;Alternative splicing;Disease mutation;Membrane;Mitochondrion;Mitochondrion outer membrane;Neurogenesis;Reference proteome;Transit peptide		
PDSS2	positive	IPO8	ENSG00000133704	PDSS2	1	PDSS2	1	0.00655000888535318					GO:0005634;GO:0005737;GO:0006886;GO:0015031;GO:0005515;GO:0008536;GO:0005829;GO:0005654;GO:0005635;GO:0006606;GO:0060964;GO:0007165;GO:0005623	intracellular protein transport;Ran GTPase binding;nucleus;cytoplasm;protein transport;protein binding;cytosol;nucleoplasm;nuclear envelope;protein import into nucleus;regulation of gene silencing by miRNA;signal transduction	Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-74160;R-HSA-211000;R-HSA-5578749	Gene expression (Transcription);Gene Silencing by RNA;Transcriptional regulation by small RNAs
PDSS2	positive	HSD17B4	ENSG00000133835	PDSS2	1	PDSS2	1	0.00655000888535318	WBGene00000991;WBGene00017123;WBGene00003773	WBGene00000991(1)		Bifunctional enzyme deficiency;Perrault syndrome;D-BIFUNCTIONAL PROTEIN DEFICIENCY;Perrault syndrome;D-BIFUNCTIONAL PROTEIN DEFICIENCY;PERRAULT SYNDROME 1	GO:0016020;GO:0016853;GO:0016491;GO:0055114;GO:0016829;GO:0006629;GO:0006631;GO:0042803;GO:0005777;GO:0005778;GO:0005829;GO:0006625;GO:0005782;GO:0006699;GO:0033540;GO:0036109;GO:0006635;GO:0001649;GO:0008210;GO:0008209;GO:0003857;GO:0016508;GO:0033989;GO:0044594;GO:0036111;GO:0036112;GO:0000038;GO:0060009	oxidoreductase activity;membrane;isomerase activity;oxidation-reduction process;lyase activity;lipid metabolic process;fatty acid metabolic process;protein homodimerization activity;peroxisome;peroxisomal membrane;cytosol;protein targeting to peroxisome;peroxisomal matrix;bile acid biosynthetic process;fatty acid beta-oxidation using acyl-CoA oxidase;alpha-linolenic acid metabolic process;fatty acid beta-oxidation;osteoblast differentiation;estrogen metabolic process;androgen metabolic process;enoyl-CoA hydratase activity;3-hydroxyacyl-CoA dehydrogenase activity;long-chain-enoyl-CoA hydratase activity;3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity;17-beta-hydroxysteroid dehydrogenase (NAD+) activity;very long-chain fatty-acyl-CoA metabolic process;medium-chain fatty-acyl-CoA metabolic process;very long-chain fatty acid metabolic process;Sertoli cell development	3D-structure;Acetylation;Alternative splicing;Deafness;Direct protein sequencing;Disease mutation;Fatty acid metabolism;Isomerase;Lipid metabolism;Lyase;NAD;Oxidoreductase;Peroxisome;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-390918;R-HSA-9033241;R-HSA-9609507;R-HSA-8957322;R-HSA-9033500;R-HSA-192105;R-HSA-193368;R-HSA-194068;R-HSA-2046104;R-HSA-2046106;R-HSA-389887;R-HSA-390247	Metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal lipid metabolism;Peroxisomal protein import;Protein localization;Metabolism of steroids;TYSND1 cleaves peroxisomal proteins;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Bile acid and bile salt metabolism;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;alpha-linolenic acid (ALA) metabolism;Beta-oxidation of pristanoyl-CoA;Beta-oxidation of very long chain fatty acids
PDSS2	positive	SUCLA2	ENSG00000136143	PDSS2	1	PDSS2	1	0.00655000888535318	WBGene00009812;WBGene00016844	WBGene00009812(1)		Mitochondrial DNA depletion syndrome encephalomyopathic form with methylmalonic aciduria;Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	GO:0046872;GO:0000166;GO:0005524;GO:0006099;GO:0005739;GO:0003824;GO:0016874;GO:0005515;GO:0000287;GO:0004775;GO:0070062;GO:0005759;GO:0006104;GO:0042709;GO:0006781;GO:0006105	metal ion binding;nucleotide binding;ATP binding;tricarboxylic acid cycle;mitochondrion;catalytic activity;ligase activity;protein binding;magnesium ion binding;succinate-CoA ligase (ADP-forming) activity;extracellular exosome;mitochondrial matrix;succinyl-CoA metabolic process;succinate-CoA ligase complex;succinyl-CoA pathway;succinate metabolic process	3D-structure;ATP-binding;Acetylation;Alternative splicing;Disease mutation;Ligase;Magnesium;Metal-binding;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Primary mitochondrial disease;Reference proteome;Transit peptide;Tricarboxylic acid cycle	R-HSA-1430728;R-HSA-1428517;R-HSA-71406;R-HSA-71403	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Pyruvate metabolism and Citric Acid (TCA) cycle;Citric acid cycle (TCA cycle)
PDSS2	positive	PPA2	ENSG00000138777	PDSS2	1	PDSS2	1	0.00655000888535318	WBGene00008149	WBGene00008149(1)		Sudden arrhythmic cardiac death after infectious or alcohol trigger;SUDDEN CARDIAC FAILURE ALCOHOL-INDUCED;SUDDEN CARDIAC FAILURE INFANTILE	GO:0005737;GO:0046872;GO:0000287;GO:0016787;GO:0005739;GO:0006470;GO:0004427;GO:0006796;GO:0005759;GO:0006418;GO:0051881;GO:0071344;GO:0004722	magnesium ion binding;cytoplasm;inorganic diphosphatase activity;phosphate-containing compound metabolic process;metal ion binding;hydrolase activity;mitochondrion;protein dephosphorylation;mitochondrial matrix;tRNA aminoacylation for protein translation;regulation of mitochondrial membrane potential;diphosphate metabolic process;protein serine/threonine phosphatase activity	Acetylation;Alternative splicing;Direct protein sequencing;Disease mutation;Hydrolase;Magnesium;Metal-binding;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-392499;R-HSA-1430728;R-HSA-72766;R-HSA-379724;R-HSA-379726;R-HSA-71737	Metabolism of proteins;Metabolism;Translation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Pyrophosphate hydrolysis
PDSS2	positive	HADH	ENSG00000138796	PDSS2	1	PDSS2	1	0.00655000888535318	WBGene00007129;WBGene00010035;WBGene00001157;WBGene00001158;WBGene00019978	WBGene00001158(0);WBGene00001157(0)		Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency;3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency;3-@HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;HYPERINSULINEMIC HYPOGLYCEMIA FAMILIAL 4	GO:0005654;GO:0055114;GO:0016491;GO:0005739;GO:0003857;GO:0006631;GO:0005759;GO:0006629;GO:0070403;GO:0005737;GO:0120162;GO:0006635;GO:0009725;GO:0014823;GO:0032868;GO:0042493;GO:0046676	oxidation-reduction process;oxidoreductase activity;3-hydroxyacyl-CoA dehydrogenase activity;fatty acid metabolic process;nucleoplasm;mitochondrion;NAD+ binding;mitochondrial matrix;lipid metabolic process;cytoplasm;positive regulation of cold-induced thermogenesis;fatty acid beta-oxidation;response to hormone;response to activity;response to insulin;response to drug;negative regulation of insulin secretion	3D-structure;Acetylation;Alternative splicing;Disease mutation;Fatty acid metabolism;Lipid metabolism;Mitochondrion;NAD;Oxidoreductase;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289;R-HSA-77286;R-HSA-77346;R-HSA-77348;R-HSA-77350;R-HSA-77352;R-HSA-77310	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA;Beta oxidation of octanoyl-CoA to hexanoyl-CoA;Beta oxidation of hexanoyl-CoA to butanoyl-CoA;Beta oxidation of butanoyl-CoA to acetyl-CoA;Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA
PDSS2	positive	DFFB	ENSG00000169598	PDSS2	1	PDSS2	1	0.00655000888535318					GO:0005634;GO:0005737;GO:0005730;GO:0016787;GO:0000790;GO:0005829;GO:0006915;GO:0005515;GO:0004518;GO:0004536;GO:0006309;GO:0005654;GO:0019899;GO:0019904;GO:0051260;GO:0042802;GO:0097718;GO:0006308;GO:0030263;GO:0005622;GO:0003677	nucleus;hydrolase activity;cytoplasm;apoptotic process;apoptotic DNA fragmentation;deoxyribonuclease activity;nucleoplasm;nucleolus;nuclear chromatin;cytosol;protein binding;nuclease activity;enzyme binding;protein-containing complex;protein domain specific binding;identical protein binding;disordered domain specific binding;DNA catabolic process;apoptotic chromosome condensation;DNA binding	3D-structure;Alternative splicing;Apoptosis;Cytoplasm;Hydrolase;Nuclease;Nucleus;Polymorphism;Reference proteome	R-HSA-109581;R-HSA-5357801;R-HSA-140342;R-HSA-75153	Apoptosis;Programmed Cell Death;Apoptosis induced DNA fragmentation;Apoptotic execution phase
PDSS2	positive	CREB3L2	ENSG00000182158	PDSS2	1	PDSS2	1	0.00655000888535318	WBGene00016162	WBGene00016162(0);WBGene00000222(0)		Myxofibrosarcoma	GO:0005634;GO:0016020;GO:0016021;GO:0005783;GO:0005654;GO:0005789;GO:0006355;GO:0003677;GO:0003700;GO:0007275;GO:0045944;GO:0051216;GO:0045893;GO:0035497;GO:0030968;GO:0000981;GO:0000790;GO:0006986;GO:0044212;GO:0034976;GO:0002062;GO:0000978;GO:0001228;GO:0006888;GO:0009611;GO:0010628;GO:0010976;GO:0000785;GO:0097038	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;positive regulation of transcription by RNA polymerase II;cAMP response element binding;endoplasmic reticulum unfolded protein response;nucleus;membrane;integral component of membrane;endoplasmic reticulum;nucleoplasm;endoplasmic reticulum membrane;DNA binding;multicellular organism development;cartilage development;positive regulation of transcription, DNA-templated;response to unfolded protein;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;transcription regulatory region DNA binding;response to endoplasmic reticulum stress;chondrocyte differentiation;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;endoplasmic reticulum to Golgi vesicle-mediated transport;response to wounding;positive regulation of gene expression;positive regulation of neuron projection development;chromatin;perinuclear endoplasmic reticulum	Activator;Alternative splicing;Chromosomal rearrangement;DNA-binding;Developmental protein;Endoplasmic reticulum;Glycoprotein;Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;Signal-anchor;Transcription;Transcription regulation;Transmembrane;Transmembrane helix;Ubl conjugation;Unfolded protein response	R-HSA-392499;R-HSA-381119;R-HSA-8874211	Metabolism of proteins;Unfolded Protein Response (UPR);CREB3 factors activate genes
PDSS2	positive	TPK1	ENSG00000196511	PDSS2	1	PDSS2	1	0.00655000888535318	WBGene00014027	WBGene00014027(1)		Childhood encephalopathy due to thiamine pyrophosphokinase deficiency;THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0004788;GO:0030975;GO:0006772;GO:0009229;GO:0005829;GO:0042723	ATP binding;thiamine diphosphokinase activity;thiamine metabolic process;thiamine diphosphate biosynthetic process;thiamine binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;identical protein binding;cytosol;thiamine-containing compound metabolic process	3D-structure;ATP-binding;Alternative splicing;Disease mutation;Kinase;Nucleotide-binding;Reference proteome;Transferase	R-HSA-1430728;R-HSA-196854;R-HSA-196849;R-HSA-196819	Metabolism;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Vitamin B1 (thiamin) metabolism
PDSS2	positive	MAP2K4	ENSG00000065559	PDSS2	1	PDSS2	1	0.00755925640190536	WBGene00003368;WBGene00012162;WBGene00022613;WBGene00004758	WBGene00012162(1);WBGene00003368(1)			GO:0005634;GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0004713;GO:0018108;GO:0005515;GO:0006915;GO:0038095;GO:0005829;GO:0071260;GO:0007165;GO:0023014;GO:0032147;GO:0004708;GO:0008545;GO:0000187;GO:0007254;GO:0007257;GO:0031435;GO:0000165;GO:0001934;GO:0009611;GO:0034393;GO:0043065;GO:0043525;GO:0045740;GO:0051770;GO:0061049;GO:0072709;GO:2000672;GO:0030424;GO:0032839;GO:0043204	ATP binding;protein phosphorylation;protein kinase activity;nucleus;cytoplasm;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;protein tyrosine kinase activity;peptidyl-tyrosine phosphorylation;protein binding;apoptotic process;Fc-epsilon receptor signaling pathway;cytosol;cellular response to mechanical stimulus;signal transduction;regulation of mitotic cell cycle;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;MAP kinase kinase activity;JUN kinase kinase activity;activation of MAPK activity;JNK cascade;activation of JUN kinase activity;mitogen-activated protein kinase kinase kinase binding;MAPK cascade;positive regulation of protein phosphorylation;response to wounding;positive regulation of smooth muscle cell apoptotic process;positive regulation of apoptotic process;positive regulation of neuron apoptotic process;positive regulation of DNA replication;positive regulation of nitric-oxide synthase biosynthetic process;cell growth involved in cardiac muscle cell development;cellular response to sorbitol;negative regulation of motor neuron apoptotic process;axon;dendrite cytoplasm;perikaryon	3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Cytoplasm;Kinase;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Stress response;Transferase;Tyrosine-protein kinase	R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871796;R-HSA-1643685;R-HSA-5663205;R-HSA-1280215;R-HSA-2262752;R-HSA-446652;R-HSA-449147;R-HSA-8953897;R-HSA-9020702;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-975138;R-HSA-975155;R-HSA-2559580;R-HSA-2559583;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-450321;R-HSA-5210891;R-HSA-5339562;R-HSA-975871;R-HSA-5684264	Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;Disease;Infectious disease;Cytokine Signaling in Immune system;Cellular responses to stress;Interleukin-1 family signaling;Signaling by Interleukins;Cellular responses to external stimuli;Interleukin-1 signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Oxidative Stress Induced Senescence;Cellular Senescence;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;MyD88 cascade initiated on plasma membrane;MAP3K8 (TPL2)-dependent MAPK1/3 activation
PDSS2	positive	ETFB	ENSG00000105379	PDSS2	1	PDSS2	1	0.00755925640190536	WBGene00017734	WBGene00017734(1)		Multiple acyl-CoA dehydrogenase deficiency mild type;Multiple acyl-CoA dehydrogenase deficiency severe neonatal type;glutaric aciduria type 2B;MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY	GO:0055114;GO:0005739;GO:0005759;GO:0005515;GO:0009055;GO:0033539;GO:0022904;GO:0022900	electron transfer activity;oxidation-reduction process;mitochondrion;mitochondrial matrix;protein binding;fatty acid beta-oxidation using acyl-CoA dehydrogenase;respiratory electron transport chain;electron transport chain	3D-structure;Acetylation;Alternative splicing;Disease mutation;Electron transport;Glutaricaciduria;Methylation;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Transport	R-HSA-392499;R-HSA-597592;R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-8876725	Metabolism of proteins;Post-translational protein modification;Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Protein methylation
PDSS2	positive	PCYOX1	ENSG00000116005	PDSS2	1	PDSS2	1	0.00755925640190536					GO:0055114;GO:0001735;GO:0016670;GO:0030328;GO:0016491;GO:1902476;GO:0005764;GO:0070062;GO:0034361;GO:0030327;GO:0008555;GO:0006821;GO:0005886	oxidation-reduction process;oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor;prenylcysteine catabolic process;prenylcysteine oxidase activity;oxidoreductase activity;chloride transmembrane transport;lysosome;extracellular exosome;very-low-density lipoprotein particle;prenylated protein catabolic process;ATPase-coupled chloride transmembrane transporter activity;chloride transport;plasma membrane	Alternative splicing;Direct protein sequencing;FAD;Flavoprotein;Glycoprotein;Lysosome;Oxidoreductase;Polymorphism;Reference proteome;Signal		
PDSS2	positive	ECHS1	ENSG00000127884	PDSS2	1	PDSS2	1	0.00755925640190536	WBGene00001155;WBGene00001156	WBGene00001156(1);WBGene00001155(1)		Leigh syndrome with leukodystrophy;MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY	GO:0005739;GO:0003824;GO:0016829;GO:0005759;GO:0006629;GO:0006631;GO:0005515;GO:0006635;GO:0004300;GO:0016853	catalytic activity;mitochondrion;lyase activity;mitochondrial matrix;lipid metabolic process;fatty acid metabolic process;protein binding;fatty acid beta-oxidation;enoyl-CoA hydratase activity	3D-structure;Acetylation;Direct protein sequencing;Disease mutation;Fatty acid metabolism;Lipid metabolism;Lyase;Mitochondrion;Neurodegeneration;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289;R-HSA-77286;R-HSA-77346;R-HSA-77348;R-HSA-77350;R-HSA-77352;R-HSA-77310	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA;Beta oxidation of octanoyl-CoA to hexanoyl-CoA;Beta oxidation of hexanoyl-CoA to butanoyl-CoA;Beta oxidation of butanoyl-CoA to acetyl-CoA;Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA
PDSS2	positive	IVD	ENSG00000128928	PDSS2	1	PDSS2	1	0.00755925640190536	WBGene00015326	WBGene00015326(1)		ISOVALERIC ACIDEMIA;ISOVALERIC ACIDEMIA;ISOVALERIC ACIDEMIA	GO:0050660;GO:0055114;GO:0016627;GO:0003995;GO:0005654;GO:0016491;GO:0005739;GO:0005759;GO:0009083;GO:0033539;GO:0008470;GO:0006552	flavin adenine dinucleotide binding;oxidation-reduction process;oxidoreductase activity, acting on the CH-CH group of donors;acyl-CoA dehydrogenase activity;nucleoplasm;oxidoreductase activity;mitochondrion;mitochondrial matrix;identical protein binding;branched-chain amino acid catabolic process;fatty acid beta-oxidation using acyl-CoA dehydrogenase;butyryl-CoA dehydrogenase activity;isovaleryl-CoA dehydrogenase activity;leucine catabolic process;mitochondrial membrane	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Disease mutation;FAD;Fatty acid metabolism;Flavoprotein;Lipid metabolism;Mitochondrion;Oxidoreductase;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-70895	Metabolism;Metabolism of amino acids and derivatives;Branched-chain amino acid catabolism
PDSS2	positive	XPA	ENSG00000136936	PDSS2	1	PDSS2	1	0.00755925640190536	WBGene00006963	WBGene00006963(1)		Xeroderma pigmentosum;Xeroderma pigmentosum group A;XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP A	GO:0005634;GO:0003684;GO:0006289;GO:0046872;GO:0003677;GO:0045171;GO:0042803;GO:0005515;GO:0006281;GO:0006974;GO:0005654;GO:0006284;GO:0019904;GO:0006283;GO:0005662;GO:0006293;GO:0006295;GO:0006296;GO:0033683;GO:0070911;GO:0070914;GO:0000110;GO:0000717;GO:0006294;GO:0000715;GO:0006979;GO:0008630;GO:0009411;GO:0009636;GO:0009650;GO:0010506;GO:0010996;GO:0034504;GO:0035264;GO:1901255;GO:0005737	nucleus;damaged DNA binding;nucleotide-excision repair;metal ion binding;nucleoplasm;DNA binding;intercellular bridge;protein homodimerization activity;protein binding;DNA repair;cellular response to DNA damage stimulus;base-excision repair;protein domain specific binding;transcription-coupled nucleotide-excision repair;DNA replication factor A complex;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;global genome nucleotide-excision repair;UV-damage excision repair;nucleotide-excision repair factor 1 complex;nucleotide-excision repair, DNA duplex unwinding;nucleotide-excision repair, preincision complex assembly;nucleotide-excision repair, DNA damage recognition;response to oxidative stress;intrinsic apoptotic signaling pathway in response to DNA damage;response to UV;response to toxic substance;UV protection;regulation of autophagy;response to auditory stimulus;protein localization to nucleus;multicellular organism growth;positive regulation of transcription initiation from RNA polymerase II promoter;nucleotide-excision repair involved in interstrand cross-link repair;cytoplasm	3D-structure;Acetylation;DNA damage;DNA repair;DNA-binding;Disease mutation;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Xeroderma pigmentosum;Zinc;Zinc-finger	R-HSA-73894;R-HSA-5696398;R-HSA-6781823;R-HSA-6781827;R-HSA-6782135;R-HSA-5696395;R-HSA-5696399;R-HSA-5696400	DNA Repair;Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Formation of Incision Complex in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER
PDSS2	positive	AGL	ENSG00000162688	PDSS2	1	PDSS2	1	0.00755925640190536	WBGene00011050	WBGene00011050(1)		Glycogen storage disease due to glycogen debranching enzyme deficiency;Glycogen Storage Disease Type III;GLYCOGEN STORAGE DISEASE III	GO:0005737;GO:0016740;GO:0016787;GO:0003824;GO:0016757;GO:0008152;GO:0016798;GO:0005978;GO:0005576;GO:0005515;GO:0004134;GO:0004135;GO:0005980;GO:0005829;GO:0043312;GO:0034774;GO:1904813;GO:0004133;GO:0102500;GO:0043033;GO:0030246;GO:0030247;GO:0031593;GO:0005977;GO:0007584;GO:0009725;GO:0051384;GO:0005634;GO:0016234;GO:0016529	catalytic activity;glycogen biosynthetic process;4-alpha-glucanotransferase activity;amylo-alpha-1,6-glucosidase activity;glycogen catabolic process;cytoplasm;transferase activity;hydrolase activity;transferase activity, transferring glycosyl groups;metabolic process;hydrolase activity, acting on glycosyl bonds;extracellular region;protein binding;cytosol;neutrophil degranulation;secretory granule lumen;ficolin-1-rich granule lumen;glycogen debranching enzyme activity;beta-maltose 4-alpha-glucanotransferase activity;isoamylase complex;carbohydrate binding;polysaccharide binding;polyubiquitin modification-dependent protein binding;glycogen metabolic process;response to nutrient;response to hormone;response to glucocorticoid;nucleus;inclusion body;sarcoplasmic reticulum	Alternative splicing;Cytoplasm;Direct protein sequencing;Disease mutation;Glycogen biosynthesis;Glycogen storage disease;Glycosidase;Glycosyltransferase;Hydrolase;Multifunctional enzyme;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-71387;R-HSA-6798695;R-HSA-70221;R-HSA-8982491	Innate Immune System;Immune System;Metabolism;Metabolism of carbohydrates;Neutrophil degranulation;Glycogen breakdown (glycogenolysis);Glycogen metabolism
PDSS2	positive	TMED10	ENSG00000170348	PDSS2	1	PDSS2	1	0.00755925640190536	WBGene00009829	WBGene00009829(1)			GO:0016020;GO:0016021;GO:0006886;GO:0015031;GO:0005794;GO:0005783;GO:0005789;GO:0005886;GO:0005515;GO:0042470;GO:0031410;GO:0044877;GO:0001822;GO:0007030;GO:0043279;GO:0045055;GO:0048199;GO:0051259;GO:0005793;GO:0005801;GO:0030137;GO:0030667;GO:0042589;GO:0043231;GO:0070765;GO:0016192;GO:0006888;GO:0030134;GO:0006890;GO:0019905;GO:0030140;GO:0000139;GO:0030133;GO:0048208;GO:0012507;GO:0033116;GO:0030658;GO:0035459;GO:0035964;GO:0048205;GO:1902003	cell;membrane;integral component of membrane;intracellular protein transport;protein transport;Golgi apparatus;endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;protein binding;melanosome;cytoplasmic vesicle;protein-containing complex binding;kidney development;Golgi organization;response to alkaloid;regulated exocytosis;vesicle targeting, to, from or within Golgi;endoplasmic reticulum-Golgi intermediate compartment;cis-Golgi network;COPI-coated vesicle;secretory granule membrane;zymogen granule membrane;intracellular membrane-bounded organelle;gamma-secretase complex;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;vesicle-mediated transport;endoplasmic reticulum to Golgi vesicle-mediated transport;COPII-coated ER to Golgi transport vesicle;syntaxin binding;trans-Golgi network transport vesicle;Golgi membrane;transport vesicle;COPII vesicle coating;endoplasmic reticulum-Golgi intermediate compartment membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;vesicle cargo loading;COPI-coated vesicle budding;COPI coating of Golgi vesicle;regulation of amyloid-beta formation	Cell membrane;Cytoplasmic vesicle;Direct protein sequencing;ER-Golgi transport;Endoplasmic reticulum;Glycoprotein;Golgi apparatus;Membrane;Methylation;Polymorphism;Protein transport;Reference proteome;Signal;Transmembrane;Transmembrane helix;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-446203;R-HSA-199977;R-HSA-6807878;R-HSA-948021;R-HSA-204005;R-HSA-5694530	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;COPII-mediated vesicle transport;Cargo concentration in the ER
PDSS2	positive	B4GAT1	ENSG00000174684	PDSS2	1	PDSS2	1	0.00755925640190536	WBGene00017723;WBGene00009032;WBGene00011779;WBGene00008290;WBGene00008491;WBGene00010167;WBGene00010694;WBGene00015982	WBGene00008491(0)		Walker-Warburg syndrome;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 13	GO:0016020;GO:0016021;GO:0046872;GO:0016740;GO:0016757;GO:0005794;GO:0005515;GO:0000139;GO:0006486;GO:0015020;GO:0070062;GO:0035269;GO:0030173;GO:0018146;GO:0006493	membrane;integral component of membrane;metal ion binding;transferase activity;transferase activity, transferring glycosyl groups;Golgi apparatus;protein binding;protein glycosylation;Golgi membrane;glucuronosyltransferase activity;extracellular exosome;protein O-linked mannosylation;integral component of Golgi membrane;keratan sulfate biosynthetic process;protein O-linked glycosylation	Congenital muscular dystrophy;Disease mutation;Dystroglycanopathy;Glycoprotein;Glycosyltransferase;Golgi apparatus;Lissencephaly;Manganese;Membrane;Metal-binding;Polymorphism;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-1430728;R-HSA-1643685;R-HSA-3781865;R-HSA-3906995;R-HSA-5173105;R-HSA-71387;R-HSA-1630316;R-HSA-1638074;R-HSA-2022854;R-HSA-5083627	Metabolism of proteins;Post-translational protein modification;Metabolism;Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;O-linked glycosylation;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Defective LARGE causes MDDGA6 and MDDGB6
PDSS2	positive	RPE	ENSG00000197713	PDSS2	1	PDSS2	1	0.00755925640190536	WBGene00017272	WBGene00017272(0)			GO:0046872;GO:0016853;GO:0003824;GO:0005975;GO:0042803;GO:0042802;GO:0005829;GO:0006098;GO:0070062;GO:0016857;GO:0004750;GO:0009052;GO:0019323;GO:0044262	racemase and epimerase activity, acting on carbohydrates and derivatives;carbohydrate metabolic process;catalytic activity;pentose-phosphate shunt;ribulose-phosphate 3-epimerase activity;metal ion binding;isomerase activity;protein homodimerization activity;cytosol;identical protein binding;extracellular exosome;pentose-phosphate shunt, non-oxidative branch;pentose catabolic process;cellular carbohydrate metabolic process	3D-structure;Acetylation;Alternative splicing;Carbohydrate metabolism;Cobalt;Iron;Isomerase;Manganese;Metal-binding;Reference proteome;Zinc	R-HSA-1430728;R-HSA-71387;R-HSA-71336	Metabolism;Metabolism of carbohydrates;Pentose phosphate pathway
PDSS2	positive	NFATC3	ENSG00000072736	PDSS2	1	PDSS2	1	0.00870302060408768			CTSD;TFF1		GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:1905064;GO:0005634;GO:0005737;GO:0005515;GO:0007275;GO:0038095;GO:0044798;GO:0000978;GO:0045944;GO:0000981;GO:0000790;GO:0008134;GO:0005667;GO:0001228;GO:0003682;GO:0006954;GO:0006366;GO:0006357;GO:1902894;GO:0001227;GO:0001816;GO:0033173;GO:0045893	DNA binding;regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleoplasm;cytosol;negative regulation of vascular smooth muscle cell differentiation;nucleus;cytoplasm;protein binding;multicellular organism development;Fc-epsilon receptor signaling pathway;nuclear transcription factor complex;RNA polymerase II cis-regulatory region sequence-specific DNA binding;positive regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;transcription factor binding;transcription factor complex;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;inflammatory response;transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;DNA-binding transcription repressor activity, RNA polymerase II-specific;cytokine production;calcineurin-NFAT signaling cascade;positive regulation of transcription, DNA-templated	3D-structure;Acetylation;Activator;Alternative splicing;Cytoplasm;DNA-binding;Developmental protein;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871809;R-HSA-983705;R-HSA-1168372;R-HSA-5607764;R-HSA-5621481;R-HSA-5607763;R-HSA-2025928	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Signaling by the B Cell Receptor (BCR);Downstream signaling events of B Cell Receptor (BCR);CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);CLEC7A (Dectin-1) induces NFAT activation;Calcineurin activates NFAT
PDSS2	positive	MTHFD1	ENSG00000100714	PDSS2	1	PDSS2	1	0.00870302060408768	WBGene00019492;WBGene00000929			Cervical spina bifida aperta;Cervical spina bifida cystica;Cervicothoracic spina bifida aperta;Cervicothoracic spina bifida cystica;Lumbosacral spina bifida aperta;Lumbosacral spina bifida cystica;Thoracolumbosacral spina bifida aperta;Thoracolumbosacral spina bifida cystica;Total spina bifida aperta;Total spina bifida cystica;Upper thoracic spina bifida aperta;Upper thoracic spina bifida cystica;COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUTHYPERHOMOCYSTEINEMIA;Neural tube defects folate-sensitive	GO:0005524;GO:0005829;GO:0055114;GO:0003824;GO:0004488;GO:0004329;GO:0005737;GO:0016020;GO:0000166;GO:0016491;GO:0016787;GO:0006730;GO:0016874;GO:0005515;GO:0008152;GO:0008652;GO:0006164;GO:0035999;GO:0070062;GO:0005739;GO:0001843;GO:0007507;GO:0046655;GO:0004477;GO:0004486;GO:0004487;GO:0000105;GO:0006555;GO:0009069;GO:0009070;GO:0009086;GO:0009113;GO:0009257;GO:0048702;GO:0048703;GO:0061053;GO:0001780;GO:0019346	ATP binding;oxidation-reduction process;catalytic activity;formate-tetrahydrofolate ligase activity;methylenetetrahydrofolate dehydrogenase (NADP+) activity;cytosol;cytoplasm;membrane;nucleotide binding;oxidoreductase activity;hydrolase activity;one-carbon metabolic process;ligase activity;protein binding;metabolic process;cellular amino acid biosynthetic process;purine nucleotide biosynthetic process;tetrahydrofolate interconversion;extracellular exosome;mitochondrion;neural tube closure;heart development;purine nucleobase biosynthetic process;folic acid metabolic process;methenyltetrahydrofolate cyclohydrolase activity;methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity;methylenetetrahydrofolate dehydrogenase (NAD+) activity;histidine biosynthetic process;methionine metabolic process;serine family amino acid metabolic process;serine family amino acid biosynthetic process;methionine biosynthetic process;10-formyltetrahydrofolate biosynthetic process;embryonic neurocranium morphogenesis;embryonic viscerocranium morphogenesis;somite development;neutrophil homeostasis;transsulfuration	3D-structure;ATP-binding;Acetylation;Amino-acid biosynthesis;Cytoplasm;Direct protein sequencing;Disease mutation;Histidine biosynthesis;Hydrolase;Ligase;Methionine biosynthesis;Multifunctional enzyme;NADP;Nucleotide-binding;One-carbon metabolism;Oxidoreductase;Phosphoprotein;Polymorphism;Purine biosynthesis;Reference proteome	R-HSA-1430728;R-HSA-196854;R-HSA-196849;R-HSA-196757	Metabolism;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Metabolism of folate and pterines
PDSS2	positive	DHRS7B	ENSG00000109016	PDSS2	1	PDSS2	1	0.00870302060408768	WBGene00000993;WBGene00219274;WBGene00016350;WBGene00020810	WBGene00000993(0);WBGene00219274(0);WBGene00000975(0);WBGene00011424(0);WBGene00000981(0);WBGene00000970(0);WBGene00008986(0);WBGene00008985(0);WBGene00022809(0)			GO:0016020;GO:0016021;GO:0016491;GO:0055114;GO:0005783;GO:0005789;GO:0003674;GO:0008150;GO:0008611;GO:0030223	membrane;integral component of membrane;oxidoreductase activity;oxidation-reduction process;endoplasmic reticulum;endoplasmic reticulum membrane;molecular_function;biological_process;ether lipid biosynthetic process;neutrophil differentiation	Endoplasmic reticulum;Membrane;NAD;NADP;Oxidoreductase;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-556833;R-HSA-75896;R-HSA-8848584	Metabolism;Metabolism of lipids;Plasmalogen biosynthesis;Wax and plasmalogen biosynthesis
PDSS2	positive	ABCD3	ENSG00000117528	PDSS2	1	PDSS2	1	0.00870302060408768	WBGene00004059;WBGene00004058;WBGene00004060;WBGene00004061	WBGene00004058(1);WBGene00004059(1)		BILE ACID SYNTHESIS DEFECT CONGENITAL 5	GO:0016020;GO:0016021;GO:0043231;GO:0055085;GO:0000166;GO:0005524;GO:0006633;GO:0042803;GO:0005515;GO:0005777;GO:0016887;GO:0042626;GO:0005778;GO:0015910;GO:0005829;GO:0007031;GO:0005782;GO:0006635;GO:0005324;GO:0043621;GO:0014070;GO:0042493;GO:0042760;GO:0005739	integral component of membrane;ATP binding;transmembrane transport;protein homodimerization activity;peroxisome;ATPase-coupled transmembrane transporter activity;ATPase activity;long-chain fatty acid transporter activity;long-chain fatty acid import into peroxisome;membrane;intracellular membrane-bounded organelle;nucleotide binding;fatty acid biosynthetic process;protein binding;peroxisomal membrane;cytosol;peroxisome organization;peroxisomal matrix;fatty acid beta-oxidation;protein self-association;response to organic cyclic compound;response to drug;very long-chain fatty acid catabolic process;mitochondrion	ATP-binding;Acetylation;Alternative splicing;Glycoprotein;Membrane;Nucleotide-binding;Peroxisome;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-382556;R-HSA-9609507;R-HSA-9603798;R-HSA-1369062	Transport of small molecules;ABC-family proteins mediated transport;Protein localization;Class I peroxisomal membrane protein import;ABC transporters in lipid homeostasis
PDSS2	positive	HAT1	ENSG00000128708	PDSS2	1	PDSS2	1	0.00870302060408768	WBGene00044069	WBGene00044069(1)			GO:0006325;GO:0005634;GO:0005737;GO:0043231;GO:0016740;GO:0005654;GO:0016746;GO:0000790;GO:0005515;GO:0042393;GO:0004402;GO:0016573;GO:0032991;GO:0000784;GO:0043967;GO:0016363;GO:0010485;GO:0006323;GO:0006335;GO:0006336;GO:0006348;GO:0006475;GO:0007584	chromatin organization;nucleus;histone acetyltransferase activity;histone acetylation;histone binding;chromatin silencing at telomere;cytoplasm;transferase activity;nucleoplasm;transferase activity, transferring acyl groups;nuclear chromatin;protein binding;protein-containing complex;nuclear chromosome, telomeric region;histone H4 acetylation;nuclear matrix;H4 histone acetyltransferase activity;DNA packaging;DNA replication-dependent nucleosome assembly;DNA replication-independent nucleosome assembly;internal protein amino acid acetylation;response to nutrient	3D-structure;Acetylation;Acyltransferase;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transferase	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
PDSS2	positive	BBS4	ENSG00000140463	PDSS2	1	PDSS2	1	0.00870302060408768	WBGene00043992			Bardet-Biedl syndrome;BARDET-BIEDL SYNDROME TYPE 4;BARDET-BIEDL SYNDROME 4	GO:0005737;GO:0016020;GO:0015031;GO:0005829;GO:0031514;GO:0005886;GO:0005856;GO:0042995;GO:0005515;GO:0050896;GO:0005813;GO:0005815;GO:0005634;GO:0000226;GO:0001764;GO:0001843;GO:0001895;GO:0003085;GO:0007286;GO:0007608;GO:0008104;GO:0010629;GO:0016358;GO:0019216;GO:0021591;GO:0021756;GO:0021766;GO:0021987;GO:0030534;GO:0030837;GO:0033210;GO:0033365;GO:0034260;GO:0035176;GO:0035845;GO:0038108;GO:0040018;GO:0044321;GO:0045444;GO:0045494;GO:0045724;GO:0046548;GO:0048854;GO:0051492;GO:0060271;GO:0060296;GO:0060324;GO:0060613;GO:0071539;GO:1902855;GO:1903546;GO:1905515;GO:0001750;GO:0001917;GO:0032391;GO:0034451;GO:0034464;GO:0005929;GO:0030030;GO:0007601;GO:0060170;GO:0007098;GO:0035869;GO:0061512;GO:0001947;GO:0000242;GO:0003777;GO:0097730;GO:0034452;GO:0043014;GO:0000281;GO:0034454;GO:0005814;GO:0036064;GO:0001103;GO:0032402;GO:0050893;GO:0048487;GO:0032465;GO:0046907;GO:0051457;GO:0016021	protein binding;cell;cytoplasm;membrane;protein transport;cytosol;motile cilium;cytoskeleton;plasma membrane;cell projection;response to stimulus;centrosome;microtubule organizing center;nucleus;microtubule cytoskeleton organization;neuron migration;neural tube closure;retina homeostasis;negative regulation of systemic arterial blood pressure;spermatid development;sensory perception of smell;protein localization;negative regulation of gene expression;dendrite development;regulation of lipid metabolic process;ventricular system development;striatum development;hippocampus development;cerebral cortex development;adult behavior;negative regulation of actin filament polymerization;leptin-mediated signaling pathway;protein localization to organelle;negative regulation of GTPase activity;social behavior;photoreceptor cell outer segment organization;negative regulation of appetite by leptin-mediated signaling pathway;positive regulation of multicellular organism growth;response to leptin;fat cell differentiation;photoreceptor cell maintenance;positive regulation of cilium assembly;retinal rod cell development;brain morphogenesis;regulation of stress fiber assembly;cilium assembly;regulation of cilium beat frequency involved in ciliary motility;face development;fat pad development;protein localization to centrosome;regulation of non-motile cilium assembly;protein localization to photoreceptor outer segment;non-motile cilium assembly;photoreceptor outer segment;photoreceptor inner segment;photoreceptor connecting cilium;centriolar satellite;BBSome;cilium;cell projection organization;visual perception;ciliary membrane;centrosome cycle;ciliary transition zone;protein localization to cilium;heart looping;pericentriolar material;microtubule motor activity;non-motile cilium;dynactin binding;alpha-tubulin binding;mitotic cytokinesis;microtubule anchoring at centrosome;centriole;ciliary basal body;RNA polymerase II repressing transcription factor binding;melanosome transport;sensory processing;beta-tubulin binding;regulation of cytokinesis;intracellular transport;maintenance of protein location in nucleus;integral component of membrane	Alternative splicing;Bardet-Biedl syndrome;Cell membrane;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Disease mutation;Flagellum;Membrane;Mental retardation;Obesity;Polymorphism;Protein transport;Reference proteome;Repeat;Sensory transduction;TPR repeat;Transport;Vision	R-HSA-1852241;R-HSA-5617833;R-HSA-5620920;R-HSA-5620922	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
PDSS2	positive	CAMK2G	ENSG00000148660	PDSS2	1	PDSS2	1	0.00870302060408768	WBGene00006779;WBGene00000553				GO:0016020;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005515;GO:0007275;GO:0006470;GO:0030154;GO:0004683;GO:0005516;GO:0042802;GO:0005737;GO:0007399;GO:0043005;GO:0005654;GO:0005829;GO:0016529;GO:1900034;GO:0042803;GO:0030666;GO:0051924;GO:0033017;GO:0060333;GO:0030073;GO:0004723;GO:0014733;GO:0005954;GO:0000082;GO:0006816;GO:0046777;GO:1901897;GO:0014069	ATP binding;protein phosphorylation;protein kinase activity;calmodulin binding;calmodulin-dependent protein kinase activity;membrane;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;protein binding;multicellular organism development;protein dephosphorylation;cell differentiation;identical protein binding;cytoplasm;nervous system development;neuron projection;nucleoplasm;cytosol;sarcoplasmic reticulum;regulation of cellular response to heat;protein homodimerization activity;endocytic vesicle membrane;regulation of calcium ion transport;sarcoplasmic reticulum membrane;interferon-gamma-mediated signaling pathway;insulin secretion;regulation of neuron projection development;calcium-dependent protein serine/threonine phosphatase activity;regulation of skeletal muscle adaptation;calcium- and calmodulin-dependent protein kinase complex;G1/S transition of mitotic cell cycle;calcium ion transport;protein autophosphorylation;regulation of relaxation of cardiac muscle;postsynaptic density	3D-structure;ATP-binding;Alternative splicing;Calmodulin-binding;Developmental protein;Differentiation;Kinase;Membrane;Mental retardation;Neurogenesis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Sarcoplasmic reticulum;Serine/threonine-protein kinase;Transferase	R-HSA-168256;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-382551;R-HSA-162582;R-HSA-983712;R-HSA-372790;R-HSA-388396;R-HSA-1643685;R-HSA-1280215;R-HSA-2262752;R-HSA-449147;R-HSA-449836;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-8953897;R-HSA-9006925;R-HSA-9607240;R-HSA-418594;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-438064;R-HSA-442755;R-HSA-9609736;R-HSA-3371556;R-HSA-913531;R-HSA-111885;R-HSA-112040;R-HSA-112043;R-HSA-8986944;R-HSA-397014;R-HSA-5576891;R-HSA-5578775;R-HSA-936837;R-HSA-6802952;R-HSA-6802957;R-HSA-5576892;R-HSA-877300;R-HSA-442742;R-HSA-442982;R-HSA-9022692;R-HSA-438066;R-HSA-9617324;R-HSA-9620244;R-HSA-111933;R-HSA-111996;R-HSA-111997;R-HSA-1489509;R-HSA-6802949;R-HSA-399719;R-HSA-399721;R-HSA-5673000;R-HSA-6802946;R-HSA-6802955;R-HSA-3371571;R-HSA-111932;R-HSA-442729	Immune System;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transport of small molecules;Signal Transduction;Ion channel transport;Signaling by GPCR;GPCR downstream signalling;Disease;Cytokine Signaling in Immune system;Cellular responses to stress;Signaling by Interleukins;Other interleukin signaling;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Cellular responses to external stimuli;Intracellular signaling by second messengers;FLT3 Signaling;G alpha (i) signalling events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Assembly and cell surface presentation of NMDA receptors;Cellular response to heat stress;Interferon Signaling;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Transcriptional Regulation by MECP2;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Phase 0 - rapid depolarisation;Interferon gamma signaling;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Ras activation upon Ca2+ influx through NMDA receptor;Regulation of MECP2 expression and activity;Unblocking of NMDA receptors, glutamate binding and activation;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Calmodulin induced events;Ca-dependent events;CaM pathway;DAG and IP3 signaling;Signaling by RAS mutants;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;RAF activation;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;HSF1-dependent transactivation;CaMK IV-mediated phosphorylation of CREB;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
PDSS2	positive	DBI	ENSG00000155368	PDSS2	1	PDSS2	1	0.00870302060408768	WBGene00016655;WBGene00009818;WBGene00012457	WBGene00016655(0)			GO:0005783;GO:0005794;GO:0000062;GO:0008289;GO:0070062;GO:0006637;GO:0005788;GO:0046983;GO:0030156;GO:0036042;GO:0036151	fatty-acyl-CoA binding;endoplasmic reticulum;Golgi apparatus;identical protein binding;lipid binding;extracellular exosome;acyl-CoA metabolic process;endoplasmic reticulum lumen;positive regulation of phospholipid transport;benzodiazepine receptor binding;long-chain fatty acyl-CoA binding;phosphatidylcholine acyl-chain remodeling;negative regulation of protein lipidation;positive regulation of CoA-transferase activity;protein-lipid complex	3D-structure;Acetylation;Alternative promoter usage;Alternative splicing;Direct protein sequencing;Endoplasmic reticulum;Golgi apparatus;Lipid-binding;Phosphoprotein;Polymorphism;Reference proteome;Transport	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation
PDSS2	positive	AIFM1	ENSG00000156709	PDSS2	1	PDSS2	1	0.00870302060408768	WBGene00006937	WBGene00006937(1)		Severe X-linked mitochondrial encephalomyopathy;Spondyloepimetaphyseal dysplasia Bieganski type;X-linked Charcot-Marie-Tooth disease type 4;X-linked hereditary sensory and autonomic neuropathy with deafness;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6;COWCHOCK SYNDROME;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6;COWCHOCK SYNDROME;Deafness X-linked 5	GO:0050660;GO:0055114;GO:0046983;GO:0016491;GO:0005634;GO:0005737;GO:0016020;GO:0005743;GO:0003677;GO:0005739;GO:0005829;GO:0005515;GO:0006915;GO:0048471;GO:0005758;GO:0043065;GO:0030261;GO:0006919;GO:0070059;GO:0016174;GO:0016651;GO:0071949;GO:0002931;GO:0009636;GO:0010942;GO:0043525;GO:0051402;GO:0070301;GO:0071392;GO:0071732;GO:0090650;GO:1902065;GO:1902510;GO:1904045	flavin adenine dinucleotide binding;oxidation-reduction process;oxidoreductase activity;protein dimerization activity;nucleus;cytoplasm;membrane;mitochondrial inner membrane;DNA binding;mitochondrion;cytosol;protein binding;apoptotic process;perinuclear region of cytoplasm;mitochondrial intermembrane space;positive regulation of apoptotic process;chromosome condensation;FAD binding;activation of cysteine-type endopeptidase activity involved in apoptotic process;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;NAD(P)H oxidase activity;oxidoreductase activity, acting on NAD(P)H;mitochondrial respiratory chain complex assembly;protein import into mitochondrial intermembrane space;response to ischemia;response to toxic substance;positive regulation of cell death;positive regulation of neuron apoptotic process;neuron apoptotic process;cellular response to hydrogen peroxide;cellular response to estradiol stimulus;cellular response to nitric oxide;cellular response to oxygen-glucose deprivation;response to L-glutamate;regulation of apoptotic DNA fragmentation;cellular response to aldosterone	3D-structure;Acetylation;Alternative splicing;Apoptosis;Charcot-Marie-Tooth disease;Cytoplasm;DNA-binding;Deafness;Direct protein sequencing;Disease mutation;FAD;Flavoprotein;Isopeptide bond;Membrane;Mental retardation;Mitochondrion;Mitochondrion inner membrane;NAD;Neurodegeneration;Neuropathy;Nucleus;Oxidoreductase;Phosphoprotein;Primary mitochondrial disease;Reference proteome;Transit peptide;Ubl conjugation		
PDSS2	positive	NFU1	ENSG00000169599	PDSS2	1	PDSS2	1	0.00870302060408768	WBGene00003064	WBGene00003064(1)		Multiple mitochondrial dysfunctions syndrome type 1;Multiple mitochondrial dysfunctions syndrome 1;Multiple mitochondrial dysfunctions syndrome 1	GO:0005634;GO:0005737;GO:0046872;GO:0005829;GO:0005654;GO:0005739;GO:0005506;GO:0005515;GO:0051536;GO:0051539;GO:0016226;GO:0097428	iron-sulfur cluster binding;iron ion binding;iron-sulfur cluster assembly;nucleus;cytoplasm;metal ion binding;nucleoplasm;cytosol;mitochondrion;protein binding;4 iron, 4 sulfur cluster binding;protein maturation by iron-sulfur cluster transfer	3D-structure;Alternative splicing;Cytoplasm;Disease mutation;Iron;Iron-sulfur;Metal-binding;Mitochondrion;Polymorphism;Primary mitochondrial disease;Reference proteome;Transit peptide		
PDSS2	positive	MPHOSPH9	ENSG00000051825	PDSS2	1	PDSS2	1	0.00999579640792003					GO:0005737;GO:0016020;GO:0005794;GO:0005856;GO:0000139;GO:0005814	cytoplasm;membrane;Golgi apparatus;cytoskeleton;Golgi membrane;centriole	Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Reference proteome		
PDSS2	positive	RPA3	ENSG00000106399	PDSS2	1	PDSS2	1	0.00999579640792003					GO:0005634;GO:0003677;GO:0006281;GO:0005515;GO:0006310;GO:0006974;GO:0006260;GO:0006298;GO:0005654;GO:0007346;GO:0042127;GO:1900034;GO:0036297;GO:0003697;GO:0006284;GO:1901796;GO:0000082;GO:0000724;GO:0019985;GO:0006283;GO:0003684;GO:0005662;GO:0042276;GO:0006289;GO:0035861;GO:0000723;GO:0042769;GO:0006293;GO:0006295;GO:0006296;GO:0033683;GO:0006294;GO:0032201;GO:0006297;GO:0070987	DNA binding;nucleus;DNA repair;DNA replication;DNA recombination;protein binding;cellular response to DNA damage stimulus;mismatch repair;nucleoplasm;regulation of mitotic cell cycle;regulation of cell population proliferation;regulation of cellular response to heat;interstrand cross-link repair;base-excision repair;single-stranded DNA binding;regulation of signal transduction by p53 class mediator;G1/S transition of mitotic cell cycle;double-strand break repair via homologous recombination;translesion synthesis;transcription-coupled nucleotide-excision repair;damaged DNA binding;DNA replication factor A complex;error-prone translesion synthesis;nucleotide-excision repair;site of double-strand break;telomere maintenance;DNA damage response, detection of DNA damage;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;nucleotide-excision repair, preincision complex assembly;telomere maintenance via semi-conservative replication;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis	3D-structure;Acetylation;DNA damage;DNA recombination;DNA repair;DNA replication;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-6783310;R-HSA-73894;R-HSA-2262752;R-HSA-69002;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-8953897;R-HSA-3371453;R-HSA-3371556;R-HSA-73886;R-HSA-5633007;R-HSA-453279;R-HSA-69206;R-HSA-6804756;R-HSA-176187;R-HSA-68962;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-912446;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5685938;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-3371511;R-HSA-5696395;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174417;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-110320;R-HSA-5696397;R-HSA-174414;R-HSA-174437;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Fanconi Anemia Pathway;DNA Repair;Cellular responses to stress;DNA Replication Pre-Initiation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Chromosome Maintenance;Regulation of TP53 Activity;Mitotic G1 phase and G1/S transition;G1/S Transition;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Meiotic recombination;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through Single Strand Annealing (SSA);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;HSF1 activation;Formation of Incision Complex in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
PDSS2	positive	DCPS	ENSG00000110063	PDSS2	1	PDSS2	1	0.00999579640792003	WBGene00000940	WBGene00000940(1)		Autosomal recessive non-syndromic intellectual disability;AL-RAQAD SYNDROME	GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0016787;GO:0005739;GO:0090503;GO:0000290;GO:0000932;GO:0000288;GO:0005515;GO:0000340;GO:0043928;GO:0045292;GO:0050072;GO:0043069;GO:0004532;GO:0036245	hydrolase activity;deadenylation-dependent decapping of nuclear-transcribed mRNA;mRNA processing;RNA splicing;nucleus;cytoplasm;nucleoplasm;cytosol;mitochondrion;RNA phosphodiester bond hydrolysis, exonucleolytic;protein binding;P-body;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;RNA 7-methylguanosine cap binding;exonucleolytic catabolism of deadenylated mRNA;mRNA cis splicing, via spliceosome;m7G(5')pppN diphosphatase activity;negative regulation of programmed cell death;exoribonuclease activity;cellular response to menadione	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Disease mutation;Hydrolase;Mental retardation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-429914;R-HSA-429958	Metabolism of RNA;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease
PDSS2	positive	HBS1L	ENSG00000112339	PDSS2	1	PDSS2	1	0.00999579640792003	WBGene00010622	WBGene00010622(0)			GO:0016020;GO:0006412;GO:0000166;GO:0003924;GO:0005525;GO:0005515;GO:0003746;GO:0006414;GO:0005829;GO:0070062;GO:0007165;GO:0043928;GO:0016021	GTP binding;GTPase activity;membrane;translation;nucleotide binding;protein binding;translation elongation factor activity;translational elongation;cytosol;extracellular exosome;signal transduction;exonucleolytic catabolism of deadenylated mRNA;integral component of membrane	3D-structure;Acetylation;Alternative splicing;Elongation factor;GTP-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome	R-HSA-8953854;R-HSA-429914;R-HSA-429958	Metabolism of RNA;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease
PDSS2	positive	CUTC	ENSG00000119929	PDSS2	1	PDSS2	1	0.00999579640792003	WBGene00022702	WBGene00022702(1)			GO:0005634;GO:0005737;GO:0046872;GO:0005730;GO:0005829;GO:0005654;GO:0005515;GO:0005507;GO:0055070;GO:0006825;GO:0051262	copper ion binding;copper ion homeostasis;nucleus;cytoplasm;metal ion binding;nucleoplasm;nucleolus;cytosol;protein binding;copper ion transport;protein tetramerization	3D-structure;Copper;Cytoplasm;Metal-binding;Nucleus;Polymorphism;Reference proteome	R-HSA-382551;R-HSA-983712;R-HSA-936837	Transport of small molecules;Ion channel transport;Ion transport by P-type ATPases
PDSS2	positive	TEX2	ENSG00000136478	PDSS2	1	PDSS2	1	0.00999579640792003	WBGene00018872	WBGene00018872(0)			GO:0016020;GO:0016021;GO:0007165;GO:0008289;GO:0006869;GO:0006665;GO:0005783;GO:0003674	lipid binding;membrane;integral component of membrane;signal transduction;lipid transport;sphingolipid metabolic process;endoplasmic reticulum;molecular_function	Alternative splicing;Endoplasmic reticulum;Glycoprotein;Lipid transport;Lipid-binding;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport		
PDSS2	positive	VPS45	ENSG00000136631	PDSS2	1	PDSS2	1	0.00999579640792003	WBGene00016643	WBGene00016643(0)		Congenital neutropenia-myelofibrosis-nephromegaly syndrome;NEUTROPENIA SEVERE CONGENITAL 5 AUTOSOMAL RECESSIVE	GO:0016192;GO:0006904;GO:0016020;GO:0006886;GO:0015031;GO:0005794;GO:0005515;GO:0000139;GO:0005768;GO:0003674;GO:0005575;GO:0010008;GO:0007596;GO:0016021;GO:0008021	vesicle-mediated transport;vesicle docking involved in exocytosis;membrane;intracellular protein transport;protein transport;endosome;Golgi apparatus;protein binding;Golgi membrane;molecular_function;cellular_component;endosome membrane;blood coagulation;integral component of membrane;synaptic vesicle	Alternative splicing;Disease mutation;Endosome;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transport	R-HSA-109582;R-HSA-5653656;R-HSA-199991;R-HSA-6811442;R-HSA-983231;R-HSA-6811438	Hemostasis;Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Factors involved in megakaryocyte development and platelet production;Intra-Golgi traffic
PDSS2	positive	DYNC2LI1	ENSG00000138036	PDSS2	1	PDSS2	1	0.00999579640792003	WBGene00006960	WBGene00006960(1)		ELLIS-VAN CREVELD SYNDROME;Jeune syndrome;SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY	GO:0045177;GO:0005737;GO:0003774;GO:0005856;GO:0042995;GO:0005515;GO:0007275;GO:0005874;GO:0005868;GO:0005813;GO:0005815;GO:0030286;GO:0005929;GO:0036064;GO:0035735;GO:0097542;GO:0030030;GO:0035869;GO:1902017;GO:0035721;GO:0045504;GO:0005930;GO:0031514;GO:0005881;GO:0008569;GO:0030990;GO:0007368;GO:0060271	cytoplasmic dynein complex;intraciliary transport involved in cilium assembly;intraciliary retrograde transport;apical part of cell;cytoplasm;motor activity;cytoskeleton;cell projection;protein binding;multicellular organism development;microtubule;dynein complex;centrosome;microtubule organizing center;cilium;ciliary basal body;ciliary tip;cell projection organization;ciliary transition zone;regulation of cilium assembly;dynein heavy chain binding;axoneme;motile cilium;cytoplasmic microtubule;ATP-dependent microtubule motor activity, minus-end-directed;intraciliary transport particle;determination of left/right symmetry;cilium assembly	3D-structure;Alternative splicing;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Developmental protein;Disease mutation;Dynein;Microtubule;Motor protein;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-5620924	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
PDSS2	positive	WDR61	ENSG00000140395	PDSS2	1	PDSS2	1	0.00999579640792003	WBGene00008533				GO:0005515;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0016055;GO:0016567;GO:0045944;GO:0032968;GO:0006366;GO:0006368;GO:0045638;GO:0043928;GO:0080182;GO:0035327;GO:0051571;GO:0016593;GO:0055087;GO:2001162	protein binding;nucleus;cytoplasm;nucleoplasm;cytosol;Wnt signaling pathway;protein ubiquitination;positive regulation of transcription by RNA polymerase II;positive regulation of transcription elongation from RNA polymerase II promoter;transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;negative regulation of myeloid cell differentiation;exonucleolytic catabolism of deadenylated mRNA;histone H3-K4 trimethylation;transcriptionally active chromatin;positive regulation of histone H3-K4 methylation;Cdc73/Paf1 complex;Ski complex;positive regulation of histone H3-K79 methylation	3D-structure;Acetylation;Cytoplasm;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;WD repeat;Wnt signaling pathway	R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866654;R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-429914;R-HSA-112382;R-HSA-674695;R-HSA-75955;R-HSA-429958	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Deadenylation-dependent mRNA decay;Formation of RNA Pol II elongation complex ;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription Elongation;mRNA decay by 3' to 5' exoribonuclease
PDSS2	positive	PLPBP	ENSG00000147471	PDSS2	1	PDSS2	1	0.00999579640792003	WBGene00017286;WBGene00017285	WBGene00017285(0);WBGene00017286(1)		Pyridoxine-dependent epilepsy;Vitamin-B6-Dependent Epilepsy;EPILEPSY EARLY-ONSET VITAMIN B6-DEPENDENT	GO:0005737;GO:0030170;GO:0008150;GO:0005622	pyridoxal phosphate binding;cytoplasm;cytosol;biological_process;intracellular	Disease mutation;Epilepsy;Phosphoprotein;Polymorphism;Pyridoxal phosphate;Reference proteome		
PDSS2	positive	CDK19	ENSG00000155111	PDSS2	1	PDSS2	1	0.00999579640792003	WBGene00000409				GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0051726;GO:0005634;GO:0005829;GO:0016592;GO:0004693;GO:0008353;GO:0043065;GO:0050729;GO:0071222	ATP binding;protein phosphorylation;protein kinase activity;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;regulation of cell cycle;nucleus;cytosol;mediator complex;cyclin-dependent protein serine/threonine kinase activity;RNA polymerase II CTD heptapeptide repeat kinase activity;positive regulation of apoptotic process;positive regulation of inflammatory response;cellular response to lipopolysaccharide	ATP-binding;Acetylation;Alternative splicing;Kinase;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-1266738;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206	Developmental Biology;Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha
PDSS2	negative	SPHK1	ENSG00000176170	PDSS2	1	PDSS2	1	0.000521536925128352	WBGene00007918	WBGene00020398(0);WBGene00007918(0)			GO:0005737;GO:0005634;GO:0016020;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0043066;GO:0005829;GO:0005886;GO:0003951;GO:0005515;GO:0000287;GO:0030054;GO:0045202;GO:0046834;GO:0005905;GO:0008289;GO:0005768;GO:0003376;GO:0005516;GO:0010800;GO:0031901;GO:0010008;GO:0030335;GO:0031398;GO:0006457;GO:0007165;GO:0051092;GO:1901224;GO:0003677;GO:0030307;GO:0035556;GO:0030148;GO:0045766;GO:0035924;GO:0034612;GO:0019722;GO:0030139;GO:0006473;GO:1900745;GO:0050764;GO:0045931;GO:0038036;GO:0030100;GO:0045987;GO:0150077;GO:0016407;GO:0032740;GO:0098793;GO:0046512;GO:0048146;GO:0051721;GO:0010803;GO:0006670;GO:0008481;GO:0017050;GO:0046521;GO:1900060;GO:1903978;GO:1905364;GO:0008284;GO:0045840;GO:0006954;GO:0001568;GO:0007420;GO:0032651;GO:0070301;GO:0071897;GO:0090520	kinase activity;NAD+ kinase activity;cytoplasm;nucleus;membrane;nucleotide binding;ATP binding;transferase activity;phosphorylation;negative regulation of apoptotic process;cytosol;plasma membrane;endosome;protein binding;cell junction;lipid phosphorylation;magnesium ion binding;lipid binding;clathrin-coated pit;synapse;sphingosine-1-phosphate receptor signaling pathway;calmodulin binding;regulation of endocytosis;positive regulation of peptidyl-threonine phosphorylation;early endosome membrane;endosome membrane;positive regulation of cell migration;positive regulation of protein ubiquitination;protein folding;positive regulation of NF-kappaB transcription factor activity;positive regulation of NIK/NF-kappaB signaling;DNA binding;positive regulation of cell growth;intracellular signal transduction;sphingosine metabolic process;sphingolipid biosynthetic process;positive regulation of angiogenesis;cellular response to vascular endothelial growth factor stimulus;response to tumor necrosis factor;calcium-mediated signaling;presynapse;endocytic vesicle;protein acetylation;positive regulation of p38MAPK cascade;regulation of phagocytosis;positive regulation of mitotic cell cycle;sphingosine-1-phosphate receptor activity;positive regulation of smooth muscle contraction;regulation of neuroinflammatory response;acetyltransferase activity;positive regulation of interleukin-17 production;sphingosine biosynthetic process;positive regulation of fibroblast proliferation;protein phosphatase 2A binding;regulation of tumor necrosis factor-mediated signaling pathway;sphinganine kinase activity;D-erythro-sphingosine kinase activity;sphingoid catabolic process;negative regulation of ceramide biosynthetic process;regulation of microglial cell activation;regulation of endosomal vesicle fusion;blood vessel development;inflammatory response;brain development;positive regulation of cell population proliferation;regulation of interleukin-1 beta production;positive regulation of mitotic nuclear division;cellular response to hydrogen peroxide;DNA biosynthetic process;sphingolipid mediated signaling pathway	3D-structure;ATP-binding;Alternative splicing;Calmodulin-binding;Cell junction;Cell membrane;Coated pit;Cytoplasm;Endosome;Kinase;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Synapse;Transferase	R-HSA-392499;R-HSA-1430728;R-HSA-428157;R-HSA-556833;R-HSA-162582;R-HSA-390466;R-HSA-391251;R-HSA-9006934;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-194138;R-HSA-4420097;R-HSA-390471;R-HSA-1660661;R-HSA-5218921	Metabolism of proteins;Metabolism;Sphingolipid metabolism;Metabolism of lipids;Signal Transduction;Chaperonin-mediated protein folding;Protein folding;Signaling by Receptor Tyrosine Kinases;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Signaling by VEGF;VEGFA-VEGFR2 Pathway;Association of TriC/CCT with target proteins during biosynthesis;Sphingolipid de novo biosynthesis;VEGFR2 mediated cell proliferation
PDSS2	negative	SOCS1	ENSG00000185338	PDSS2	1	PDSS2	1	0.000521536925128352	WBGene00009556				GO:0005634;GO:0005737;GO:0005654;GO:0016567;GO:0035556;GO:0005515;GO:0043551;GO:0031410;GO:0036464;GO:0046426;GO:0005829;GO:0019901;GO:0040008;GO:0006469;GO:0046854;GO:0046935;GO:0005942;GO:0019221;GO:0005159;GO:0009968;GO:0038111;GO:0004860;GO:0042532;GO:0060334;GO:0001932;GO:0043372;GO:0043377;GO:0019210;GO:0033673;GO:0045591;GO:0046627;GO:0007259;GO:0010533;GO:0042509;GO:0045444;GO:0046425;GO:0050707;GO:0071230	cytoplasm;intracellular signal transduction;negative regulation of receptor signaling pathway via JAK-STAT;regulation of interferon-gamma-mediated signaling pathway;nucleus;nucleoplasm;protein ubiquitination;protein binding;regulation of phosphatidylinositol 3-kinase activity;cytoplasmic vesicle;cytoplasmic ribonucleoprotein granule;cytosol;protein kinase binding;regulation of growth;negative regulation of protein kinase activity;phosphatidylinositol phosphorylation;1-phosphatidylinositol-3-kinase regulator activity;phosphatidylinositol 3-kinase complex;cytokine-mediated signaling pathway;insulin-like growth factor receptor binding;negative regulation of signal transduction;interleukin-7-mediated signaling pathway;protein kinase inhibitor activity;negative regulation of tyrosine phosphorylation of STAT protein;regulation of protein phosphorylation;positive regulation of CD4-positive, alpha-beta T cell differentiation;negative regulation of CD8-positive, alpha-beta T cell differentiation;kinase inhibitor activity;negative regulation of kinase activity;positive regulation of regulatory T cell differentiation;negative regulation of insulin receptor signaling pathway;receptor signaling pathway via JAK-STAT;regulation of activation of Janus kinase activity;regulation of tyrosine phosphorylation of STAT protein;fat cell differentiation;regulation of receptor signaling pathway via JAK-STAT;regulation of cytokine secretion;cellular response to amino acid stimulus	Cytoplasmic vesicle;Growth regulation;Nucleus;Polymorphism;Reference proteome;SH2 domain;Signal transduction inhibitor;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-983168;R-HSA-983169;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-9006934;R-HSA-913531;R-HSA-166016;R-HSA-166058;R-HSA-168179;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-1266695;R-HSA-1433557;R-HSA-6785807;R-HSA-877300;R-HSA-1433559;R-HSA-982772;R-HSA-877312;R-HSA-909733;R-HSA-912694	Adaptive Immune System;Innate Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Interferon Signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Interleukin-7 signaling;Signaling by SCF-KIT;Interleukin-4 and Interleukin-13 signaling;Interferon gamma signaling;Regulation of KIT signaling;Growth hormone receptor signaling;Regulation of IFNG signaling;Interferon alpha/beta signaling;Regulation of IFNA signaling
PDSS2	negative	MAP3K8	ENSG00000107968	PDSS2	1	PDSS2	1	0.000808245976771538				LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED	GO:0005737;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0000287;GO:0007165;GO:0005515;GO:0007049;GO:0004709;GO:0002376;GO:0000186;GO:0070498;GO:0023014;GO:0032147;GO:0051403;GO:0031295	ATP binding;magnesium ion binding;signal transduction;cytoplasm;protein phosphorylation;protein kinase activity;MAP kinase kinase kinase activity;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;cytosol;protein binding;cell cycle;immune system process;activation of MAPKK activity;interleukin-1-mediated signaling pathway;regulation of mitotic cell cycle;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;stress-activated MAPK cascade;T cell costimulation;MAPK cascade	3D-structure;ATP-binding;Alternative initiation;Cell cycle;Cytoplasm;Immunity;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-388841;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-9020702;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-975138;R-HSA-975155;R-HSA-389356;R-HSA-389357;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-975871;R-HSA-5684264	Adaptive Immune System;Innate Immune System;Immune System;Costimulation by the CD28 family;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;MyD88 cascade initiated on plasma membrane;MAP3K8 (TPL2)-dependent MAPK1/3 activation
PDSS2	negative	SAT1	ENSG00000130066	PDSS2	1	PDSS2	1	0.00100061415634123	WBGene00008408	WBGene00008408(1)		Keratosis follicularis spinulosa decalvans	GO:0004145;GO:0005515;GO:0008080;GO:0005737;GO:0016740;GO:0016746;GO:0042802;GO:0005829;GO:0019809;GO:0006595;GO:0006598;GO:0032918;GO:0042127;GO:0001525;GO:0005622;GO:0006596;GO:0009447	protein binding;diamine N-acetyltransferase activity;N-acetyltransferase activity;cytoplasm;transferase activity;transferase activity, transferring acyl groups;cytosol;identical protein binding;spermidine binding;polyamine metabolic process;polyamine catabolic process;spermidine acetylation;regulation of cell population proliferation;angiogenesis;intracellular;polyamine biosynthetic process;putrescine catabolic process	3D-structure;Acyltransferase;Cytoplasm;Direct protein sequencing;Reference proteome;Transferase	R-HSA-1430728;R-HSA-71291;R-HSA-351202;R-HSA-351200	Metabolism;Metabolism of amino acids and derivatives;Metabolism of polyamines;Interconversion of polyamines
PDSS2	negative	CDKN1A	ENSG00000124762	PDSS2	1	PDSS2	1	0.00123421211449537				Multiple endocrine neoplasia type 1	GO:1904706;GO:0008285;GO:0005634;GO:0048146;GO:0005737;GO:0046872;GO:0016301;GO:0016310;GO:0005654;GO:0005515;GO:0007049;GO:0016604;GO:0007050;GO:0004860;GO:0004861;GO:0007346;GO:0072331;GO:0006977;GO:0005829;GO:0031625;GO:0032991;GO:0006367;GO:0000082;GO:0019221;GO:0005730;GO:0007507;GO:0030308;GO:0071493;GO:0000079;GO:0034198;GO:0006357;GO:2000379;GO:0007265;GO:0090398;GO:0006974;GO:0071479;GO:0050821;GO:0000307;GO:0070557;GO:0019901;GO:0044877;GO:0019912;GO:0030332;GO:0000086;GO:0031668;GO:0042326;GO:0045860;GO:0071850;GO:0090400;GO:0097193;GO:1904030;GO:1904031;GO:1905179;GO:2000134;GO:0006606;GO:0006978;GO:0009411;GO:0009636;GO:0010033;GO:0010165;GO:0010243;GO:0010629;GO:0010942;GO:0014070;GO:0030890;GO:0031100;GO:0034605;GO:0042246;GO:0042493;GO:0042771;GO:0043066;GO:0043068;GO:0045736;GO:0046685;GO:0051384;GO:0051412;GO:0051726;GO:0055093;GO:0060574;GO:0071480;GO:0090399;GO:2000278;GO:0048471	nucleus;cyclin-dependent protein serine/threonine kinase inhibitor activity;cell cycle arrest;regulation of mitotic cell cycle;signal transduction by p53 class mediator;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell population proliferation;positive regulation of fibroblast proliferation;cytoplasm;metal ion binding;kinase activity;phosphorylation;nucleoplasm;protein binding;cell cycle;nuclear body;protein kinase inhibitor activity;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cytosol;ubiquitin protein ligase binding;protein-containing complex;transcription initiation from RNA polymerase II promoter;G1/S transition of mitotic cell cycle;cytokine-mediated signaling pathway;mitotic G2 DNA damage checkpoint;nucleolus;heart development;negative regulation of protein binding;negative regulation of cell growth;cellular response to UV-B;regulation of cyclin-dependent protein serine/threonine kinase activity;cellular response to amino acid starvation;regulation of transcription by RNA polymerase II;positive regulation of reactive oxygen species metabolic process;Ras protein signal transduction;cellular senescence;cellular response to DNA damage stimulus;cellular response to ionizing radiation;protein stabilization;cyclin-dependent protein kinase holoenzyme complex;PCNA-p21 complex;protein kinase binding;protein-containing complex binding;cyclin-dependent protein kinase activating kinase activity;cyclin binding;protein sequestering activity;G2/M transition of mitotic cell cycle;cellular response to extracellular stimulus;negative regulation of phosphorylation;positive regulation of protein kinase activity;mitotic cell cycle arrest;stress-induced premature senescence;intrinsic apoptotic signaling pathway;regulation of cell cycle G1/S phase transition;negative regulation of cyclin-dependent protein kinase activity;positive regulation of cyclin-dependent protein kinase activity;negative regulation of cardiac muscle tissue regeneration;negative regulation of G1/S transition of mitotic cell cycle;negative regulation of DNA biosynthetic process;protein import into nucleus;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;response to UV;response to toxic substance;response to organic substance;response to X-ray;response to organonitrogen compound;negative regulation of gene expression;positive regulation of cell death;response to organic cyclic compound;positive regulation of B cell proliferation;animal organ regeneration;cellular response to heat;tissue regeneration;response to drug;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;negative regulation of apoptotic process;positive regulation of programmed cell death;negative regulation of cyclin-dependent protein serine/threonine kinase activity;response to arsenic-containing substance;response to glucocorticoid;response to corticosterone;regulation of cell cycle;response to hyperoxia;intestinal epithelial cell maturation;cellular response to gamma radiation;replicative senescence;regulation of DNA biosynthetic process;perinuclear region of cytoplasm	3D-structure;Acetylation;Cell cycle;Cytoplasm;Direct protein sequencing;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Protein kinase inhibitor;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	R-HSA-168256;R-HSA-1266738;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-6804116;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1640170;R-HSA-1643685;R-HSA-1257604;R-HSA-1280215;R-HSA-2262752;R-HSA-449147;R-HSA-453274;R-HSA-5663202;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69563;R-HSA-69580;R-HSA-69615;R-HSA-69620;R-HSA-8852276;R-HSA-8878166;R-HSA-8953897;R-HSA-9006925;R-HSA-2219528;R-HSA-5674400;R-HSA-9614085;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-2559583;R-HSA-6785807;R-HSA-69231;R-HSA-69236;R-HSA-2559582;R-HSA-9617828;R-HSA-198323;R-HSA-2559586;R-HSA-9616222;R-HSA-8864260;R-HSA-8866911;R-HSA-8941855;R-HSA-69560;R-HSA-69895	Immune System;Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cell Cycle;Disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Cellular responses to stress;Signaling by Interleukins;Mitotic G2-G2/M phases;Diseases of signal transduction;S Phase;G2/M Transition;Cell Cycle, Mitotic;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint;Transcriptional regulation by RUNX2;Cellular responses to external stimuli;Intracellular signaling by second messengers;PI3K/AKT Signaling in Cancer;Constitutive Signaling by AKT1 E17K in Cancer;FOXO-mediated transcription;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Cellular Senescence;Interleukin-4 and Interleukin-13 signaling;Cyclin D associated events in G1;G1 Phase;Senescence-Associated Secretory Phenotype (SASP);FOXO-mediated transcription of cell cycle genes;AKT phosphorylates targets in the cytosol;DNA Damage/Telomere Stress Induced Senescence;Transcriptional regulation of granulopoiesis;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of cell cycle factors;RUNX3 regulates CDKN1A transcription;Transcriptional activation of p53 responsive genes  ;Transcriptional  activation of  cell cycle inhibitor p21 
PDSS2	negative	TIMP1	ENSG00000102265	PDSS2	1	PDSS2	1	0.00151675807860363	WBGene00019478				GO:1901164;GO:0046872;GO:0008270;GO:0008083;GO:0005615;GO:0010951;GO:0005515;GO:0005576;GO:0005581;GO:0005125;GO:0008191;GO:0031012;GO:0030414;GO:0010466;GO:0070062;GO:0044267;GO:0043687;GO:0002020;GO:0008284;GO:0002576;GO:0005788;GO:0031093;GO:0019221;GO:0022617;GO:2001044;GO:0004857;GO:0043086;GO:0010033;GO:0001775;GO:0002248;GO:0007568;GO:0009725;GO:0034097;GO:0042060;GO:0043066;GO:0043434;GO:0051045;GO:0051216;GO:1905049;GO:0005604	protein binding;metalloendopeptidase inhibitor activity;negative regulation of trophoblast cell migration;metal ion binding;zinc ion binding;growth factor activity;extracellular space;negative regulation of endopeptidase activity;extracellular region;collagen trimer;cytokine activity;extracellular matrix;peptidase inhibitor activity;negative regulation of peptidase activity;extracellular exosome;cellular protein metabolic process;post-translational protein modification;protease binding;positive regulation of cell population proliferation;platelet degranulation;endoplasmic reticulum lumen;platelet alpha granule lumen;cytokine-mediated signaling pathway;extracellular matrix disassembly;regulation of integrin-mediated signaling pathway;enzyme inhibitor activity;negative regulation of catalytic activity;response to organic substance;cell activation;connective tissue replacement involved in inflammatory response wound healing;aging;response to hormone;response to cytokine;wound healing;negative regulation of apoptotic process;response to peptide hormone;negative regulation of membrane protein ectodomain proteolysis;cartilage development;negative regulation of metallopeptidase activity;basement membrane	3D-structure;Direct protein sequencing;Disulfide bond;Glycoprotein;Growth factor;Metal-binding;Metalloenzyme inhibitor;Metalloprotease inhibitor;Phosphoprotein;Protease inhibitor;Reference proteome;Secreted;Signal;Zinc	R-HSA-109582;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-1280215;R-HSA-449147;R-HSA-1474228;R-HSA-1474244;R-HSA-76002;R-HSA-76005;R-HSA-114608;R-HSA-381426;R-HSA-8957275;R-HSA-6783783;R-HSA-6785807;R-HSA-1592389	Hemostasis;Immune System;Metabolism of proteins;Post-translational protein modification;Cytokine Signaling in Immune system;Signaling by Interleukins;Degradation of the extracellular matrix;Extracellular matrix organization;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation ;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Activation of Matrix Metalloproteinases
PDSS2	negative	RHEBL1	ENSG00000167550	PDSS2	1	PDSS2	1	0.00151675807860363	WBGene00010038				GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0007165;GO:0003924;GO:0005525;GO:0005515;GO:0005886;GO:0012505;GO:0007264;GO:0051092;GO:0019003;GO:0031929	signal transduction;membrane;GTP binding;GTPase activity;cytoplasm;metal ion binding;nucleotide binding;protein binding;plasma membrane;endomembrane system;small GTPase mediated signal transduction;positive regulation of NF-kappaB transcription factor activity;GDP binding;TOR signaling	3D-structure;Alternative splicing;Cytoplasm;GTP-binding;Lipoprotein;Magnesium;Membrane;Metal-binding;Methylation;Nucleotide-binding;Prenylation;Reference proteome		
PDSS2	negative	TRAF1	ENSG00000056558	PDSS2	1	PDSS2	1	0.00185716112082879	WBGene00022454;WBGene00006612	WBGene00006612(0);WBGene00022454(0)			GO:0008270;GO:0005164;GO:0007165;GO:0042981;GO:0005515;GO:0006915;GO:0042802;GO:0031625;GO:0005829;GO:0005737;GO:0051092;GO:0065003;GO:0031996;GO:0009898;GO:0032991;GO:0035631;GO:0010803;GO:2001236	zinc ion binding;protein binding;signal transduction;regulation of apoptotic process;tumor necrosis factor receptor binding;apoptotic process;identical protein binding;ubiquitin protein ligase binding;cytosol;protein K63-linked ubiquitination;cytoplasm;positive regulation of NF-kappaB transcription factor activity;protein-containing complex assembly;thioesterase binding;tumor necrosis factor-mediated signaling pathway;regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of JNK cascade;cytoplasmic side of plasma membrane;regulation of tumor necrosis factor-mediated signaling pathway;regulation of extrinsic apoptotic signaling pathway	3D-structure;Alternative splicing;Apoptosis;Coiled coil;Isopeptide bond;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-162582;R-HSA-73887;R-HSA-5357905;R-HSA-5357956;R-HSA-75893	Signal Transduction;Death Receptor Signalling;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNF signaling
PDSS2	negative	PPP1R15A	ENSG00000087074	PDSS2	1	PDSS2	1	0.00185716112082879					GO:0016020;GO:0005783;GO:0005789;GO:0005739;GO:0005515;GO:0006915;GO:0005741;GO:0005737;GO:0005829;GO:0019901;GO:0006417;GO:0070059;GO:0005794;GO:0007050;GO:0034976;GO:0006974;GO:0000164;GO:0008157;GO:0019888;GO:0072542;GO:0032058;GO:0032515;GO:0032516;GO:0035308;GO:0036496;GO:0070972;GO:1902310;GO:1903898;GO:1903917	membrane;endoplasmic reticulum;endoplasmic reticulum membrane;mitochondrion;protein binding;apoptotic process;mitochondrial outer membrane;cytoplasm;cytosol;protein kinase binding;regulation of translation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;Golgi apparatus;cell cycle arrest;response to endoplasmic reticulum stress;cellular response to DNA damage stimulus;protein phosphatase regulator activity;protein phosphatase 1 binding;protein phosphatase activator activity;positive regulation of translational initiation in response to stress;negative regulation of phosphoprotein phosphatase activity;positive regulation of phosphoprotein phosphatase activity;negative regulation of protein dephosphorylation;regulation of translational initiation by eIF2 alpha dephosphorylation;protein localization to endoplasmic reticulum;positive regulation of peptidyl-serine dephosphorylation;negative regulation of PERK-mediated unfolded protein response;positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation;protein phosphatase type 1 complex	3D-structure;Alternative splicing;Apoptosis;Endoplasmic reticulum;Membrane;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Stress response;Translation regulation;Ubl conjugation	R-HSA-162582;R-HSA-9006936;R-HSA-170834;R-HSA-2173788;R-HSA-2173789	Signal Transduction;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs
PDSS2	negative	SH2B3	ENSG00000111252	PDSS2	1	PDSS2	1	0.00185716112082879				Essential thrombocythemia;Growth retardation-mild developmental delay-chronic hepatitis syndrome;ERYTHROCYTOSIS FAMILIAL 1;MYELOFIBROSIS MYELOFIBROSIS WITH MYELOID METAPLASIA INCLUDED;THROMBOCYTHEMIA 1	GO:0008285;GO:0051898;GO:0046426;GO:0060761;GO:0042532;GO:0007165;GO:0035591;GO:0009967;GO:0005515;GO:0035556;GO:0005886;GO:0005829;GO:0030097;GO:0007596;GO:0001780;GO:0090331;GO:0005070;GO:0035162;GO:0035855;GO:0038163;GO:1990782;GO:0007169;GO:0005068;GO:1990869;GO:0005173;GO:0030154;GO:0035702;GO:0036016;GO:0043407;GO:0048821;GO:0070100;GO:1900235	signal transduction;hemopoiesis;signaling adaptor activity;negative regulation of tyrosine phosphorylation of STAT protein;negative regulation of cell population proliferation;negative regulation of protein kinase B signaling;negative regulation of receptor signaling pathway via JAK-STAT;negative regulation of response to cytokine stimulus;positive regulation of signal transduction;protein binding;plasma membrane;intracellular signal transduction;cytosol;blood coagulation;neutrophil homeostasis;negative regulation of platelet aggregation;SH3/SH2 adaptor activity;embryonic hemopoiesis;megakaryocyte development;thrombopoietin-mediated signaling pathway;protein tyrosine kinase binding;transmembrane receptor protein tyrosine kinase signaling pathway;transmembrane receptor protein tyrosine kinase adaptor activity;cellular response to chemokine;stem cell factor receptor binding;cell differentiation;monocyte homeostasis;cellular response to interleukin-3;negative regulation of MAP kinase activity;erythrocyte development;negative regulation of chemokine-mediated signaling pathway;negative regulation of Kit signaling pathway	Diabetes mellitus;Phosphoprotein;Polymorphism;Reference proteome;SH2 domain	R-HSA-109582;R-HSA-162582;R-HSA-983231;R-HSA-9006934;R-HSA-1433557;R-HSA-1433559	Hemostasis;Signal Transduction;Factors involved in megakaryocyte development and platelet production;Signaling by Receptor Tyrosine Kinases;Signaling by SCF-KIT;Regulation of KIT signaling
PDSS2	negative	BTG3	ENSG00000154640	PDSS2	1	PDSS2	1	0.00185716112082879					GO:0005515;GO:0005634;GO:0005737;GO:0008285;GO:0045930	protein binding;nucleus;cytoplasm;negative regulation of cell population proliferation;negative regulation of mitotic cell cycle	Alternative splicing;Reference proteome		
PDSS2	negative	SQSTM1	ENSG00000161011	PDSS2	1	PDSS2	1	0.00185716112082879		WBGene00015552(0);WBGene00012067(0);WBGene00021495(0);WBGene00011737(0);WBGene00012516(0)		Amyotrophic lateral sclerosis;Behavioral variant of frontotemporal dementia;Frontotemporal dementia with motor neuron disease;Frontotemporal dementia and/or amyotrophic lateral sclerosis 3;MYOPATHY DISTAL WITH RIMMED VACUOLES;NEURODEGENERATION WITH ATAXIA DYSTONIA AND GAZE PALSY CHILDHOOD-ONSET;PAGET DISEASE OF BONE 3	GO:0008270;GO:0046872;GO:0005634;GO:0005737;GO:0043231;GO:0004674;GO:0005829;GO:0005783;GO:0006468;GO:0005515;GO:0006915;GO:0031410;GO:0006914;GO:0030154;GO:0002376;GO:0005764;GO:0042802;GO:0005768;GO:0005776;GO:0000932;GO:0045944;GO:0005654;GO:0070062;GO:0019901;GO:0061635;GO:0042169;GO:0070498;GO:0016236;GO:0031625;GO:0016197;GO:0005770;GO:0016605;GO:0007032;GO:0043130;GO:0019899;GO:0008104;GO:0035556;GO:0043065;GO:0043066;GO:0030017;GO:0043122;GO:0006511;GO:0005080;GO:0010821;GO:0000423;GO:0000422;GO:1900273;GO:1903078;GO:0007005;GO:0070530;GO:0016234;GO:0046578;GO:0030971;GO:0035255;GO:0042803;GO:0000122;GO:0001934;GO:0002931;GO:0035973;GO:0051291;GO:0061912;GO:0098780;GO:1905719;GO:0000407;GO:0005739;GO:0016235;GO:0044753;GO:0044754;GO:0097225;GO:0097413	zinc ion binding;metal ion binding;protein binding;nucleus;cytoplasm;intracellular membrane-bounded organelle;protein serine/threonine kinase activity;cytosol;endoplasmic reticulum;endosome;protein phosphorylation;apoptotic process;cytoplasmic vesicle;autophagy;cell differentiation;immune system process;lysosome;identical protein binding;autophagosome;P-body;PML body;positive regulation of transcription by RNA polymerase II;nucleoplasm;extracellular exosome;protein kinase binding;regulation of protein complex stability;SH2 domain binding;interleukin-1-mediated signaling pathway;macroautophagy;ubiquitin protein ligase binding;endosomal transport;late endosome;endosome organization;ubiquitin binding;enzyme binding;protein localization;intracellular signal transduction;negative regulation of protein ubiquitination;positive regulation of apoptotic process;negative regulation of apoptotic process;sarcomere;regulation of I-kappaB kinase/NF-kappaB signaling;ubiquitin-dependent protein catabolic process;protein kinase C binding;regulation of mitochondrion organization;mitophagy;aggresome;autophagy of mitochondrion;positive regulation of long-term synaptic potentiation;positive regulation of protein localization to plasma membrane;mitochondrion organization;K63-linked polyubiquitin modification-dependent protein binding;inclusion body;regulation of Ras protein signal transduction;receptor tyrosine kinase binding;ionotropic glutamate receptor binding;protein-containing complex binding;negative regulation of transcription by RNA polymerase II;positive regulation of protein phosphorylation;response to ischemia;aggrephagy;selective autophagy;response to mitochondrial depolarisation;protein localization to perinuclear region of cytoplasm;phagophore assembly site;mitochondrion;amphisome;autolysosome;sperm midpiece;Lewy body	3D-structure;Acetylation;Alternative splicing;Amyotrophic lateral sclerosis;Apoptosis;Autophagy;Cytoplasm;Cytoplasmic vesicle;Differentiation;Direct protein sequencing;Disease mutation;Endoplasmic reticulum;Endosome;Immunity;Isopeptide bond;Lysosome;Metal-binding;Neurodegeneration;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	R-HSA-168256;R-HSA-162582;R-HSA-193704;R-HSA-204998;R-HSA-73887;R-HSA-9612973;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-8953897;R-HSA-9020702;R-HSA-193639;R-HSA-209543;R-HSA-209560;R-HSA-1632852;R-HSA-5205647;R-HSA-5205685;R-HSA-205043	Immune System;Signal Transduction;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Death Receptor Signalling;Autophagy;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;Cellular responses to external stimuli;Interleukin-1 signaling;p75NTR signals via NF-kB;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;NRIF signals cell death from the nucleus
PDSS2	negative	F2R	ENSG00000181104	PDSS2	1	PDSS2	1	0.00185716112082879					GO:0008285;GO:0046427;GO:0006919;GO:0030335;GO:0045893;GO:0005623;GO:0016020;GO:0016021;GO:0004930;GO:0007186;GO:0005886;GO:0005515;GO:0007165;GO:0006954;GO:0045211;GO:0007596;GO:0009986;GO:0001965;GO:0015057;GO:0031681;GO:0007204;GO:0014068;GO:0030194;GO:0032496;GO:0032651;GO:0035025;GO:0045907;GO:0048873;GO:0070374;GO:0070493;GO:0099553;GO:1900134;GO:0005576;GO:0005769;GO:0005887;GO:0043547;GO:0007599;GO:0051928;GO:2000778;GO:0005770;GO:0043123;GO:0008284;GO:0043524;GO:2000484;GO:0005794;GO:0030168;GO:0051482;GO:0009653;GO:0005102;GO:0007205;GO:0031594;GO:0051281;GO:0000186;GO:0005901;GO:0051209;GO:0060155;GO:0009611;GO:0032967;GO:0007200;GO:0043410;GO:0045217;GO:0051930;GO:0002248;GO:0003105;GO:0007529;GO:0030193;GO:0043280;GO:0045987;GO:0031094	G protein-coupled receptor signaling pathway;integral component of membrane;G protein-coupled receptor activity;blood coagulation;thrombin-activated receptor activity;thrombin-activated receptor signaling pathway;negative regulation of cell population proliferation;positive regulation of receptor signaling pathway via JAK-STAT;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of cell migration;cell;positive regulation of transcription, DNA-templated;membrane;plasma membrane;protein binding;signal transduction;synapse;inflammatory response;cell surface;postsynaptic membrane;G-protein alpha-subunit binding;G-protein beta-subunit binding;positive regulation of cytosolic calcium ion concentration;positive regulation of phosphatidylinositol 3-kinase signaling;positive regulation of blood coagulation;response to lipopolysaccharide;regulation of interleukin-1 beta production;positive regulation of Rho protein signal transduction;positive regulation of vasoconstriction;homeostasis of number of cells within a tissue;positive regulation of ERK1 and ERK2 cascade;trans-synaptic signaling by endocannabinoid, modulating synaptic transmission;negative regulation of renin secretion into blood stream;extracellular region;early endosome;integral component of plasma membrane;positive regulation of GTPase activity;hemostasis;positive regulation of calcium ion transport;positive regulation of interleukin-6 secretion;late endosome;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of cell population proliferation;negative regulation of neuron apoptotic process;positive regulation of interleukin-8 secretion;Golgi apparatus;platelet activation;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;anatomical structure morphogenesis;signaling receptor binding;protein kinase C-activating G protein-coupled receptor signaling pathway;neuromuscular junction;positive regulation of release of sequestered calcium ion into cytosol;activation of MAPKK activity;caveola;release of sequestered calcium ion into cytosol;platelet dense granule organization;response to wounding;positive regulation of collagen biosynthetic process;phospholipase C-activating G protein-coupled receptor signaling pathway;positive regulation of MAPK cascade;cell-cell junction maintenance;regulation of sensory perception of pain;connective tissue replacement involved in inflammatory response wound healing;negative regulation of glomerular filtration;establishment of synaptic specificity at neuromuscular junction;regulation of blood coagulation;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of smooth muscle contraction;platelet dense tubular network	3D-structure;Blood coagulation;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Hemostasis;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Signal;Transducer;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-416476;R-HSA-76002;R-HSA-500792;R-HSA-373076;R-HSA-375276;R-HSA-456926;R-HSA-140875;R-HSA-140877	Hemostasis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Thrombin signalling through proteinase activated receptors (PARs);Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade)
PDSS2	negative	TSPYL2	ENSG00000184205	PDSS2	1	PDSS2	1	0.00185716112082879	WBGene00005007	WBGene00005007(0)			GO:0005634;GO:0005737;GO:0006325;GO:0006334;GO:0005515;GO:0007049;GO:0005730;GO:0005654;GO:0030308;GO:0045786;GO:0009966;GO:0036498;GO:0045859;GO:0000182;GO:0008156	nucleus;nucleosome assembly;cytoplasm;chromatin organization;protein binding;cell cycle;nucleolus;nucleoplasm;negative regulation of cell growth;negative regulation of cell cycle;regulation of signal transduction;IRE1-mediated unfolded protein response;regulation of protein kinase activity;rDNA binding;negative regulation of DNA replication	Cell cycle;Chromatin regulator;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-381038;R-HSA-381070;R-HSA-381119	Metabolism of proteins;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
PDSS2	negative	SRC	ENSG00000197122	PDSS2	1	PDSS2	1	0.00185716112082879	WBGene00005077;WBGene00005078			Hereditary thrombocytopenia with early-onset myelofibrosis;Colorectal Cancer;THROMBOCYTOPENIA 6	GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0043066;GO:0005829;GO:0005743;GO:0007155;GO:0004713;GO:0005739;GO:0005886;GO:0005856;GO:0005515;GO:0007049;GO:0004715;GO:0048471;GO:0007229;GO:0002376;GO:0005764;GO:0038096;GO:0050900;GO:0020037;GO:0030154;GO:0007169;GO:0045296;GO:0031234;GO:0070062;GO:0071902;GO:0042169;GO:0002223;GO:0016032;GO:0005770;GO:0007186;GO:0051902;GO:0005102;GO:0044325;GO:0007165;GO:0019899;GO:0005178;GO:0030168;GO:0007411;GO:0014068;GO:0051897;GO:0048013;GO:0046777;GO:0048010;GO:0007179;GO:0043154;GO:2001243;GO:0005070;GO:0038128;GO:0097110;GO:0035556;GO:0032463;GO:0070851;GO:0045453;GO:0007173;GO:0051219;GO:2001237;GO:0010634;GO:0050731;GO:0031295;GO:0019900;GO:0051895;GO:0070555;GO:0016236;GO:0033625;GO:0005901;GO:0035635;GO:2000641;GO:0036035;GO:0010632;GO:0018108;GO:0008022;GO:0042127;GO:0051974;GO:0045124;GO:2000811;GO:0038083;GO:0046875;GO:0007172;GO:0032211;GO:0043114;GO:2000394;GO:0005080;GO:0005158;GO:0019901;GO:0019904;GO:0030331;GO:0031625;GO:0044877;GO:0050839;GO:0070700;GO:0071253;GO:0001545;GO:0008283;GO:0009612;GO:0009615;GO:0010447;GO:0010628;GO:0010641;GO:0010907;GO:0010954;GO:0014911;GO:0016477;GO:0018105;GO:0022407;GO:0030900;GO:0031648;GO:0031667;GO:0031954;GO:0032148;GO:0032869;GO:0033146;GO:0034332;GO:0034446;GO:0034614;GO:0035306;GO:0036120;GO:0042476;GO:0042493;GO:0042542;GO:0043065;GO:0043149;GO:0043393;GO:0043406;GO:0043552;GO:0045056;GO:0045737;GO:0045785;GO:0045892;GO:0045893;GO:0046628;GO:0048011;GO:0048477;GO:0050715;GO:0050847;GO:0051057;GO:0051222;GO:0051385;GO:0051602;GO:0060065;GO:0060444;GO:0060491;GO:0070301;GO:0070374;GO:0070542;GO:0071222;GO:0071375;GO:0071393;GO:0071398;GO:0071456;GO:0071498;GO:0071560;GO:0071803;GO:0086098;GO:0090263;GO:0098609;GO:0098962;GO:1900182;GO:1902533;GO:1903997;GO:2000386;GO:2000573;GO:2000588;GO:2001286;GO:0002102;GO:0005884;GO:0014069;GO:0032587;GO:0043005;GO:0098978;GO:0099091	ATP binding;protein binding;protein phosphorylation;protein kinase activity;protein tyrosine kinase activity;nucleus;cytoplasm;membrane;nucleotide binding;kinase activity;transferase activity;phosphorylation;negative regulation of apoptotic process;cytosol;plasma membrane;mitochondrial inner membrane;cell adhesion;mitochondrion;cytoskeleton;focal adhesion;cell junction;cell cycle;non-membrane spanning protein tyrosine kinase activity;perinuclear region of cytoplasm;integrin-mediated signaling pathway;immune system process;lysosome;Fc-gamma receptor signaling pathway involved in phagocytosis;leukocyte migration;heme binding;cell differentiation;transmembrane receptor protein tyrosine kinase signaling pathway;cadherin binding;extrinsic component of cytoplasmic side of plasma membrane;extracellular exosome;positive regulation of protein serine/threonine kinase activity;SH2 domain binding;stimulatory C-type lectin receptor signaling pathway;viral process;late endosome;G protein-coupled receptor signaling pathway;regulation of cell population proliferation;negative regulation of mitochondrial depolarization;stress fiber assembly;signaling receptor binding;ion channel binding;signal transduction;enzyme binding;focal adhesion assembly;integrin binding;platelet activation;axon guidance;positive regulation of phosphatidylinositol 3-kinase signaling;positive regulation of protein kinase B signaling;ephrin receptor signaling pathway;protein autophosphorylation;vascular endothelial growth factor receptor signaling pathway;transforming growth factor beta receptor signaling pathway;negative regulation of protein-containing complex assembly;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of intrinsic apoptotic signaling pathway;SH3/SH2 adaptor activity;ERBB2 signaling pathway;scaffold protein binding;intracellular signal transduction;growth factor receptor binding;bone resorption;epidermal growth factor receptor signaling pathway;phosphoprotein binding;negative regulation of extrinsic apoptotic signaling pathway;positive regulation of epithelial cell migration;positive regulation of peptidyl-tyrosine phosphorylation;T cell costimulation;kinase binding;negative regulation of focal adhesion assembly;response to interleukin-1;membrane raft;macroautophagy;positive regulation of integrin activation;caveola;entry of bacterium into host cell;regulation of early endosome to late endosome transport;regulation of epithelial cell migration;peptidyl-tyrosine phosphorylation;ATPase binding;protein C-terminus binding;negative regulation of telomerase activity;regulation of bone resorption;negative regulation of anoikis;peptidyl-tyrosine autophosphorylation;ephrin receptor binding;signal complex assembly;negative regulation of telomere maintenance via telomerase;regulation of vascular permeability;positive regulation of lamellipodium morphogenesis;protein kinase C binding;insulin receptor binding;protein kinase binding;protein domain specific binding;estrogen receptor binding;ubiquitin protein ligase binding;protein-containing complex binding;cell adhesion molecule binding;BMP receptor binding;connexin binding;primary ovarian follicle growth;cell population proliferation;response to mechanical stimulus;response to virus;response to acidic pH;positive regulation of gene expression;positive regulation of platelet-derived growth factor receptor signaling pathway;positive regulation of glucose metabolic process;positive regulation of protein processing;positive regulation of smooth muscle cell migration;cell migration;peptidyl-serine phosphorylation;regulation of cell-cell adhesion;forebrain development;protein destabilization;response to nutrient levels;positive regulation of protein autophosphorylation;activation of protein kinase B activity;cellular response to insulin stimulus;regulation of intracellular estrogen receptor signaling pathway;adherens junction organization;substrate adhesion-dependent cell spreading;cellular response to reactive oxygen species;positive regulation of dephosphorylation;osteoclast development;cellular response to platelet-derived growth factor stimulus;odontogenesis;response to drug;response to hydrogen peroxide;positive regulation of apoptotic process;regulation of protein binding;positive regulation of MAP kinase activity;positive regulation of phosphatidylinositol 3-kinase activity;transcytosis;positive regulation of cyclin-dependent protein serine/threonine kinase activity;positive regulation of cell adhesion;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of insulin receptor signaling pathway;neurotrophin TRK receptor signaling pathway;oogenesis;positive regulation of cytokine secretion;progesterone receptor signaling pathway;positive regulation of small GTPase mediated signal transduction;positive regulation of protein transport;response to mineralocorticoid;response to electrical stimulus;uterus development;branching involved in mammary gland duct morphogenesis;regulation of cell projection assembly;cellular response to hydrogen peroxide;positive regulation of ERK1 and ERK2 cascade;response to fatty acid;cellular response to lipopolysaccharide;cellular response to peptide hormone stimulus;cellular response to progesterone stimulus;cellular response to fatty acid;cellular response to hypoxia;cellular response to fluid shear stress;cellular response to transforming growth factor beta stimulus;positive regulation of podosome assembly;angiotensin-activated signaling pathway involved in heart process;positive regulation of canonical Wnt signaling pathway;cell-cell adhesion;regulation of postsynaptic neurotransmitter receptor activity;positive regulation of protein localization to nucleus;positive regulation of intracellular signal transduction;positive regulation of non-membrane spanning protein tyrosine kinase activity;positive regulation of ovarian follicle development;positive regulation of DNA biosynthetic process;positive regulation of platelet-derived growth factor receptor-beta signaling pathway;regulation of caveolin-mediated endocytosis;podosome;actin filament;postsynaptic density;ruffle membrane;neuron projection;glutamatergic synapse;postsynaptic specialization, intracellular component	3D-structure;ATP-binding;Alternative splicing;Cell adhesion;Cell cycle;Cell junction;Cell membrane;Cytoplasm;Cytoskeleton;Disease mutation;Host-virus interaction;Immunity;Kinase;Lipoprotein;Membrane;Mitochondrion;Mitochondrion inner membrane;Myristate;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;SH2 domain;SH3 domain;Transferase;Tyrosine-protein kinase;Ubl conjugation	R-HSA-109582;R-HSA-168256;R-HSA-1266738;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-422475;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-1643685;R-HSA-418555;R-HSA-5663205;R-HSA-1257604;R-HSA-1280215;R-HSA-376176;R-HSA-449147;R-HSA-449836;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-8878166;R-HSA-8878171;R-HSA-9006925;R-HSA-9607240;R-HSA-418594;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-438064;R-HSA-442755;R-HSA-186797;R-HSA-9006934;R-HSA-76002;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-2219528;R-HSA-6802952;R-HSA-6802957;R-HSA-8878159;R-HSA-8941858;R-HSA-199418;R-HSA-2219530;R-HSA-6811558;R-HSA-373752;R-HSA-418885;R-HSA-166520;R-HSA-186763;R-HSA-1227986;R-HSA-1236394;R-HSA-1251985;R-HSA-177929;R-HSA-180292;R-HSA-6806834;R-HSA-8876384;R-HSA-8874081;R-HSA-8875878;R-HSA-8940973;R-HSA-8941326;R-HSA-9620244;R-HSA-354192;R-HSA-76009;R-HSA-9006921;R-HSA-6802949;R-HSA-9006115;R-HSA-5673000;R-HSA-6802946;R-HSA-6802955;R-HSA-8876493;R-HSA-428542;R-HSA-418886;R-HSA-5674135;R-HSA-6802948;R-HSA-9034015;R-HSA-354194;R-HSA-372708;R-HSA-1253288;R-HSA-8934593;R-HSA-9032500;R-HSA-9603381	Hemostasis;Immune System;Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Axon guidance;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Disease;G alpha (s) signalling events;Infectious disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signaling by ROBO receptors;Signaling by Interleukins;Other interleukin signaling;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;Intracellular signaling by second messengers;FLT3 Signaling;G alpha (i) signalling events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases;Platelet activation, signaling and aggregation;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;PI3K/AKT Signaling in Cancer;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Negative regulation of the PI3K/AKT network;Constitutive Signaling by Aberrant PI3K in Cancer;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Netrin-1 signaling;DCC mediated attractive signaling;Signaling by NTRKs;Downstream signal transduction;Signaling by ERBB2;Signaling by ERBB4;Nuclear signaling by ERBB4;Signaling by EGFR;GAB1 signalosome;Signaling by MET;Listeria monocytogenes entry into host cells;MET activates PTK2 signaling;MET promotes cell motility;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Long-term potentiation;Integrin signaling;Platelet Aggregation (Plug Formation);;Signaling by RAS mutants;Signaling by NTRK2 (TRKB);RAF activation;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;InlA-mediated entry of Listeria monocytogenes into host cells;Regulation of commissural axon pathfinding by SLIT and ROBO;Netrin mediated repulsion signals;MAP2K and MAPK activation;Signaling by high-kinase activity BRAF mutants;Signaling by NTRK3 (TRKC);GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Downregulation of ERBB4 signaling;Regulation of RUNX1 Expression and Activity;Activated NTRK2 signals through FYN;Activated NTRK3 signals through PI3K
PDSS2	negative	PRR7	ENSG00000131188	PDSS2	1	PDSS2	1	0.00226565167276316					GO:0016020;GO:0016021;GO:0005634;GO:0005737;GO:0005886;GO:0042995;GO:0048471;GO:0030054;GO:0045202;GO:0045211;GO:0044877;GO:0030217;GO:0031397;GO:0099527;GO:0014069;GO:0043005;GO:0098978;GO:0099092;GO:0002376;GO:0030425;GO:0002250;GO:0005515;GO:0043065;GO:2001269;GO:0044389;GO:0010942;GO:1990782;GO:0036041	membrane;integral component of membrane;nucleus;cytoplasm;plasma membrane;cell projection;perinuclear region of cytoplasm;cell junction;protein-containing complex binding;negative regulation of protein ubiquitination;T cell differentiation in thymus;alpha-beta T cell differentiation;postsynapse to nucleus signaling pathway;postsynaptic density;neuron projection;synapse;glutamatergic synapse;postsynaptic density, intracellular component;postsynaptic membrane;immune system process;dendrite;adaptive immune response;protein binding;postsynaptic density membrane;positive regulation of apoptotic process;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;ubiquitin-like protein ligase binding;positive regulation of cell death;protein tyrosine kinase binding;long-chain fatty acid binding	Adaptive immunity;Alternative splicing;Cell junction;Cell membrane;Cell projection;Cytoplasm;Immunity;Lipoprotein;Membrane;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Postsynaptic cell membrane;Reference proteome;Signal-anchor;Synapse;Transmembrane;Transmembrane helix		
PDSS2	negative	EMP3	ENSG00000142227	PDSS2	1	PDSS2	1	0.00226565167276316					GO:0016020;GO:0016021;GO:0016049;GO:0005886;GO:0005515;GO:0008219;GO:0032060	integral component of membrane;membrane;plasma membrane;protein binding;cell death;bleb assembly	Glycoprotein;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
PDSS2	negative	PPP1R18	ENSG00000146112	PDSS2	1	PDSS2	1	0.00226565167276316					GO:0005737;GO:0003779;GO:0005856;GO:0005515;GO:0019902	phosphatase binding;cytoplasm;actin binding;cytoskeleton;protein binding	Acetylation;Actin-binding;Alternative splicing;Cytoplasm;Cytoskeleton;Phosphoprotein;Polymorphism;Reference proteome		
PDSS2	negative	HLA-G	ENSG00000204632	PDSS2	1	PDSS2	1	0.00226565167276316				ASTHMA SUSCEPTIBILITY TO	GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0042803;GO:0005886;GO:0042995;GO:0005515;GO:0005576;GO:0002376;GO:0006955;GO:0005615;GO:0009897;GO:0050776;GO:0042802;GO:0005768;GO:0005769;GO:0042605;GO:0002474;GO:0042612;GO:0031901;GO:0002479;GO:0005102;GO:0030670;GO:0045953;GO:0032735;GO:0000139;GO:0016525;GO:0060333;GO:0012507;GO:0051898;GO:0060337;GO:0045591;GO:0071556;GO:0006968;GO:0060907;GO:0031527;GO:0002729;GO:2000353;GO:0002480;GO:0042270;GO:0055038;GO:0001916;GO:0002476;GO:0002486;GO:0042610;GO:0050777;GO:0001915;GO:0070207;GO:2000774;GO:0002451;GO:0002645;GO:0002666;GO:0002767;GO:0042130;GO:0070317;GO:2001199;GO:0033106	membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;endosome;protein homodimerization activity;plasma membrane;cell projection;protein binding;extracellular region;immune system process;extracellular space;external side of plasma membrane;regulation of immune response;identical protein binding;early endosome;peptide antigen binding;early endosome membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of peptide antigen via MHC class I;MHC class I protein complex;signaling receptor binding;phagocytic vesicle membrane;negative regulation of natural killer cell mediated cytotoxicity;positive regulation of interleukin-12 production;Golgi membrane;negative regulation of angiogenesis;interferon-gamma-mediated signaling pathway;ER to Golgi transport vesicle membrane;negative regulation of protein kinase B signaling;type I interferon signaling pathway;positive regulation of regulatory T cell differentiation;integral component of lumenal side of endoplasmic reticulum membrane;cellular defense response;positive regulation of macrophage cytokine production;filopodium membrane;positive regulation of natural killer cell cytokine production;positive regulation of endothelial cell apoptotic process;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;protection from natural killer cell mediated cytotoxicity;recycling endosome membrane;negative regulation of immune response;CD8 receptor binding;positive regulation of T cell mediated cytotoxicity;negative regulation of T cell mediated cytotoxicity;antigen processing and presentation of endogenous peptide antigen via MHC class Ib;protein homotrimerization;positive regulation of cellular senescence;peripheral B cell tolerance induction;positive regulation of tolerance induction;positive regulation of T cell tolerance induction;immune response-inhibiting cell surface receptor signaling pathway;negative regulation of T cell proliferation;negative regulation of G0 to G1 transition;negative regulation of dendritic cell differentiation;cis-Golgi network membrane	3D-structure;Alternative splicing;Cell membrane;Cell projection;Disulfide bond;Endoplasmic reticulum;Endosome;Glycoprotein;Immunity;MHC I;Membrane;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix	R-HSA-1280218;R-HSA-168256;R-HSA-198933;R-HSA-983169;R-HSA-1236974;R-HSA-1236975;R-HSA-1280215;R-HSA-913531;R-HSA-877300;R-HSA-909733;R-HSA-983170;R-HSA-1236977	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Class I MHC mediated antigen processing & presentation;ER-Phagosome pathway;Antigen processing-Cross presentation;Cytokine Signaling in Immune system;Interferon Signaling;Interferon gamma signaling;Interferon alpha/beta signaling;Antigen Presentation: Folding, assembly and peptide loading of class I MHC;Endosomal/Vacuolar pathway
PDSS2	negative	DUSP2	ENSG00000158050	PDSS2	1	PDSS2	1	0.00275391584538021					GO:0005634;GO:0016787;GO:0031965;GO:0004721;GO:0006470;GO:0004725;GO:0016311;GO:0035335;GO:0016791;GO:0008138;GO:0017017;GO:0005737;GO:0005515;GO:0000188;GO:0008330;GO:0051019	phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;MAP kinase tyrosine/serine/threonine phosphatase activity;nucleus;nucleoplasm;hydrolase activity;nuclear membrane;phosphoprotein phosphatase activity;peptidyl-tyrosine dephosphorylation;protein binding;cytoplasm;inactivation of MAPK activity;endoderm formation;protein tyrosine/threonine phosphatase activity;mitogen-activated protein kinase binding	3D-structure;Hydrolase;Nucleus;Protein phosphatase;Reference proteome	R-HSA-168256;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-112409;R-HSA-5675221	Immune System;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;RAF-independent MAPK1/3 activation;Negative regulation of MAPK pathway
PDSS2	negative	BAMBI	ENSG00000095739	PDSS2	1	PDSS2	1	0.00333523142055203					GO:0008284;GO:0010718;GO:0005737;GO:0030512;GO:0090263;GO:0008360;GO:0045893;GO:0016020;GO:0016021;GO:0005886;GO:0005109;GO:0032092;GO:0016477;GO:0005114;GO:0007179	negative regulation of transforming growth factor beta receptor signaling pathway;positive regulation of canonical Wnt signaling pathway;positive regulation of cell population proliferation;positive regulation of epithelial to mesenchymal transition;cytoplasm;regulation of cell shape;positive regulation of transcription, DNA-templated;membrane;integral component of membrane;plasma membrane;frizzled binding;positive regulation of protein binding;cell migration;transforming growth factor beta receptor signaling pathway;type II transforming growth factor beta receptor binding	Direct protein sequencing;Glycoprotein;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-9006936;R-HSA-170834;R-HSA-2173788;R-HSA-2173789	Signal Transduction;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs
PDSS2	negative	SDCBP	ENSG00000137575	PDSS2	1	PDSS2	1	0.00333523142055203		WBGene00002999(0)			GO:0005737;GO:0005634;GO:0016020;GO:0016021;GO:0043231;GO:0005829;GO:0005654;GO:0005783;GO:0005789;GO:0035556;GO:0031965;GO:0005615;GO:0005886;GO:0030036;GO:0005856;GO:0005515;GO:0005576;GO:0042470;GO:0030054;GO:0045121;GO:0007268;GO:0005925;GO:0008289;GO:0042802;GO:0006930;GO:0070062;GO:0072562;GO:0030335;GO:0005912;GO:0005546;GO:0043312;GO:0007346;GO:0008284;GO:0032435;GO:0030511;GO:0006612;GO:0047485;GO:0046982;GO:0010862;GO:0048013;GO:0005109;GO:0005137;GO:0008093;GO:0045545;GO:0002091;GO:0010718;GO:0030307;GO:0042327;GO:0046330;GO:1903543;GO:1903553;GO:0005895;GO:0035578;GO:1903561;GO:0008022;GO:0019838;GO:0042043;GO:0042803;GO:0046875;GO:0050839;GO:0007265;GO:0099054	protein binding;chemical synaptic transmission;intracellular signal transduction;actin cytoskeleton organization;cytoplasm;nucleus;membrane;integral component of membrane;nucleoplasm;cytosol;endoplasmic reticulum;endoplasmic reticulum membrane;cytoskeleton;focal adhesion;nuclear membrane;extracellular space;plasma membrane;extracellular region;melanosome;synapse;cell junction;lipid binding;membrane raft;identical protein binding;substrate-dependent cell migration, cell extension;extracellular exosome;blood microparticle;positive regulation of cell migration;adherens junction;phosphatidylinositol-4,5-bisphosphate binding;neutrophil degranulation;regulation of mitotic cell cycle;positive regulation of cell population proliferation;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of transforming growth factor beta receptor signaling pathway;protein targeting to membrane;protein N-terminus binding;protein heterodimerization activity;positive regulation of pathway-restricted SMAD protein phosphorylation;ephrin receptor signaling pathway;frizzled binding;interleukin-5 receptor binding;cytoskeletal adaptor activity;syndecan binding;negative regulation of receptor internalization;positive regulation of epithelial to mesenchymal transition;positive regulation of cell growth;positive regulation of phosphorylation;positive regulation of JNK cascade;positive regulation of exosomal secretion;positive regulation of extracellular exosome assembly;interleukin-5 receptor complex;azurophil granule lumen;extracellular vesicle;protein C-terminus binding;growth factor binding;neurexin family protein binding;protein-containing complex binding;ephrin receptor binding;cell adhesion molecule binding;Ras protein signal transduction;presynapse assembly	3D-structure;Acetylation;Alternative splicing;Cell junction;Cell membrane;Cytoplasm;Cytoskeleton;Direct protein sequencing;Endoplasmic reticulum;Lipid-binding;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Secreted	R-HSA-168249;R-HSA-168256;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-6798695;R-HSA-2682334;R-HSA-3928664;R-HSA-447043	Innate Immune System;Immune System;Developmental Biology;L1CAM interactions;Axon guidance;Neutrophil degranulation;EPH-Ephrin signaling;Ephrin signaling;Neurofascin interactions
PDSS2	negative	CXCL8	ENSG00000169429	PDSS2	1	PDSS2	1	0.00333523142055203					GO:0007165;GO:0005576;GO:0005615;GO:0006955;GO:0006935;GO:0005125;GO:0006954;GO:0008009;GO:0006952;GO:0005153;GO:0030593;GO:0042119;GO:0071222;GO:0005515;GO:0070098;GO:0007050;GO:0071347;GO:0071356;GO:0030155;GO:0007186;GO:0001525;GO:0019221;GO:0034976;GO:0035556;GO:0090023;GO:0008285;GO:0030595;GO:0061844;GO:0044344;GO:0019722;GO:0045744;GO:0050930;GO:0031623;GO:0048566;GO:0045766;GO:0036499;GO:0002237;GO:0045091;GO:2000535	extracellular region;chemotaxis;immune response;defense response;chemokine activity;interleukin-8 receptor binding;neutrophil chemotaxis;neutrophil activation;cellular response to lipopolysaccharide;signal transduction;extracellular space;protein binding;cytokine activity;inflammatory response;chemokine-mediated signaling pathway;cell cycle arrest;cellular response to interleukin-1;cellular response to tumor necrosis factor;regulation of cell adhesion;G protein-coupled receptor signaling pathway;angiogenesis;cytokine-mediated signaling pathway;response to endoplasmic reticulum stress;intracellular signal transduction;positive regulation of neutrophil chemotaxis;negative regulation of cell population proliferation;CXCR chemokine receptor binding;leukocyte chemotaxis;antimicrobial humoral immune response mediated by antimicrobial peptide;cellular response to fibroblast growth factor stimulus;calcium-mediated signaling;negative regulation of G protein-coupled receptor signaling pathway;induction of positive chemotaxis;receptor internalization;embryonic digestive tract development;positive regulation of angiogenesis;PERK-mediated unfolded protein response;response to molecule of bacterial origin;regulation of single stranded viral RNA replication via double stranded DNA intermediate;regulation of entry of bacterium into host cell	3D-structure;Chemotaxis;Citrullination;Cytokine;Direct protein sequencing;Disulfide bond;Inflammatory response;Reference proteome;Secreted;Signal	R-HSA-168256;R-HSA-392499;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-1280215;R-HSA-2262752;R-HSA-449147;R-HSA-8953897;R-HSA-418594;R-HSA-500792;R-HSA-373076;R-HSA-375276;R-HSA-2559583;R-HSA-380108;R-HSA-6783783;R-HSA-6785807;R-HSA-2559582;R-HSA-381119;R-HSA-380994;R-HSA-381042	Immune System;Metabolism of proteins;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Cytokine Signaling in Immune system;Cellular responses to stress;Signaling by Interleukins;Cellular responses to external stimuli;G alpha (i) signalling events;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Cellular Senescence;Chemokine receptors bind chemokines;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Senescence-Associated Secretory Phenotype (SASP);Unfolded Protein Response (UPR);ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression
PDSS2	negative	SERPINB9	ENSG00000170542	PDSS2	1	PDSS2	1	0.00333523142055203	WBGene00005642;WBGene00005647;WBGene00005648;WBGene00005649;WBGene00005643;WBGene00005644				GO:0005634;GO:0005737;GO:0016020;GO:0005615;GO:0005794;GO:0043066;GO:0005829;GO:0005654;GO:0004867;GO:0010951;GO:0005515;GO:0006955;GO:0006915;GO:0043154;GO:0030414;GO:0010466;GO:0070062;GO:0010628;GO:0062023;GO:0002020;GO:0071391;GO:0043027;GO:0009617;GO:0042270;GO:0002448;GO:0033668	extracellular space;serine-type endopeptidase inhibitor activity;nucleus;cytoplasm;membrane;Golgi apparatus;negative regulation of apoptotic process;nucleoplasm;cytosol;negative regulation of endopeptidase activity;protein binding;immune response;apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;peptidase inhibitor activity;negative regulation of peptidase activity;extracellular exosome;positive regulation of gene expression;collagen-containing extracellular matrix;protease binding;cellular response to estrogen stimulus;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;response to bacterium;protection from natural killer cell mediated cytotoxicity;mast cell mediated immunity;negative regulation by symbiont of host apoptotic process	Acetylation;Cytoplasm;Protease inhibitor;Reference proteome;Serine protease inhibitor		
PDSS2	negative	CLCF1	ENSG00000175505	PDSS2	1	PDSS2	1	0.00333523142055203				Cold-induced sweating syndrome;CRISPONI SYNDROME;CRISPONI/COLD-INDUCED SWEATING SYNDROME 2	GO:0008284;GO:0042531;GO:0005615;GO:0005576;GO:0005125;GO:0007166;GO:0005515;GO:0046982;GO:0019221;GO:0005102;GO:0043524;GO:0005127;GO:0097058;GO:0030890;GO:0008083;GO:0030183;GO:0048711;GO:0007259;GO:0097059;GO:0002639;GO:0048295	positive regulation of cell population proliferation;positive regulation of tyrosine phosphorylation of STAT protein;extracellular space;extracellular region;cytokine activity;cell surface receptor signaling pathway;protein binding;cytokine-mediated signaling pathway;signaling receptor binding;negative regulation of neuron apoptotic process;ciliary neurotrophic factor receptor binding;CRLF-CLCF1 complex;positive regulation of B cell proliferation;growth factor activity;B cell differentiation;positive regulation of astrocyte differentiation;receptor signaling pathway via JAK-STAT;CNTFR-CLCF1 complex;positive regulation of immunoglobulin production;positive regulation of isotype switching to IgE isotypes	Alternative splicing;Cytokine;Disease mutation;Glycoprotein;Reference proteome;Secreted;Signal	R-HSA-168256;R-HSA-1280215;R-HSA-449147;R-HSA-6783589;R-HSA-6788467	Immune System;Cytokine Signaling in Immune system;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
PDSS2	negative	FOSL1	ENSG00000175592	PDSS2	1	PDSS2	1	0.00333523142055203	WBGene00001345				GO:0005634;GO:0005654;GO:0006355;GO:0003677;GO:0006357;GO:0003700;GO:0005515;GO:0000978;GO:0000981;GO:0000790;GO:0006935;GO:0006366;GO:0009615;GO:0061614;GO:0006968;GO:0008284;GO:2000144;GO:0000977;GO:0001228;GO:0001701;GO:0007296;GO:0007565;GO:0007612;GO:0008285;GO:0009612;GO:0009629;GO:0014070;GO:0031668;GO:0032570;GO:0034097;GO:0042493;GO:0042542;GO:0043065;GO:0045787;GO:0045944;GO:0051091;GO:0051412;GO:0051591;GO:0060674;GO:0005829;GO:0042734;GO:0043005;GO:0043231	DNA binding;nucleus;DNA-binding transcription factor activity;regulation of transcription by RNA polymerase II;nucleoplasm;regulation of transcription, DNA-templated;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II cis-regulatory region sequence-specific DNA binding;nuclear chromatin;chemotaxis;transcription by RNA polymerase II;response to virus;pri-miRNA transcription by RNA polymerase II;cellular defense response;positive regulation of cell population proliferation;positive regulation of DNA-templated transcription, initiation;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;in utero embryonic development;vitellogenesis;female pregnancy;learning;negative regulation of cell population proliferation;response to mechanical stimulus;response to gravity;response to organic cyclic compound;cellular response to extracellular stimulus;response to progesterone;response to cytokine;response to drug;response to hydrogen peroxide;positive regulation of apoptotic process;positive regulation of cell cycle;positive regulation of transcription by RNA polymerase II;positive regulation of DNA-binding transcription factor activity;response to corticosterone;response to cAMP;placenta blood vessel development;cytosol;presynaptic membrane;neuron projection;intracellular membrane-bounded organelle	Alternative splicing;DNA-binding;Nucleus;Phosphoprotein;Reference proteome		
PDSS2	negative	MMP1	ENSG00000196611	PDSS2	1	PDSS2	1	0.00333523142055203	WBGene00016283;WBGene00006987;WBGene00010423	WBGene00010524(0);WBGene00016283(0);WBGene00012364(0);WBGene00012185(0);WBGene00194737(0)		Severe generalized recessive dystrophic epidermolysis bullosa;EPIDERMOLYSIS BULLOSA DYSTROPHICA AUTOSOMAL RECESSIVE;PULMONARY DISEASE CHRONIC OBSTRUCTIVE	GO:0008270;GO:0046872;GO:0016787;GO:0008233;GO:0006508;GO:0005576;GO:0004222;GO:0008237;GO:0031012;GO:0050900;GO:0030198;GO:0044267;GO:0031334;GO:0016032;GO:0019221;GO:0022617;GO:0030574;GO:0004252;GO:0004175	zinc ion binding;proteolysis;metalloendopeptidase activity;metallopeptidase activity;extracellular matrix;metal ion binding;hydrolase activity;peptidase activity;extracellular region;leukocyte migration;extracellular matrix organization;cellular protein metabolic process;positive regulation of protein-containing complex assembly;viral process;cytokine-mediated signaling pathway;extracellular matrix disassembly;collagen catabolic process;serine-type endopeptidase activity;endopeptidase activity	3D-structure;Autocatalytic cleavage;Calcium;Collagen degradation;Direct protein sequencing;Disulfide bond;Extracellular matrix;Glycoprotein;Host-virus interaction;Hydrolase;Metal-binding;Metalloprotease;Phosphoprotein;Polymorphism;Protease;Reference proteome;Repeat;Secreted;Signal;Zinc;Zymogen	R-HSA-109582;R-HSA-168256;R-HSA-202733;R-HSA-392499;R-HSA-1280215;R-HSA-449147;R-HSA-1474228;R-HSA-1474244;R-HSA-1442490;R-HSA-381426;R-HSA-6785807;R-HSA-210991;R-HSA-1592389	Hemostasis;Immune System;Cell surface interactions at the vascular wall;Metabolism of proteins;Cytokine Signaling in Immune system;Signaling by Interleukins;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen degradation;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Interleukin-4 and Interleukin-13 signaling;Basigin interactions;Activation of Matrix Metalloproteinases
PDSS2	negative	MAMLD1	ENSG00000013619	PDSS2	1	PDSS2	1	0.00402460291123574				Familial hypospadias;X-linked myotubular myopathy-abnormal genitalia syndrome;X-LINKED HYPOSPADIAS TYPE 2;HYPOSPADIAS 2 X-LINKED	GO:0005634;GO:0005794;GO:0005813;GO:0005654;GO:0016604;GO:0003674;GO:0008584	nucleus;Golgi apparatus;nucleoplasm;centrosome;nuclear body;molecular_function;male gonad development	Activator;Alternative splicing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation	R-HSA-1266738;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-5663202;R-HSA-157118;R-HSA-1980143;R-HSA-1980145;R-HSA-2644602;R-HSA-2644603;R-HSA-2644606;R-HSA-2894858;R-HSA-2894862;R-HSA-9012852;R-HSA-8878159;R-HSA-9013694;R-HSA-1912422;R-HSA-1912408;R-HSA-2122947;R-HSA-350054;R-HSA-186712;R-HSA-9013508;R-HSA-210744;R-HSA-2197563;R-HSA-9013695;R-HSA-8941856	Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;Diseases of signal transduction;Signaling by NOTCH;Signaling by NOTCH1;Signaling by NOTCH2;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Signaling by NOTCH3;Transcriptional regulation by RUNX3;Signaling by NOTCH4;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;NOTCH1 Intracellular Domain Regulates Transcription;Notch-HLH transcription pathway;Regulation of beta-cell development;NOTCH3 Intracellular Domain Regulates Transcription;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH2 intracellular domain regulates transcription;NOTCH4 Intracellular Domain Regulates Transcription;RUNX3 regulates NOTCH signaling
PDSS2	negative	LGMN	ENSG00000100600	PDSS2	1	PDSS2	1	0.00402460291123574	WBGene00012144	WBGene00012144(1)			GO:0010629;GO:1904646;GO:0005737;GO:0016787;GO:0008233;GO:0008234;GO:0006508;GO:0005764;GO:0070062;GO:0004197;GO:0019886;GO:0002224;GO:0043202;GO:0048156;GO:0042359;GO:0051603;GO:0003014;GO:1900273;GO:0005576;GO:0008284;GO:0048471;GO:0007613;GO:0036021;GO:0043524;GO:0090026;GO:0005770;GO:0097061;GO:0032801;GO:0071277;GO:0008306;GO:0097202;GO:0006624;GO:0010447;GO:0035729;GO:0045931;GO:0097264;GO:1901185;GO:2001028;GO:0040015;GO:0045177	proteolysis;peptidase activity;negative regulation of gene expression;cellular response to amyloid-beta;cytoplasm;hydrolase activity;cysteine-type peptidase activity;lysosome;extracellular exosome;cysteine-type endopeptidase activity;antigen processing and presentation of exogenous peptide antigen via MHC class II;toll-like receptor signaling pathway;lysosomal lumen;tau protein binding;positive regulation of cell population proliferation;vitamin D metabolic process;proteolysis involved in cellular protein catabolic process;perinuclear region of cytoplasm;renal system process;positive regulation of long-term synaptic potentiation;extracellular region;memory;endolysosome lumen;negative regulation of neuron apoptotic process;positive regulation of monocyte chemotaxis;late endosome;dendritic spine organization;receptor catabolic process;cellular response to calcium ion;associative learning;activation of cysteine-type endopeptidase activity;vacuolar protein processing;response to acidic pH;cellular response to hepatocyte growth factor stimulus;positive regulation of mitotic cell cycle;self proteolysis;negative regulation of ERBB signaling pathway;positive regulation of endothelial cell chemotaxis;negative regulation of multicellular organism growth;apical part of cell	3D-structure;Alternative splicing;Direct protein sequencing;Disulfide bond;Glycoprotein;Hydrolase;Lysosome;Polymorphism;Protease;Reference proteome;Signal;Thiol protease;Zymogen	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-556833;R-HSA-2132295;R-HSA-8957322;R-HSA-168898;R-HSA-1679131;R-HSA-196791	Adaptive Immune System;Innate Immune System;Immune System;Metabolism;Metabolism of lipids;MHC class II antigen presentation;Metabolism of steroids;Toll-like Receptor Cascades;Trafficking and processing of endosomal TLR;Vitamin D (calciferol) metabolism
PDSS2	negative	STX1A	ENSG00000106089	PDSS2	1	PDSS2	1	0.00402460291123574	WBGene00006798	WBGene00006798(1)		Cystic Fibrosis	GO:0016020;GO:0016021;GO:0006886;GO:0016192;GO:0006887;GO:0005886;GO:0005515;GO:0005576;GO:0030054;GO:0031410;GO:0045202;GO:0042802;GO:0000149;GO:0017157;GO:0005484;GO:0005829;GO:0031201;GO:0006906;GO:0048278;GO:0012505;GO:0008021;GO:0031629;GO:0043005;GO:0016925;GO:0050796;GO:0019221;GO:0014047;GO:0030672;GO:0007269;GO:0042734;GO:0006836;GO:0019869;GO:0019900;GO:0008076;GO:0016079;GO:0048488;GO:0048787;GO:0032940;GO:0045956;GO:0010701;GO:0033605;GO:0017022;GO:0019855;GO:0019904;GO:0030674;GO:0032028;GO:0043008;GO:0044325;GO:0046982;GO:0047485;GO:0048306;GO:0001956;GO:0009629;GO:0010807;GO:0016081;GO:0017156;GO:0030073;GO:0035493;GO:0045055;GO:0045921;GO:0046879;GO:0072657;GO:0098815;GO:2000463;GO:0005887;GO:0014069;GO:0030141;GO:0030285;GO:0030424;GO:0031965;GO:0032991;GO:0042641;GO:0043229;GO:0070032;GO:0070033;GO:0070044;GO:0098978;GO:0099056	integral component of membrane;membrane;intracellular protein transport;vesicle-mediated transport;SNAP receptor activity;SNARE binding;regulation of exocytosis;exocytosis;plasma membrane;protein binding;extracellular region;cell junction;cytoplasmic vesicle;synapse;identical protein binding;neuron projection;cytosol;endomembrane system;SNARE complex;vesicle fusion;vesicle docking;synaptic vesicle;synaptic vesicle fusion to presynaptic active zone membrane;protein sumoylation;regulation of insulin secretion;cytokine-mediated signaling pathway;glutamate secretion;synaptic vesicle membrane;neurotransmitter secretion;presynaptic membrane;neurotransmitter transport;chloride channel inhibitor activity;kinase binding;voltage-gated potassium channel complex;synaptic vesicle exocytosis;synaptic vesicle endocytosis;presynaptic active zone membrane;secretion by cell;positive regulation of calcium ion-dependent exocytosis;positive regulation of norepinephrine secretion;positive regulation of catecholamine secretion;myosin binding;calcium channel inhibitor activity;protein domain specific binding;protein binding, bridging;myosin head/neck binding;ATP-dependent protein binding;ion channel binding;protein-containing complex binding;protein N-terminus binding;calcium-dependent protein binding;positive regulation of neurotransmitter secretion;response to gravity;regulation of synaptic vesicle priming;synaptic vesicle docking;calcium-ion regulated exocytosis;insulin secretion;SNARE complex assembly;regulated exocytosis;positive regulation of exocytosis;hormone secretion;protein localization to membrane;modulation of excitatory postsynaptic potential;positive regulation of excitatory postsynaptic potential;integral component of plasma membrane;postsynaptic density;secretory granule;integral component of synaptic vesicle membrane;axon;nuclear membrane;protein-containing complex;actomyosin;intracellular organelle;synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex;synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex;synaptobrevin 2-SNAP-25-syntaxin-1a complex;glutamatergic synapse;integral component of presynaptic membrane	Alternative splicing;Cell junction;Cell membrane;Coiled coil;Cytoplasmic vesicle;Exocytosis;Isopeptide bond;Membrane;Neurotransmitter transport;Phosphoprotein;Reference proteome;Secreted;Synapse;Synaptosome;Transmembrane;Transmembrane helix;Transport;Ubl conjugation;Williams-Beuren syndrome	R-HSA-168256;R-HSA-1266738;R-HSA-392499;R-HSA-1430728;R-HSA-1643685;R-HSA-5663205;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-112315;R-HSA-112316;R-HSA-2980736;R-HSA-9609507;R-HSA-9609523;R-HSA-112310;R-HSA-210500;R-HSA-163685;R-HSA-422356;R-HSA-264876;R-HSA-6794361;R-HSA-6794362;R-HSA-5339562;R-HSA-181429;R-HSA-181430;R-HSA-212676;R-HSA-264642;R-HSA-888590;R-HSA-5682910;R-HSA-168799;R-HSA-5250971	Immune System;Developmental Biology;Metabolism of proteins;Metabolism;Disease;Infectious disease;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;Transmission across Chemical Synapses;Neuronal System;Peptide hormone metabolism;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Neurotransmitter release cycle;Glutamate Neurotransmitter Release Cycle;Integration of energy metabolism;Regulation of insulin secretion;Insulin processing;Neurexins and neuroligins;Protein-protein interactions at synapses;Uptake and actions of bacterial toxins;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;GABA synthesis, release, reuptake and degradation;LGI-ADAM interactions;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type C (BoNT/C)
PDSS2	negative	BTN2A1	ENSG00000112763	PDSS2	1	PDSS2	1	0.00402460291123574					GO:0016020;GO:0016021;GO:0009897;GO:0005886;GO:0003674;GO:0005887;GO:0005102;GO:0050776;GO:0050852;GO:0006629;GO:0005515	protein binding;membrane;integral component of membrane;external side of plasma membrane;plasma membrane;molecular_function;integral component of plasma membrane;signaling receptor binding;regulation of cytokine production;regulation of immune response;T cell receptor signaling pathway;lipid metabolic process	Alternative splicing;Coiled coil;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-1280218;R-HSA-168256;R-HSA-8851680	Adaptive Immune System;Immune System;Butyrophilin (BTN) family interactions
PDSS2	negative	UBE2B	ENSG00000119048	PDSS2	1	PDSS2	1	0.00402460291123574	WBGene00006701				GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0016740;GO:0016567;GO:0005886;GO:0005515;GO:0004842;GO:0006281;GO:0006974;GO:0051865;GO:0006511;GO:0007283;GO:0000790;GO:0061631;GO:0070936;GO:0005654;GO:0050821;GO:0043161;GO:0031625;GO:0090263;GO:0009411;GO:0000785;GO:0000209;GO:0070534;GO:0043951;GO:0070979;GO:0005657;GO:0006513;GO:0033503;GO:0033522;GO:0042493;GO:0042769;GO:0006301;GO:0001701;GO:0006344;GO:0007288;GO:0010845;GO:0031056;GO:0033128;GO:0043066;GO:0045141;GO:0051026;GO:0070076;GO:0070193;GO:0001741	cell;nucleus;cytoplasm;membrane;nucleotide binding;ATP binding;transferase activity;protein ubiquitination;plasma membrane;protein binding;ubiquitin-protein transferase activity;DNA repair;cellular response to DNA damage stimulus;protein autoubiquitination;ubiquitin-dependent protein catabolic process;spermatogenesis;nuclear chromatin;ubiquitin conjugating enzyme activity;protein K48-linked ubiquitination;nucleoplasm;protein stabilization;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin protein ligase binding;protein polyubiquitination;positive regulation of canonical Wnt signaling pathway;response to UV;chromatin;protein K63-linked ubiquitination;negative regulation of cAMP-mediated signaling;protein K11-linked ubiquitination;replication fork;protein monoubiquitination;HULC complex;histone H2A ubiquitination;response to drug;DNA damage response, detection of DNA damage;postreplication repair;histone ubiquitination;in utero embryonic development;maintenance of chromatin silencing;sperm axoneme assembly;positive regulation of reciprocal meiotic recombination;regulation of histone modification;negative regulation of histone phosphorylation;negative regulation of apoptotic process;meiotic telomere clustering;chiasma assembly;histone lysine demethylation;synaptonemal complex organization;XY body	3D-structure;ATP-binding;Cell membrane;DNA damage;DNA repair;Direct protein sequencing;Membrane;Nucleotide-binding;Nucleus;Reference proteome;Transferase;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866654;R-HSA-8866652;R-HSA-983168;R-HSA-983169;R-HSA-73894;R-HSA-73893;R-HSA-110314	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;DNA Repair;DNA Damage Bypass;Recognition of DNA damage by PCNA-containing replication complex
PDSS2	negative	GNG11	ENSG00000127920	PDSS2	1	PDSS2	1	0.00402460291123574	WBGene00001681				GO:0016020;GO:0007186;GO:0003924;GO:0005886;GO:0005515;GO:0007165;GO:0005834;GO:0031681;GO:0031680	G protein-coupled receptor signaling pathway;GTPase activity;heterotrimeric G-protein complex;membrane;plasma membrane;protein binding;signal transduction;G-protein beta-subunit binding;G-protein beta/gamma-subunit complex	Cell membrane;Lipoprotein;Membrane;Methylation;Prenylation;Reference proteome;Transducer	R-HSA-109582;R-HSA-392499;R-HSA-1430728;R-HSA-382551;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-416482;R-HSA-418555;R-HSA-195721;R-HSA-3858494;R-HSA-416476;R-HSA-418594;R-HSA-418597;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-390466;R-HSA-391251;R-HSA-111885;R-HSA-202040;R-HSA-392170;R-HSA-392518;R-HSA-6814122;R-HSA-76002;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-373080;R-HSA-500792;R-HSA-456926;R-HSA-418346;R-HSA-163685;R-HSA-422356;R-HSA-445717;R-HSA-381676;R-HSA-392451;R-HSA-392851;R-HSA-397795;R-HSA-400042;R-HSA-4086398;R-HSA-418217;R-HSA-418592;R-HSA-420092;R-HSA-428930;R-HSA-432040;R-HSA-451326;R-HSA-500657;R-HSA-8964315;R-HSA-8964616;R-HSA-163359	Hemostasis;Metabolism of proteins;Metabolism;Transport of small molecules;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;G alpha (s) signalling events;Signaling by WNT;Beta-catenin independent WNT signaling;G alpha (q) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Chaperonin-mediated protein folding;Protein folding;Opioid Signalling;G-protein activation;ADP signalling through P2Y purinoceptor 12;Signal amplification;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Class B/2 (Secretin family receptors);GPCR ligand binding;Thrombin signalling through proteinase activated receptors (PARs);Platelet homeostasis;Integration of energy metabolism;Regulation of insulin secretion;Aquaporin-mediated transport;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;G beta:gamma signalling through PI3Kgamma;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G beta:gamma signalling through PLC beta;ADP signalling through P2Y purinoceptor 1;Glucagon-type ligand receptors;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Activation of kainate receptors upon glutamate binding;Presynaptic function of Kainate receptors;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Glucagon signaling in metabolic regulation
PDSS2	negative	OASL	ENSG00000135114	PDSS2	1	PDSS2	1	0.00402460291123574					GO:0003723;GO:0005634;GO:0005737;GO:0016020;GO:0003725;GO:0005524;GO:0005829;GO:0005654;GO:0003677;GO:0005515;GO:0006955;GO:0016740;GO:0051607;GO:0002376;GO:0045087;GO:0005730;GO:0009615;GO:0045071;GO:0060333;GO:0060337;GO:0046966;GO:0060700	ATP binding;protein binding;RNA binding;immune response;transferase activity;double-stranded RNA binding;defense response to virus;nucleus;cytoplasm;membrane;nucleoplasm;cytosol;DNA binding;immune system process;innate immune response;nucleolus;response to virus;negative regulation of viral genome replication;interferon-gamma-mediated signaling pathway;type I interferon signaling pathway;thyroid hormone receptor binding;regulation of ribonuclease activity	3D-structure;Acetylation;Alternative splicing;Antiviral defense;Cytoplasm;Immunity;Innate immunity;Nucleus;Polymorphism;RNA-binding;Reference proteome;Repeat	R-HSA-168256;R-HSA-1280215;R-HSA-1169410;R-HSA-913531;R-HSA-877300;R-HSA-909733;R-HSA-8983711	Immune System;Cytokine Signaling in Immune system;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling;Interferon gamma signaling;Interferon alpha/beta signaling;OAS antiviral response
PDSS2	negative	HLA-A	ENSG00000206503	PDSS2	1	PDSS2	1	0.00402460291123574				Birdshot chorioretinopathy;Phenytoin or carbamazepine toxicity;SEVERE CUTANEOUS ADVERSE REACTION SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS SUSCEPTIBILITY TO INCLUDED	GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0005794;GO:0005886;GO:0006955;GO:0009986;GO:0002376;GO:0050776;GO:0005887;GO:0042605;GO:0019882;GO:0002474;GO:0042612;GO:0016567;GO:0070062;GO:0002479;GO:0030670;GO:0000139;GO:0060333;GO:0012507;GO:0060337;GO:0071556;GO:0031901;GO:0002480;GO:0042270;GO:0055038;GO:0030881;GO:0046977;GO:0036037;GO:0042590;GO:0001913	immune response;antigen processing and presentation;RNA binding;membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;plasma membrane;cell surface;immune system process;innate immune response;adaptive immune response;regulation of immune response;protein binding;defense response to Gram-positive bacterium;integral component of plasma membrane;peptide antigen binding;protein ubiquitination;extracellular exosome;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;viral process;antibacterial humoral response;antigen processing and presentation of peptide antigen via MHC class I;MHC class I protein complex;phagocytic vesicle membrane;T cell receptor signaling pathway;Golgi membrane;interferon-gamma-mediated signaling pathway;signaling receptor binding;endoplasmic reticulum exit site;ER to Golgi transport vesicle membrane;type I interferon signaling pathway;positive regulation of T cell mediated cytotoxicity;TAP complex binding;MHC class I peptide loading complex;integral component of lumenal side of endoplasmic reticulum membrane;early endosome membrane;detection of bacterium;positive regulation of interferon-gamma production;TAP binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent;protection from natural killer cell mediated cytotoxicity;recycling endosome membrane;beta-2-microglobulin binding;T cell receptor binding;CD8 receptor binding;T cell mediated cytotoxicity;T cell mediated cytotoxicity directed against tumor cell target;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent;positive regulation of T cell cytokine production;antigen processing and presentation of endogenous peptide antigen via MHC class I;CD8-positive, alpha-beta T cell activation;antigen processing and presentation of exogenous peptide antigen via MHC class I;positive regulation of CD8-positive, alpha-beta T cell proliferation;positive regulation of memory T cell activation;positive regulation of CD8-positive, alpha-beta T cell activation;Golgi medial cisterna	3D-structure;Adaptive immunity;Alternative splicing;Cell membrane;Direct protein sequencing;Disulfide bond;Endoplasmic reticulum;Glycoprotein;Host-virus interaction;Immunity;Immunoglobulin domain;Innate immunity;MHC I;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Signal;Sulfation;Transmembrane;Transmembrane helix;Ubl conjugation	R-HSA-1280218;R-HSA-168256;R-HSA-198933;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866654;R-HSA-983169;R-HSA-1236974;R-HSA-1236975;R-HSA-1280215;R-HSA-913531;R-HSA-877300;R-HSA-909733;R-HSA-983170;R-HSA-1236977	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Class I MHC mediated antigen processing & presentation;ER-Phagosome pathway;Antigen processing-Cross presentation;Cytokine Signaling in Immune system;Interferon Signaling;Interferon gamma signaling;Interferon alpha/beta signaling;Antigen Presentation: Folding, assembly and peptide loading of class I MHC;Endosomal/Vacuolar pathway
PDSS2	negative	HIST1H3H	ENSG00000278828	PDSS2	1	PDSS2	1	0.00402460291123574	WBGene00001876;WBGene00001880;WBGene00001883;WBGene00001887;WBGene00001891;WBGene00001899;WBGene00001901;WBGene00001906;WBGene00001914;WBGene00001916;WBGene00001919;WBGene00001923;WBGene00001929;WBGene00001933;WBGene00001937	WBGene00001937(1);WBGene00001929(1);WBGene00001923(1);WBGene00001883(1);WBGene00001876(1);WBGene00001906(1);WBGene00001891(1);WBGene00001919(1);WBGene00001914(1);WBGene00001916(1);WBGene00001887(1);WBGene00001880(1);WBGene00001933(1);WBGene00001899(1);WBGene00001901(1)			GO:0005634;GO:0016020;GO:0003677;GO:0046982;GO:0006334;GO:0000786;GO:0005694;GO:0005515;GO:0005576;GO:0005654;GO:0045296;GO:0070062;GO:0044267;GO:0032991;GO:0060964;GO:0038111;GO:0045652;GO:0006335;GO:0007596;GO:0000228;GO:0000183;GO:0045814;GO:0051290;GO:0000788;GO:0006325;GO:0032200;GO:0060968	DNA binding;nucleosome;protein heterodimerization activity;nucleus;membrane;nucleosome assembly;chromosome;protein binding;extracellular region;nucleoplasm;cadherin binding;extracellular exosome;cellular protein metabolic process;protein-containing complex;regulation of gene silencing by miRNA;interleukin-7-mediated signaling pathway;regulation of megakaryocyte differentiation;DNA replication-dependent nucleosome assembly;blood coagulation;nuclear chromosome;chromatin silencing at rDNA;negative regulation of gene expression, epigenetic;nuclear nucleosome;chromatin organization;telomere organization;regulation of gene silencing	3D-structure;ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Direct protein sequencing;Disease mutation;Hydroxylation;Methylation;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-168256;R-HSA-1266738;R-HSA-392499;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-194315;R-HSA-977225;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-1280215;R-HSA-195721;R-HSA-201681;R-HSA-2262752;R-HSA-449147;R-HSA-68886;R-HSA-69278;R-HSA-8878171;R-HSA-8939236;R-HSA-8953897;R-HSA-195258;R-HSA-983231;R-HSA-211000;R-HSA-5578749;R-HSA-68875;R-HSA-157118;R-HSA-8939211;R-HSA-9006931;R-HSA-201722;R-HSA-2559580;R-HSA-2559583;R-HSA-212165;R-HSA-3214815;R-HSA-3247509;R-HSA-427413;R-HSA-4839726;R-HSA-5250941;R-HSA-1266695;R-HSA-5617472;R-HSA-5619507;R-HSA-9018519;R-HSA-1912422;R-HSA-1912408;R-HSA-2559582;R-HSA-3214858;R-HSA-3214842;R-HSA-3214841;R-HSA-8936459;R-HSA-3214847;R-HSA-5625740;R-HSA-5250913;R-HSA-5250924;R-HSA-73772;R-HSA-73854;R-HSA-73864;R-HSA-912446;R-HSA-427359;R-HSA-212300;R-HSA-5625886;R-HSA-2299718;R-HSA-427389;R-HSA-5334118;R-HSA-73728;R-HSA-9616222	Hemostasis;Immune System;Developmental Biology;Metabolism of proteins;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by Rho GTPases;Amyloid fiber formation;Reproduction;Meiosis;Cell Cycle;Cytokine Signaling in Immune system;Signaling by WNT;TCF dependent signaling in response to WNT;Cellular responses to stress;Signaling by Interleukins;M Phase;Cell Cycle, Mitotic;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;RHO GTPase Effectors;Factors involved in megakaryocyte development and platelet production;Gene Silencing by RNA;Transcriptional regulation by small RNAs;Mitotic Prophase;Signaling by NOTCH;ESR-mediated signaling;Signaling by Nuclear Receptors;Formation of the beta-catenin:TCF transactivating complex;Oxidative Stress Induced Senescence;Cellular Senescence;Epigenetic regulation of gene expression;HDACs deacetylate histones;Chromatin modifying enzymes;NoRC negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Interleukin-7 signaling;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Estrogen-dependent gene expression;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;Senescence-Associated Secretory Phenotype (SASP);RMTs methylate histone arginines;HDMs demethylate histones;PKMTs methylate histone lysines;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;HATs acetylate histones;RHO GTPases activate PKNs;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;Meiotic recombination;SIRT1 negatively regulates rRNA expression;PRC2 methylates histones and DNA;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Condensation of Prophase Chromosomes;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;DNA methylation;RNA Polymerase I Promoter Opening;Transcriptional regulation of granulopoiesis
PDSS2	negative	TMEM132A	ENSG00000006118	PDSS2	1	PDSS2	1	0.00483889260427173	WBGene00022175	WBGene00022175(0)			GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0005794;GO:0000139;GO:0070062;GO:0003674;GO:0008150;GO:0044267;GO:0043687;GO:0005788	membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;Golgi membrane;extracellular exosome;molecular_function;biological_process;cellular protein metabolic process;post-translational protein modification;endoplasmic reticulum lumen	Alternative splicing;Endoplasmic reticulum;Glycoprotein;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-381426;R-HSA-8957275	Metabolism of proteins;Post-translational protein modification;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation
PDSS2	negative	CREM	ENSG00000095794	PDSS2	1	PDSS2	1	0.00483889260427173	WBGene00000793	WBGene00016162(0);WBGene00000222(0)	ACE;MC2R;SLC5A5		GO:0005634;GO:0006355;GO:0003677;GO:0003700;GO:0005515;GO:0005737;GO:0048511;GO:0007275;GO:0030154;GO:0007283;GO:0000981;GO:0000790;GO:0005667;GO:0001227;GO:0000122;GO:0007165;GO:0000977;GO:0008140;GO:0006006;GO:0006631;GO:0006687;GO:0042752;GO:0045944;GO:0048384	DNA binding;regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;protein binding;cytoplasm;rhythmic process;multicellular organism development;cell differentiation;spermatogenesis;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;transcription factor complex;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;signal transduction;RNA polymerase II regulatory region sequence-specific DNA binding;cAMP response element binding protein binding;glucose metabolic process;fatty acid metabolic process;glycosphingolipid metabolic process;regulation of circadian rhythm;positive regulation of transcription by RNA polymerase II;retinoic acid receptor signaling pathway	Activator;Alternative promoter usage;Alternative splicing;Biological rhythms;Cytoplasm;DNA-binding;Developmental protein;Differentiation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Spermatogenesis;Transcription;Transcription regulation;Ubl conjugation		
PDSS2	negative	SLC7A5	ENSG00000103257	PDSS2	1	PDSS2	1	0.00483889260427173	WBGene00000002;WBGene00000004;WBGene00000003	WBGene00000010(0);WBGene00000005(0);WBGene00015197(0);WBGene00017747(0);WBGene00000002(0);WBGene00000003(0)			GO:0016020;GO:0016021;GO:0043231;GO:0022857;GO:0055085;GO:0005829;GO:0005886;GO:0005765;GO:0005515;GO:0005764;GO:0006865;GO:0050900;GO:0042605;GO:0070062;GO:0016324;GO:0009986;GO:0016323;GO:0098591;GO:0015179;GO:0015804;GO:1902475;GO:1990184;GO:0009925;GO:0015171;GO:0015190;GO:0015196;GO:0015803;GO:0015807;GO:1904556	membrane;transmembrane transporter activity;transmembrane transport;integral component of membrane;intracellular membrane-bounded organelle;cytosol;plasma membrane;amino acid transport;lysosomal membrane;protein binding;lysosome;leukocyte migration;peptide antigen binding;extracellular exosome;apical plasma membrane;basolateral plasma membrane;external side of apical plasma membrane;L-amino acid transmembrane transporter activity;neutral amino acid transport;L-alpha-amino acid transmembrane transport;amino acid transport complex;basal plasma membrane;amino acid transmembrane transporter activity;L-leucine transmembrane transporter activity;L-tryptophan transmembrane transporter activity;branched-chain amino acid transport;L-amino acid transport;L-tryptophan transmembrane transport	3D-structure;Amino-acid transport;Cell membrane;Direct protein sequencing;Disulfide bond;Isopeptide bond;Lysosome;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport;Ubl conjugation	R-HSA-109582;R-HSA-202733;R-HSA-1430728;R-HSA-382551;R-HSA-425407;R-HSA-71291;R-HSA-425393;R-HSA-71240;R-HSA-210991;R-HSA-352230	Hemostasis;Cell surface interactions at the vascular wall;Metabolism;Transport of small molecules;SLC-mediated transmembrane transport;Metabolism of amino acids and derivatives;Transport of inorganic cations/anions and amino acids/oligopeptides;Tryptophan catabolism;Basigin interactions;Amino acid transport across the plasma membrane
PDSS2	negative	TNFAIP3	ENSG00000118503	PDSS2	1	PDSS2	1	0.00483889260427173	WBGene00021733			Hereditary pediatric Behcet-like disease;Systemic lupus erythematosus;Autoinflammatory syndrome familial Behcet-like	GO:0043231;GO:0008270;GO:0016579;GO:0003677;GO:0016567;GO:0050728;GO:2000352;GO:0031397;GO:0032088;GO:0071222;GO:0048662;GO:0005634;GO:0005737;GO:0046872;GO:0016740;GO:0016787;GO:0005515;GO:0003824;GO:0008152;GO:0008233;GO:0008234;GO:0006508;GO:0004842;GO:0006915;GO:0036459;GO:0006954;GO:0005764;GO:0042802;GO:0004843;GO:0070936;GO:0030177;GO:0005829;GO:0070062;GO:0007010;GO:0016477;GO:0045824;GO:0070536;GO:0071108;GO:0032715;GO:0032720;GO:0061578;GO:0043124;GO:0010803;GO:0032480;GO:0045732;GO:0070301;GO:1902042;GO:0070423;GO:0090291;GO:0002020;GO:0043130;GO:0032703;GO:0045779;GO:0002237;GO:0043621;GO:0034144;GO:0019900;GO:0070530;GO:0001922;GO:0002634;GO:0002677;GO:0032495;GO:0032691;GO:0034136;GO:0034140;GO:0034148;GO:0035523;GO:0035871;GO:0045736;GO:0050691;GO:0050713;GO:0050869;GO:0060548;GO:0061043;GO:0070429;GO:0070433;GO:0071947;GO:0072573;GO:0072666;GO:1903364;GO:1990168;GO:2000347;GO:2000349	protein deubiquitination;protein ubiquitination;intracellular membrane-bounded organelle;DNA binding;zinc ion binding;negative regulation of inflammatory response;negative regulation of endothelial cell apoptotic process;negative regulation of NF-kappaB transcription factor activity;negative regulation of protein ubiquitination;cellular response to lipopolysaccharide;negative regulation of smooth muscle cell proliferation;nucleus;cytoplasm;metal ion binding;transferase activity;hydrolase activity;protein binding;catalytic activity;metabolic process;peptidase activity;cysteine-type peptidase activity;proteolysis;ubiquitin-protein transferase activity;apoptotic process;thiol-dependent ubiquitinyl hydrolase activity;inflammatory response;lysosome;identical protein binding;thiol-dependent ubiquitin-specific protease activity;protein K48-linked ubiquitination;positive regulation of Wnt signaling pathway;cytosol;extracellular exosome;cytoskeleton organization;cell migration;negative regulation of innate immune response;protein K63-linked deubiquitination;protein K48-linked deubiquitination;negative regulation of interleukin-6 production;negative regulation of tumor necrosis factor production;Lys63-specific deubiquitinase activity;negative regulation of I-kappaB kinase/NF-kappaB signaling;regulation of tumor necrosis factor-mediated signaling pathway;negative regulation of type I interferon production;positive regulation of protein catabolic process;cellular response to hydrogen peroxide;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;nucleotide-binding oligomerization domain containing signaling pathway;negative regulation of osteoclast proliferation;protease binding;ubiquitin binding;negative regulation of interleukin-2 production;negative regulation of bone resorption;response to molecule of bacterial origin;protein self-association;negative regulation of toll-like receptor 4 signaling pathway;K63-linked polyubiquitin modification-dependent protein binding;B-1 B cell homeostasis;regulation of germinal center formation;negative regulation of toll-like receptor 2 signaling pathway;negative regulation of toll-like receptor 3 signaling pathway;protein K29-linked deubiquitination;protein K11-linked deubiquitination;regulation of defense response to virus by host;negative regulation of interleukin-1 beta secretion;negative regulation of B cell activation;regulation of vascular wound healing;protein deubiquitination involved in ubiquitin-dependent protein catabolic process;tolerance induction to lipopolysaccharide;protein K33-linked deubiquitination;negative regulation of CD40 signaling pathway;kinase binding;negative regulation of chronic inflammatory response;response to muramyl dipeptide;negative regulation of interleukin-1 beta production;negative regulation of toll-like receptor 5 signaling pathway;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of cell death;negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway;negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;establishment of protein localization to vacuole;positive regulation of cellular protein catabolic process;positive regulation of hepatocyte proliferation	3D-structure;Acetylation;Apoptosis;Cytoplasm;DNA-binding;Disease mutation;Hydrolase;Inflammatory response;Lysosome;Metal-binding;Multifunctional enzyme;Nucleus;Phosphoprotein;Polymorphism;Protease;Reference proteome;Repeat;Thiol protease;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-73887;R-HSA-5688426;R-HSA-168643;R-HSA-168638;R-HSA-168928;R-HSA-5357905;R-HSA-5357956;R-HSA-75893;R-HSA-936440;R-HSA-5689896;R-HSA-5357786	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Signal Transduction;Death Receptor Signalling;Deubiquitination;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;NOD1/2 Signaling Pathway;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNF signaling;Negative regulators of DDX58/IFIH1 signaling;Ovarian tumor domain proteases;TNFR1-induced proapoptotic signaling
PDSS2	negative	NR4A3	ENSG00000119508	PDSS2	1	PDSS2	1	0.00483889260427173	WBGene00003605;WBGene00004786	WBGene00003605(1)		Extraskeletal myxoid chondrosarcoma;CHONDROSARCOMA EXTRASKELETAL MYXOID	GO:1904707;GO:1904754;GO:0048008;GO:0005634;GO:0008270;GO:0046872;GO:0006355;GO:0003677;GO:0003700;GO:0042803;GO:0043565;GO:0005515;GO:0003707;GO:0004879;GO:0030522;GO:0043401;GO:0042629;GO:0000977;GO:0000122;GO:0000978;GO:0000981;GO:0000790;GO:0005667;GO:0045944;GO:0005654;GO:0045444;GO:0019901;GO:0006367;GO:0043303;GO:0097009;GO:0045652;GO:0048661;GO:0001228;GO:0050679;GO:0045333;GO:0010613;GO:0046321;GO:0007369;GO:0032765;GO:0010828;GO:0048660;GO:0035726;GO:0061469;GO:0035259;GO:0071376;GO:0044320;GO:0035497;GO:0009444;GO:0038097;GO:0071870;GO:1900625;GO:1903208;GO:2000253;GO:0001223;GO:0035035;GO:0001707;GO:0007411;GO:0021766;GO:0030534;GO:0031100;GO:0042472;GO:0042542;GO:0043066;GO:0043434;GO:0043524;GO:0045787;GO:0045893;GO:0048752;GO:0050885;GO:0060005;GO:1903204;GO:2000108	DNA binding;zinc ion binding;regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;sequence-specific DNA binding;nuclear receptor activity;positive regulation of vascular smooth muscle cell proliferation;positive regulation of vascular associated smooth muscle cell migration;platelet-derived growth factor receptor signaling pathway;metal ion binding;protein homodimerization activity;protein binding;steroid hormone receptor activity;intracellular receptor signaling pathway;steroid hormone mediated signaling pathway;mast cell granule;RNA polymerase II cis-regulatory region sequence-specific DNA binding;negative regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;transcription factor complex;positive regulation of transcription by RNA polymerase II;nucleoplasm;fat cell differentiation;protein kinase binding;transcription initiation from RNA polymerase II promoter;mast cell degranulation;energy homeostasis;regulation of megakaryocyte differentiation;positive regulation of smooth muscle cell proliferation;DNA-binding transcription activator activity, RNA polymerase II-specific;positive regulation of epithelial cell proliferation;cellular respiration;positive regulation of cardiac muscle hypertrophy;positive regulation of fatty acid oxidation;gastrulation;positive regulation of mast cell cytokine production;positive regulation of glucose transmembrane transport;regulation of smooth muscle cell proliferation;common myeloid progenitor cell proliferation;regulation of type B pancreatic cell proliferation;glucocorticoid receptor binding;cellular response to corticotropin-releasing hormone stimulus;cellular response to leptin stimulus;cAMP response element binding;pyruvate oxidation;positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway;cellular response to catecholamine stimulus;positive regulation of monocyte aggregation;negative regulation of hydrogen peroxide-induced neuron death;positive regulation of feeding behavior;transcription coactivator binding;histone acetyltransferase binding;mesoderm formation;axon guidance;hippocampus development;adult behavior;animal organ regeneration;inner ear morphogenesis;response to hydrogen peroxide;negative regulation of apoptotic process;response to peptide hormone;negative regulation of neuron apoptotic process;positive regulation of cell cycle;positive regulation of transcription, DNA-templated;semicircular canal morphogenesis;neuromuscular process controlling balance;vestibular reflex;negative regulation of oxidative stress-induced neuron death;positive regulation of leukocyte apoptotic process	Alternative splicing;Chromosomal rearrangement;DNA-binding;Metal-binding;Nucleus;Proto-oncogene;Receptor;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8878171;R-HSA-8936459	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
PDSS2	negative	TICAM1	ENSG00000127666	PDSS2	1	PDSS2	1	0.00483889260427173				Herpes simplex virus encephalitis;ENCEPHALOPATHY ACUTE INFECTION-INDUCED (HERPES-SPECIFIC)SUSCEPTIBILITY TO 6	GO:1900017;GO:0010628;GO:0140052;GO:0005737;GO:0005739;GO:0005829;GO:0005515;GO:0006915;GO:0031410;GO:0006954;GO:0002376;GO:0045087;GO:0051607;GO:0005776;GO:0019901;GO:0010008;GO:0016032;GO:0043123;GO:0002756;GO:0007249;GO:0034128;GO:0035666;GO:0070266;GO:0097190;GO:0034138;GO:0043330;GO:0097342;GO:0002735;GO:0010508;GO:0002281;GO:0030890;GO:0031398;GO:0031663;GO:0032092;GO:0032481;GO:0032496;GO:0032755;GO:0032760;GO:0032816;GO:0043254;GO:0045080;GO:0045359;GO:0045429;GO:0050871;GO:0051092;GO:0071222	innate immune response;positive regulation of cytokine production involved in inflammatory response;positive regulation of gene expression;cellular response to oxidised low-density lipoprotein particle stimulus;cytoplasm;mitochondrion;cytosol;protein binding;apoptotic process;cytoplasmic vesicle;inflammatory response;immune system process;defense response to virus;autophagosome;protein kinase binding;endosome membrane;viral process;positive regulation of I-kappaB kinase/NF-kappaB signaling;MyD88-independent toll-like receptor signaling pathway;I-kappaB kinase/NF-kappaB signaling;negative regulation of MyD88-independent toll-like receptor signaling pathway;TRIF-dependent toll-like receptor signaling pathway;necroptotic process;apoptotic signaling pathway;toll-like receptor 3 signaling pathway;response to exogenous dsRNA;ripoptosome;positive regulation of myeloid dendritic cell cytokine production;positive regulation of autophagy;macrophage activation involved in immune response;positive regulation of B cell proliferation;positive regulation of protein ubiquitination;lipopolysaccharide-mediated signaling pathway;positive regulation of protein binding;positive regulation of type I interferon production;response to lipopolysaccharide;positive regulation of interleukin-6 production;positive regulation of tumor necrosis factor production;positive regulation of natural killer cell activation;regulation of protein-containing complex assembly;positive regulation of chemokine biosynthetic process;positive regulation of interferon-beta biosynthetic process;positive regulation of nitric oxide biosynthetic process;positive regulation of B cell activation;positive regulation of NF-kappaB transcription factor activity;cellular response to lipopolysaccharide	3D-structure;Antiviral defense;Apoptosis;Cytoplasm;Cytoplasmic vesicle;Disease mutation;Host-virus interaction;Immunity;Inflammatory response;Innate immunity;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-109581;R-HSA-5357801;R-HSA-1643685;R-HSA-140534;R-HSA-166016;R-HSA-166166;R-HSA-168138;R-HSA-168181;R-HSA-168898;R-HSA-2562578;R-HSA-5260271;R-HSA-5357769;R-HSA-5602358;R-HSA-936964;R-HSA-937041;R-HSA-937061;R-HSA-937072;R-HSA-975138;R-HSA-975155;R-HSA-975163;R-HSA-168164;R-HSA-1834949;R-HSA-1606322;R-HSA-168927;R-HSA-1810476;R-HSA-5602566;R-HSA-5602571;R-HSA-9013957;R-HSA-9013973;R-HSA-9014325	Innate Immune System;Immune System;Apoptosis;Programmed Cell Death;Disease;Caspase activation via Death Receptors in the presence of ligand;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll-like Receptor Cascades;TRIF-mediated programmed cell death;Diseases of Immune System;Caspase activation via extrinsic apoptotic signalling pathway;Diseases associated with the TLR signaling cascade;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;Toll Like Receptor 3 (TLR3) Cascade;Cytosolic sensors of pathogen-associated DNA ;ZBP1(DAI) mediated induction of type I IFNs;TICAM1, RIP1-mediated IKK complex recruitment;RIP-mediated NFkB activation via ZBP1;TICAM1 deficiency - HSE;TRAF3 deficiency - HSE;TLR3-mediated TICAM1-dependent programmed cell death;TICAM1-dependent activation of IRF3/IRF7;TICAM1,TRAF6-dependent induction of TAK1 complex
PDSS2	negative	SPSB1	ENSG00000171621	PDSS2	1	PDSS2	1	0.00483889260427173	WBGene00021596;WBGene00021597	WBGene00021596(1);WBGene00021597(1)			GO:0005737;GO:0016567;GO:0005829;GO:0005515;GO:0006511;GO:0000209;GO:0043161;GO:0043687;GO:0019005;GO:1990756	protein binding;cytoplasm;protein ubiquitination;cytosol;ubiquitin-dependent protein catabolic process;protein polyubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;SCF ubiquitin ligase complex;protein binding, bridging involved in substrate recognition for ubiquitination	3D-structure;Cytoplasm;Phosphoprotein;Reference proteome;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-983168;R-HSA-983169;R-HSA-8951664	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
PDSS2	negative	SPRED2	ENSG00000198369	PDSS2	1	PDSS2	1	0.00483889260427173		WBGene00006770(0)			GO:0005737;GO:0016020;GO:0007275;GO:0005886;GO:0005515;GO:0031410;GO:0009966;GO:0005829;GO:0019901;GO:0010801;GO:0008543;GO:0030658;GO:0030291;GO:0043517;GO:0000188;GO:0090311;GO:0005173	membrane;multicellular organism development;regulation of signal transduction;cytoplasm;plasma membrane;protein binding;cytoplasmic vesicle;cytosol;protein kinase binding;negative regulation of peptidyl-threonine phosphorylation;fibroblast growth factor receptor signaling pathway;transport vesicle membrane;protein serine/threonine kinase inhibitor activity;positive regulation of DNA damage response, signal transduction by p53 class mediator;inactivation of MAPK activity;regulation of protein deacetylation;stem cell factor receptor binding	3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Cytoplasmic vesicle;Membrane;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-168256;R-HSA-162582;R-HSA-1643685;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5658442;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-9006934;R-HSA-6802957;R-HSA-190236;R-HSA-5654736;R-HSA-5658623;R-HSA-6802949	Immune System;Signal Transduction;Disease;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;Regulation of RAS by GAPs;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Signaling by Receptor Tyrosine Kinases;Oncogenic MAPK signaling;Signaling by FGFR;Signaling by FGFR1;FGFRL1 modulation of FGFR1 signaling;Signaling by RAS mutants
PDSS2	negative	TYMP	ENSG00000025708	PDSS2	1	PDSS2	1	0.00579694401645148				Mitochondrial neurogastrointestinal encephalomyopathy;MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	GO:0016763;GO:0006213;GO:0016740;GO:0016757;GO:0008083;GO:0007165;GO:0007275;GO:0030154;GO:0006935;GO:0005829;GO:0004645;GO:0006206;GO:0001525;GO:0009032;GO:0016154;GO:0043097;GO:0042803;GO:0046135;GO:0000002;GO:0031641;GO:0051969;GO:1905333	transferase activity, transferring pentosyl groups;pyrimidine nucleoside metabolic process;1,4-alpha-oligoglucan phosphorylase activity;pyrimidine nucleobase metabolic process;transferase activity, transferring glycosyl groups;pyrimidine-nucleoside phosphorylase activity;transferase activity;growth factor activity;signal transduction;multicellular organism development;cell differentiation;chemotaxis;cytosol;angiogenesis;thymidine phosphorylase activity;pyrimidine nucleoside salvage;pyrimidine nucleoside catabolic process;protein homodimerization activity;mitochondrial genome maintenance;regulation of myelination;regulation of transmission of nerve impulse;regulation of gastric motility	3D-structure;Alternative splicing;Angiogenesis;Chemotaxis;Developmental protein;Differentiation;Direct protein sequencing;Disease mutation;Glycosyltransferase;Growth factor;Neuropathy;Phosphoprotein;Polymorphism;Primary mitochondrial disease;Progressive external ophthalmoplegia;Reference proteome;Repeat;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-73614;R-HSA-8956321;R-HSA-8956319;R-HSA-73621	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Nucleotide salvage;Nucleobase catabolism;Pyrimidine catabolism
PDSS2	negative	SMOX	ENSG00000088826	PDSS2	1	PDSS2	1	0.00579694401645148	WBGene00000139;WBGene00016061	WBGene00000137(0);WBGene00011615(0);WBGene00005010(0)			GO:0005634;GO:0005737;GO:0043231;GO:0005654;GO:0016491;GO:0055114;GO:0031965;GO:0005829;GO:0006596;GO:0046592;GO:0052901;GO:0046208;GO:0052894;GO:0052895;GO:0006598	oxidation-reduction process;oxidoreductase activity;nucleus;cytoplasm;intracellular membrane-bounded organelle;nucleoplasm;nuclear membrane;cytosol;polyamine biosynthetic process;polyamine oxidase activity;spermine:oxygen oxidoreductase (spermidine-forming) activity;spermine catabolic process;norspermine:oxygen oxidoreductase activity;N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity;polyamine catabolic process	Alternative splicing;Cytoplasm;FAD;Flavoprotein;Nucleus;Oxidoreductase;Polymorphism;Reference proteome		
PDSS2	negative	GTPBP1	ENSG00000100226	PDSS2	1	PDSS2	1	0.00579694401645148	WBGene00000480;WBGene00011449	WBGene00000480(1)			GO:0003723;GO:0005737;GO:0016020;GO:0000166;GO:0003924;GO:0005525;GO:0005829;GO:0006955;GO:0007165;GO:0003746;GO:0006414;GO:0046039;GO:0061014;GO:0000177	GTP binding;GTPase activity;RNA binding;cytoplasm;membrane;nucleotide binding;cytosol;immune response;signal transduction;translation elongation factor activity;translational elongation;GTP metabolic process;positive regulation of mRNA catabolic process;cytoplasmic exosome (RNase complex)	Cytoplasm;GTP-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome		
PDSS2	negative	IFIT3	ENSG00000119917	PDSS2	1	PDSS2	1	0.00579694401645148					GO:0005737;GO:0043066;GO:0005829;GO:0005739;GO:0005515;GO:0002376;GO:0045087;GO:0042802;GO:0051607;GO:0035457;GO:0003674;GO:0008285;GO:0009615;GO:0060337	protein binding;cellular response to interferon-alpha;cytoplasm;negative regulation of apoptotic process;cytosol;mitochondrion;immune system process;innate immune response;identical protein binding;defense response to virus;RNA binding;molecular_function;negative regulation of cell population proliferation;response to virus;type I interferon signaling pathway	3D-structure;Antiviral defense;Cytoplasm;Immunity;Innate immunity;Mitochondrion;Phosphoprotein;Reference proteome;Repeat;TPR repeat	R-HSA-168256;R-HSA-1280215;R-HSA-913531;R-HSA-909733	Immune System;Cytokine Signaling in Immune system;Interferon Signaling;Interferon alpha/beta signaling
PDSS2	negative	PLXNA3	ENSG00000130827	PDSS2	1	PDSS2	1	0.00579694401645148	WBGene00004047;WBGene00004048	WBGene00004047(1)			GO:0016020;GO:0016021;GO:0043231;GO:0005634;GO:0007165;GO:0005886;GO:0030054;GO:0005515;GO:0007275;GO:0017154;GO:0071526;GO:0030334;GO:0005887;GO:0008360;GO:0004888;GO:0002116;GO:0007162;GO:0043087;GO:0050772;GO:1902287;GO:0007411;GO:0021612;GO:0021637;GO:0021766;GO:0021785;GO:0021860;GO:0048843;GO:0050919;GO:0051495;GO:0097485;GO:1990138	protein binding;signal transduction;semaphorin receptor activity;semaphorin-plexin signaling pathway;membrane;integral component of membrane;plasma membrane;multicellular organism development;regulation of cell migration;integral component of plasma membrane;regulation of cell shape;transmembrane signaling receptor activity;semaphorin receptor complex;negative regulation of cell adhesion;regulation of GTPase activity;positive regulation of axonogenesis;semaphorin-plexin signaling pathway involved in axon guidance;axon guidance;facial nerve structural organization;trigeminal nerve structural organization;hippocampus development;branchiomotor neuron axon guidance;pyramidal neuron development;negative regulation of axon extension involved in axon guidance;negative chemotaxis;positive regulation of cytoskeleton organization;neuron projection guidance;neuron projection extension	Cell membrane;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-1266738;R-HSA-422475;R-HSA-373755;R-HSA-399956;R-HSA-399954;R-HSA-399955	Developmental Biology;Axon guidance;Semaphorin interactions;CRMPs in Sema3A signaling;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
PDSS2	negative	STK17A	ENSG00000164543	PDSS2	1	PDSS2	1	0.00579694401645148	WBGene00003400				GO:0005634;GO:0016607;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005886;GO:0006915;GO:0043065;GO:0035556;GO:2000271;GO:2000377	ATP binding;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;nucleus;nuclear speck;nucleotide binding;kinase activity;transferase activity;phosphorylation;plasma membrane;apoptotic process;positive regulation of apoptotic process;intracellular signal transduction;positive regulation of fibroblast apoptotic process;regulation of reactive oxygen species metabolic process	ATP-binding;Apoptosis;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase		
PDSS2	negative	HGS	ENSG00000185359	PDSS2	1	PDSS2	1	0.00579694401645148	WBGene00004101	WBGene00004101(1)			GO:0005623;GO:0006886;GO:0016525;GO:0005737;GO:0016020;GO:0015031;GO:0043231;GO:0046872;GO:0016301;GO:0016310;GO:0005829;GO:0005515;GO:0005768;GO:0005764;GO:0070062;GO:0010628;GO:0072657;GO:0031901;GO:0016197;GO:0016236;GO:0036258;GO:0016579;GO:0007165;GO:0019904;GO:0006622;GO:0032585;GO:0061024;GO:1903543;GO:0044389;GO:0008285;GO:0042059;GO:0010324;GO:0010642;GO:0030948;GO:0042176;GO:0043405;GO:0046426;GO:0005769;GO:0033565	intracellular protein transport;metal ion binding;negative regulation of angiogenesis;negative regulation of vascular endothelial growth factor receptor signaling pathway;cytoplasm;membrane;protein transport;intracellular membrane-bounded organelle;kinase activity;phosphorylation;cytosol;endosome;protein binding;lysosome;extracellular exosome;positive regulation of gene expression;protein localization to membrane;early endosome membrane;endosomal transport;macroautophagy;multivesicular body assembly;protein deubiquitination;signal transduction;protein domain specific binding;protein targeting to lysosome;multivesicular body membrane;membrane organization;positive regulation of exosomal secretion;ubiquitin-like protein ligase binding;negative regulation of cell population proliferation;negative regulation of epidermal growth factor receptor signaling pathway;membrane invagination;negative regulation of platelet-derived growth factor receptor signaling pathway;regulation of protein catabolic process;regulation of MAP kinase activity;negative regulation of receptor signaling pathway via JAK-STAT;early endosome;ESCRT-0 complex	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Endosome;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport;Ubl conjugation;Zinc;Zinc-finger	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-199991;R-HSA-1643685;R-HSA-5663205;R-HSA-917729;R-HSA-5688426;R-HSA-5689880;R-HSA-9006934;R-HSA-199992;R-HSA-432720;R-HSA-8856828;R-HSA-8856825;R-HSA-177929;R-HSA-182971;R-HSA-6806834;R-HSA-6807004;R-HSA-8875360;R-HSA-8876384	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Signal Transduction;Membrane Trafficking;Disease;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);Deubiquitination;Ub-specific processing proteases;Signaling by Receptor Tyrosine Kinases;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Signaling by EGFR;EGFR downregulation;Signaling by MET;Negative regulation of MET activity;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells
PDSS2	negative	HIST1H2AG	ENSG00000196787	PDSS2	1	PDSS2	1	0.00579694401645148	WBGene00001877;WBGene00001881;WBGene00001886;WBGene00001890;WBGene00001893;WBGene00001895;WBGene00001904;WBGene00001907;WBGene00001909;WBGene00001917;WBGene00001921;WBGene00001925;WBGene00001927;WBGene00001931;WBGene00001935;WBGene00001939;WBGene00001942;WBGene00014240				GO:0005634;GO:0003677;GO:0046982;GO:0000786;GO:0005694;GO:0005515;GO:0000790;GO:0006325;GO:0070062;GO:0008150;GO:0019899	DNA binding;nucleosome;protein heterodimerization activity;nucleus;chromosome;protein binding;nuclear chromatin;chromatin organization;chromatin silencing;extracellular exosome;biological_process;enzyme binding	3D-structure;Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Isopeptide bond;Methylation;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-3214815;R-HSA-3247509;R-HSA-4839726;R-HSA-5689901;R-HSA-3214858;R-HSA-3214847	Metabolism of proteins;Post-translational protein modification;Deubiquitination;UCH proteinases;Ub-specific processing proteases;HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization;Metalloprotease DUBs;RMTs methylate histone arginines;HATs acetylate histones
PDSS2	negative	PLAUR	ENSG00000011422	PDSS2	1	PDSS2	1	0.00691969372765988					GO:0016020;GO:0016021;GO:0005886;GO:0042995;GO:0005515;GO:0005576;GO:0030054;GO:0019904;GO:0005925;GO:0031225;GO:0007596;GO:0005789;GO:0030162;GO:0038023;GO:0005102;GO:0043312;GO:0035579;GO:0030377;GO:0038195;GO:0006935;GO:0007165;GO:0019899;GO:0005788;GO:0019898;GO:0001934;GO:0043066;GO:0042730;GO:0071438;GO:0009986;GO:0043388;GO:0045742;GO:0090200;GO:2001243;GO:2001268;GO:0005887	urokinase plasminogen activator receptor activity;regulation of proteolysis;urokinase plasminogen activator signaling pathway;membrane;integral component of membrane;focal adhesion;plasma membrane;cell projection;protein binding;extracellular region;cell junction;protein domain specific binding;anchored component of membrane;blood coagulation;endoplasmic reticulum membrane;signaling receptor activity;signaling receptor binding;neutrophil degranulation;specific granule membrane;chemotaxis;signal transduction;enzyme binding;endoplasmic reticulum lumen;extrinsic component of membrane;positive regulation of protein phosphorylation;negative regulation of apoptotic process;fibrinolysis;invadopodium membrane;cell surface;positive regulation of DNA binding;positive regulation of epidermal growth factor receptor signaling pathway;positive regulation of release of cytochrome c from mitochondria;negative regulation of intrinsic apoptotic signaling pathway;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;positive regulation of homotypic cell-cell adhesion;integral component of plasma membrane	3D-structure;Alternative splicing;Cell junction;Cell membrane;Cell projection;Direct protein sequencing;Disulfide bond;GPI-anchor;Glycoprotein;Lipoprotein;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Secreted;Signal	R-HSA-109582;R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-163125;R-HSA-6798695;R-HSA-162791;R-HSA-75205	Hemostasis;Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Post-translational modification: synthesis of GPI-anchored proteins;Neutrophil degranulation;Attachment of GPI anchor to uPAR;Dissolution of Fibrin Clot
PDSS2	negative	SERPINB1	ENSG00000021355	PDSS2	1	PDSS2	1	0.00691969372765988	WBGene00005647;WBGene00005648;WBGene00005642;WBGene00005649;WBGene00005643				GO:0005615;GO:0005737;GO:0016020;GO:0004867;GO:0010951;GO:0005576;GO:0005515;GO:0030414;GO:0010466;GO:0070062;GO:0062023;GO:0043312;GO:0034774;GO:0044342;GO:0050713	extracellular space;serine-type endopeptidase inhibitor activity;cytoplasm;membrane;negative regulation of endopeptidase activity;extracellular region;cytoplasmic ribonucleoprotein granule;protein binding;peptidase inhibitor activity;negative regulation of peptidase activity;extracellular exosome;collagen-containing extracellular matrix;neutrophil degranulation;secretory granule lumen;type B pancreatic cell proliferation;negative regulation of interleukin-1 beta secretion	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Phosphoprotein;Polymorphism;Protease inhibitor;Reference proteome;Secreted;Serine protease inhibitor	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
PDSS2	negative	EMD	ENSG00000102119	PDSS2	1	PDSS2	1	0.00691969372765988				X-linked Emery-Dreifuss muscular dystrophy;EMERY-DREIFUSS MUSCULAR DYSTROPHY 1 X-LINKED	GO:0090090;GO:0048147;GO:0005634;GO:0016020;GO:0016021;GO:0005783;GO:0003779;GO:0031965;GO:0005515;GO:0005874;GO:0005635;GO:0045296;GO:0005637;GO:0005819;GO:0006936;GO:0032541;GO:0048487;GO:0005737;GO:0007517;GO:0071363;GO:0060828;GO:0007084;GO:0046827;GO:0005654;GO:0031616;GO:0005640;GO:0035914	nuclear envelope;negative regulation of canonical Wnt signaling pathway;negative regulation of fibroblast proliferation;nucleus;membrane;integral component of membrane;endoplasmic reticulum;actin binding;nuclear membrane;protein binding;microtubule;cadherin binding;nuclear inner membrane;spindle;muscle contraction;cortical endoplasmic reticulum;beta-tubulin binding;cytoplasm;muscle organ development;cellular response to growth factor stimulus;regulation of canonical Wnt signaling pathway;mitotic nuclear envelope reassembly;positive regulation of protein export from nucleus;nucleoplasm;spindle pole centrosome;nuclear outer membrane;skeletal muscle cell differentiation	3D-structure;Acetylation;Actin-binding;Cardiomyopathy;Direct protein sequencing;Disease mutation;Emery-Dreifuss muscular dystrophy;Membrane;Microtubule;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1640170;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-2980766;R-HSA-68875;R-HSA-9609507;R-HSA-9609523;R-HSA-2995383;R-HSA-2995410;R-HSA-4419969	Cell Cycle;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Nuclear Envelope Breakdown;Mitotic Prophase;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly;Depolymerisation of the Nuclear Lamina
PDSS2	negative	RP2	ENSG00000102218	PDSS2	1	PDSS2	1	0.00691969372765988	WBGene00019536	WBGene00019536(1)		Retinitis pigmentosa;RETINITIS PIGMENTOSA 2	GO:0005737;GO:0016020;GO:0015031;GO:0000166;GO:0005654;GO:0005886;GO:0005525;GO:0005096;GO:0043547;GO:0042995;GO:0005515;GO:0016604;GO:0000287;GO:0000902;GO:0005929;GO:0036064;GO:0005794;GO:0005814;GO:1990075;GO:0070062;GO:0007601;GO:0006457;GO:0031410;GO:0051082;GO:0006892	GTPase activator activity;cell morphogenesis;cytoplasm;membrane;protein transport;nucleotide binding;nucleoplasm;plasma membrane;GTP binding;positive regulation of GTPase activity;cell projection;protein binding;nuclear body;magnesium ion binding;cilium;ciliary basal body;Golgi apparatus;centriole;periciliary membrane compartment;extracellular exosome;visual perception;protein folding;cytoplasmic vesicle;unfolded protein binding;post-Golgi vesicle-mediated transport	3D-structure;Cell membrane;Cell projection;Cilium;Disease mutation;GTP-binding;GTPase activation;Lipoprotein;Membrane;Myristate;Nucleotide-binding;Palmitate;Polymorphism;Protein transport;Reference proteome;Retinitis pigmentosa;Transport	R-HSA-1852241;R-HSA-5617833;R-HSA-5620920;R-HSA-5624138	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;Trafficking of myristoylated proteins to the cilium
PDSS2	negative	SOD2	ENSG00000112096	PDSS2	1	PDSS2	1	0.00691969372765988	WBGene00004931;WBGene00004932	WBGene00004932(1);WBGene00004931(1)		MICROVASCULAR COMPLICATIONS OF DIABETES SUSCEPTIBILITY TO 6	GO:1904706;GO:0008285;GO:0030335;GO:1905461;GO:1905932;GO:0046872;GO:0016491;GO:0055114;GO:0005739;GO:0005759;GO:0030145;GO:0042802;GO:0004784;GO:0006801;GO:0019430;GO:0070062;GO:0006357;GO:0035722;GO:0051289;GO:0034599;GO:0043524;GO:0008217;GO:1902176;GO:0000303;GO:0001315;GO:0001836;GO:0003069;GO:0032364	metal ion binding;oxidation-reduction process;superoxide dismutase activity;superoxide metabolic process;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell population proliferation;positive regulation of cell migration;positive regulation of vascular associated smooth muscle cell apoptotic process;positive regulation of vascular smooth muscle cell differentiation involved in phenotypic switching;oxidoreductase activity;mitochondrion;mitochondrial matrix;manganese ion binding;identical protein binding;removal of superoxide radicals;extracellular exosome;regulation of transcription by RNA polymerase II;interleukin-12-mediated signaling pathway;protein homotetramerization;cellular response to oxidative stress;negative regulation of neuron apoptotic process;regulation of blood pressure;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;response to superoxide;age-dependent response to reactive oxygen species;release of cytochrome c from mitochondria;acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure;oxygen homeostasis	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Manganese;Metal-binding;Mitochondrion;Nitration;Oxidoreductase;Polymorphism;Reference proteome;Transit peptide;Ubl conjugation	R-HSA-168256;R-HSA-1852241;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-1280215;R-HSA-2262752;R-HSA-449147;R-HSA-8953897;R-HSA-9614085;R-HSA-9615017;R-HSA-447115;R-HSA-8950505;R-HSA-9020591;R-HSA-3299685;R-HSA-1592230;R-HSA-2151201;R-HSA-8862803;R-HSA-8863678	Immune System;Organelle biogenesis and maintenance;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Cytokine Signaling in Immune system;Cellular responses to stress;Signaling by Interleukins;Cellular responses to external stimuli;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Detoxification of Reactive Oxygen Species;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases
PDSS2	negative	CDKN2B	ENSG00000147883	PDSS2	1	PDSS2	1	0.00691969372765988				Familial melanoma;Multiple endocrine neoplasia type 1	GO:0008285;GO:0005737;GO:0050680;GO:0030511;GO:0005634;GO:0016301;GO:0016310;GO:0005515;GO:0007049;GO:0045736;GO:0005829;GO:0048536;GO:2000134;GO:0045944;GO:0019901;GO:0007093;GO:0030219;GO:0007050;GO:0090398;GO:0004861;GO:0000086;GO:0031668;GO:0042326;GO:0000079;GO:0031670	negative regulation of cell population proliferation;cytoplasm;negative regulation of epithelial cell proliferation;positive regulation of transforming growth factor beta receptor signaling pathway;nucleus;kinase activity;phosphorylation;protein binding;cell cycle;negative regulation of cyclin-dependent protein serine/threonine kinase activity;cytosol;spleen development;negative regulation of G1/S transition of mitotic cell cycle;positive regulation of transcription by RNA polymerase II;protein kinase binding;mitotic cell cycle checkpoint;megakaryocyte differentiation;cell cycle arrest;cellular senescence;cyclin-dependent protein serine/threonine kinase inhibitor activity;G2/M transition of mitotic cell cycle;cellular response to extracellular stimulus;negative regulation of phosphorylation;regulation of cyclin-dependent protein serine/threonine kinase activity;cellular response to nutrient	ANK repeat;Alternative splicing;Cell cycle;Cytoplasm;Polymorphism;Reference proteome;Repeat;Tumor suppressor	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1640170;R-HSA-2262752;R-HSA-69278;R-HSA-8953897;R-HSA-453279;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-2173796;R-HSA-2559580;R-HSA-2559583;R-HSA-2559585;R-HSA-69231;R-HSA-69236;R-HSA-2559582	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cell Cycle;Cellular responses to stress;Cell Cycle, Mitotic;Cellular responses to external stimuli;Mitotic G1 phase and G1/S transition;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Cyclin D associated events in G1;G1 Phase;Senescence-Associated Secretory Phenotype (SASP)
PDSS2	negative	CXCL3	ENSG00000163734	PDSS2	1	PDSS2	1	0.00691969372765988					GO:0005576;GO:0005615;GO:0006955;GO:0006935;GO:0005125;GO:0006954;GO:0008009;GO:0006952;GO:0071222;GO:0030593;GO:0070098;GO:0007186;GO:0030595;GO:0061844	extracellular region;chemotaxis;immune response;defense response;chemokine activity;extracellular space;cytokine activity;inflammatory response;cellular response to lipopolysaccharide;neutrophil chemotaxis;chemokine-mediated signaling pathway;G protein-coupled receptor signaling pathway;CXCR chemokine receptor binding;leukocyte chemotaxis;antimicrobial humoral immune response mediated by antimicrobial peptide	Chemotaxis;Cytokine;Direct protein sequencing;Disulfide bond;Inflammatory response;Polymorphism;Reference proteome;Secreted;Signal	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-500792;R-HSA-373076;R-HSA-375276;R-HSA-380108	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines
PDSS2	negative	PDGFA	ENSG00000197461	PDSS2	1	PDSS2	1	0.00691969372765988	WBGene00004249	WBGene00004249(0)			GO:0005615;GO:0008284;GO:0048008;GO:0030335;GO:0048146;GO:0016020;GO:0008083;GO:0005515;GO:0005576;GO:0007275;GO:0070374;GO:0000165;GO:0051781;GO:0043410;GO:0005902;GO:0001525;GO:0030036;GO:0042803;GO:0046982;GO:0009986;GO:0007267;GO:0002576;GO:0005788;GO:0031093;GO:0051897;GO:0000139;GO:0030198;GO:0005796;GO:0009887;GO:0014068;GO:0002053;GO:0048286;GO:0005161;GO:0031954;GO:0043406;GO:0050730;GO:0009611;GO:0010544;GO:0014910;GO:0005518;GO:0048407;GO:0010512;GO:0035793;GO:0042060;GO:0043588;GO:0001775;GO:0001942;GO:0030031;GO:0032956;GO:0050919;GO:0060683;GO:1990401;GO:0007165	growth factor activity;membrane;extracellular space;positive regulation of cell population proliferation;platelet-derived growth factor receptor signaling pathway;positive regulation of cell migration;positive regulation of fibroblast proliferation;protein binding;extracellular region;multicellular organism development;positive regulation of ERK1 and ERK2 cascade;positive regulation of cell division;MAPK cascade;positive regulation of MAPK cascade;microvillus;angiogenesis;actin cytoskeleton organization;protein homodimerization activity;protein heterodimerization activity;cell surface;cell-cell signaling;platelet degranulation;endoplasmic reticulum lumen;platelet alpha granule lumen;positive regulation of protein kinase B signaling;Golgi membrane;extracellular matrix organization;Golgi lumen;positive regulation of protein autophosphorylation;animal organ morphogenesis;positive regulation of phosphatidylinositol 3-kinase signaling;positive regulation of mesenchymal cell proliferation;lung alveolus development;platelet-derived growth factor receptor binding;positive regulation of MAP kinase activity;regulation of peptidyl-tyrosine phosphorylation;response to wounding;negative regulation of platelet activation;regulation of smooth muscle cell migration;collagen binding;platelet-derived growth factor binding;growth factor receptor binding;negative regulation of phosphatidylinositol biosynthetic process;positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway;wound healing;skin development;cell activation;hair follicle development;cell projection assembly;regulation of actin cytoskeleton organization;negative chemotaxis;regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling;embryonic lung development;signal transduction	3D-structure;Alternative splicing;Cleavage on pair of basic residues;Developmental protein;Disulfide bond;Glycoprotein;Growth factor;Mitogen;Reference proteome;Secreted;Signal	R-HSA-1474244;R-HSA-3000171	Extracellular matrix organization;Non-integrin membrane-ECM interactions
PDSS2	negative	MYLIP	ENSG00000007944	PDSS2	1	PDSS2	1	0.00823026712353247	WBGene00001491;WBGene00009932				GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0016567;GO:0005886;GO:0005856;GO:0005515;GO:0008092;GO:0004842;GO:0007399;GO:0006511;GO:0005829;GO:0000209;GO:0010977;GO:0061630;GO:0032802;GO:0010989;GO:0031648;GO:0032803;GO:0042632;GO:0045732	cytoskeleton;cytoskeletal protein binding;cytoplasm;membrane;metal ion binding;transferase activity;protein ubiquitination;plasma membrane;protein binding;ubiquitin-protein transferase activity;nervous system development;ubiquitin-dependent protein catabolic process;cytosol;protein polyubiquitination;negative regulation of neuron projection development;ubiquitin protein ligase activity;low-density lipoprotein particle receptor catabolic process;negative regulation of low-density lipoprotein particle clearance;protein destabilization;regulation of low-density lipoprotein particle receptor catabolic process;cholesterol homeostasis;positive regulation of protein catabolic process	3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Iron;Membrane;Metal-binding;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169;R-HSA-382551;R-HSA-174824;R-HSA-8964043;R-HSA-8866427	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Transport of small molecules;Plasma lipoprotein assembly, remodeling, and clearance;Plasma lipoprotein clearance;VLDLR internalisation and degradation
PDSS2	negative	JOSD1	ENSG00000100221	PDSS2	1	PDSS2	1	0.00823026712353247	WBGene00022190	WBGene00022190(1)			GO:0005737;GO:0016020;GO:0004843;GO:0016579;GO:0016787;GO:0005886;GO:0005515;GO:0008233;GO:0006508;GO:0036459;GO:0005829	protein deubiquitination;thiol-dependent ubiquitin-specific protease activity;cytoplasm;membrane;hydrolase activity;plasma membrane;protein binding;peptidase activity;proteolysis;thiol-dependent ubiquitinyl hydrolase activity;cytosol	Cell membrane;Cytoplasm;Hydrolase;Membrane;Phosphoprotein;Polymorphism;Protease;Reference proteome;Ubl conjugation;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-5688426;R-HSA-5689877	Metabolism of proteins;Post-translational protein modification;Deubiquitination;Josephin domain DUBs
PDSS2	negative	PBX4	ENSG00000105717	PDSS2	1	PDSS2	1	0.00823026712353247	WBGene00000443;WBGene00000461;WBGene00017690	WBGene00000443(0);WBGene00017690(0);WBGene00006796(0)			GO:0005634;GO:0003700;GO:0006355;GO:0045893;GO:0003677;GO:0005515;GO:0006357;GO:0000981;GO:0000790;GO:0043565;GO:0006366;GO:0001741	nucleus;DNA-binding transcription factor activity;regulation of transcription, DNA-templated;DNA binding;positive regulation of transcription, DNA-templated;protein binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;sequence-specific DNA binding;transcription by RNA polymerase II;XY body	Activator;DNA-binding;Homeobox;Nucleus;Polymorphism;Reference proteome;Transcription;Transcription regulation		
PDSS2	negative	IFIT2	ENSG00000119922	PDSS2	1	PDSS2	1	0.00823026712353247					GO:0003723;GO:0005737;GO:0005783;GO:0005515;GO:0006915;GO:0002376;GO:0045087;GO:0051607;GO:0035457;GO:0005829;GO:0009615;GO:0043065;GO:0032091;GO:0060337;GO:0008637	protein binding;cellular response to interferon-alpha;RNA binding;cytoplasm;endoplasmic reticulum;apoptotic process;immune system process;innate immune response;cytosol;defense response to virus;response to virus;positive regulation of apoptotic process;negative regulation of protein binding;type I interferon signaling pathway;apoptotic mitochondrial changes	3D-structure;Acetylation;Antiviral defense;Apoptosis;Cytoplasm;Endoplasmic reticulum;Immunity;Innate immunity;Polymorphism;RNA-binding;Reference proteome;Repeat;TPR repeat	R-HSA-168256;R-HSA-1280215;R-HSA-913531;R-HSA-909733	Immune System;Cytokine Signaling in Immune system;Interferon Signaling;Interferon alpha/beta signaling
PDSS2	negative	ULBP2	ENSG00000131015	PDSS2	1	PDSS2	1	0.00823026712353247					GO:0005615;GO:0016020;GO:0005783;GO:0005886;GO:0005515;GO:0005576;GO:0002376;GO:0006955;GO:0009897;GO:0031225;GO:0016032;GO:0009986;GO:0030101;GO:0046658;GO:0042267;GO:0046703	extracellular space;membrane;endoplasmic reticulum;plasma membrane;protein binding;extracellular region;immune system process;external side of plasma membrane;anchored component of membrane;viral process;cell surface;natural killer cell activation;anchored component of plasma membrane;natural killer cell mediated cytotoxicity;natural killer cell lectin-like receptor binding	Cell membrane;Direct protein sequencing;Disulfide bond;Endoplasmic reticulum;GPI-anchor;Glycoprotein;Host-virus interaction;Immunity;Lipoprotein;Membrane;Reference proteome;Secreted;Signal	R-HSA-392499;R-HSA-597592;R-HSA-163125	Metabolism of proteins;Post-translational protein modification;Post-translational modification: synthesis of GPI-anchored proteins
PDSS2	negative	LHFPL2	ENSG00000145685	PDSS2	1	PDSS2	1	0.00823026712353247					GO:0016020;GO:0016021;GO:0007338;GO:0005886;GO:0003674;GO:0008150;GO:0005575;GO:1905516;GO:0002576;GO:0031092;GO:0046545;GO:0046546	membrane;integral component of membrane;plasma membrane;molecular_function;biological_process;cellular_component;single fertilization;positive regulation of fertilization;platelet degranulation;platelet alpha granule membrane;development of primary female sexual characteristics;development of primary male sexual characteristics	Fertilization;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-76002;R-HSA-76005;R-HSA-114608	Hemostasis;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation 
PDSS2	negative	ERFE	ENSG00000178752	PDSS2	1	PDSS2	1	0.00823026712353247					GO:0005623;GO:0007165;GO:0005576;GO:0006879;GO:0005179;GO:0005615;GO:0042803;GO:0010906;GO:0019217;GO:0045721;GO:0046326;GO:0046628;GO:2000193;GO:0005515	protein binding;cell;signal transduction;extracellular region;cellular iron ion homeostasis;hormone activity;extracellular space;regulation of glucose metabolic process;regulation of fatty acid metabolic process;negative regulation of gluconeogenesis;positive regulation of glucose import;positive regulation of insulin receptor signaling pathway;positive regulation of fatty acid transport	Disulfide bond;Glycoprotein;Hormone;Reference proteome;Secreted;Signal		
PDSS2	negative	FHL3	ENSG00000183386	PDSS2	1	PDSS2	1	0.00823026712353247	WBGene00006407	WBGene00006407(0)			GO:0046872;GO:0005515;GO:0005925;GO:0005634;GO:0030036;GO:0003779;GO:0001725;GO:0030018;GO:0007517	nucleus;cytoplasm;metal ion binding;focal adhesion;protein binding;regulation of nucleic acid-templated transcription;transcription coregulator activity;actin cytoskeleton organization;actin binding;stress fiber;Z disc;muscle organ development	3D-structure;Acetylation;Activator;Cytoplasm;LIM domain;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		
PDSS2	negative	SBNO2	ENSG00000064932	PDSS2	1	PDSS2	1	0.00975405320534106	WBGene00002889	WBGene00002889(0)			GO:0006355;GO:0030154;GO:0005634;GO:0050727;GO:0042393;GO:0045944;GO:0005575;GO:0071222;GO:0031490;GO:0045892;GO:0001503;GO:0030316;GO:0071354;GO:0002281;GO:1990830;GO:0030282;GO:0061430;GO:0071348;GO:0072674;GO:0072675	regulation of transcription, DNA-templated;regulation of inflammatory response;cell differentiation;nucleus;histone binding;positive regulation of transcription by RNA polymerase II;cellular_component;cellular response to lipopolysaccharide;chromatin DNA binding;negative regulation of transcription, DNA-templated;ossification;osteoclast differentiation;macrophage activation involved in immune response;cellular response to interleukin-6;cellular response to leukemia inhibitory factor;bone mineralization;bone trabecula morphogenesis;cellular response to interleukin-11;multinuclear osteoclast differentiation;osteoclast fusion	Activator;Alternative splicing;Differentiation;Osteogenesis;Reference proteome;Repressor;Transcription;Transcription regulation		
PDSS2	negative	NR3C1	ENSG00000113580	PDSS2	1	PDSS2	1	0.00975405320534106			BAD;BAX;BRCA1;CALD1;CDKN1A;CYP19A1;RPS6KA3;UGT1A1	Glucocorticoid resistance;GLUCOCORTICOID RESISTANCE GENERALIZED	GO:0005634;GO:0003723;GO:0005737;GO:0016607;GO:0008270;GO:0046872;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0005739;GO:0051301;GO:0006325;GO:0043565;GO:0005856;GO:0005515;GO:0003707;GO:0007049;GO:0006915;GO:0008289;GO:0005815;GO:0005819;GO:0005496;GO:0007059;GO:0000981;GO:0000790;GO:0004883;GO:0042921;GO:0043402;GO:0000978;GO:0045944;GO:0032991;GO:0001228;GO:0007165;GO:0006366;GO:0006367;GO:0004879;GO:0006351;GO:0051879;GO:0071383;GO:0071385;GO:0000122;GO:0001047;GO:0019901;GO:0032183;GO:1990239;GO:0071549;GO:0071560;GO:1902895;GO:0005759	DNA binding;steroid hormone receptor activity;zinc ion binding;regulation of transcription, DNA-templated;nucleus;steroid binding;DNA-binding transcription factor activity;sequence-specific DNA binding;glucocorticoid receptor activity;glucocorticoid receptor signaling pathway;glucocorticoid mediated signaling pathway;RNA binding;cytoplasm;nuclear speck;metal ion binding;nucleoplasm;cytosol;mitochondrion;cytoskeleton;cell division;chromatin organization;protein binding;cell cycle;apoptotic process;lipid binding;microtubule organizing center;spindle;chromosome segregation;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;protein-containing complex;DNA-binding transcription activator activity, RNA polymerase II-specific;signal transduction;negative regulation of transcription, DNA-templated;transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;nuclear receptor activity;RNA polymerase II regulatory region sequence-specific DNA binding;transcription, DNA-templated;Hsp90 protein binding;cellular response to steroid hormone stimulus;cellular response to glucocorticoid stimulus;protein kinase binding;core promoter binding;steroid hormone binding;cellular response to dexamethasone stimulus;cellular response to transforming growth factor beta stimulus;positive regulation of pri-miRNA transcription by RNA polymerase II;mitochondrial matrix	3D-structure;Acetylation;Alternative initiation;Alternative splicing;Apoptosis;Cell cycle;Cell division;Chromatin regulator;Chromosome partition;Cytoplasm;Cytoskeleton;DNA-binding;Disease mutation;Isopeptide bond;Lipid-binding;Metal-binding;Methylation;Mitochondrion;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Pseudohermaphroditism;RNA-binding;Receptor;Reference proteome;Steroid-binding;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-2262752;R-HSA-8878166;R-HSA-8939902;R-HSA-8953897;R-HSA-3371497;R-HSA-2990846;R-HSA-3108232;R-HSA-9614085;R-HSA-9615017;R-HSA-400253;R-HSA-8848021;R-HSA-9006927;R-HSA-4090294;R-HSA-8849473	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cellular responses to stress;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Cellular responses to external stimuli;HSP90 chaperone cycle for steroid hormone receptors (SHR);SUMOylation;SUMO E3 ligases SUMOylate target proteins;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Circadian Clock;Signaling by PTK6;Signaling by Non-Receptor Tyrosine Kinases;SUMOylation of intracellular receptors;PTK6 Expression
PDSS2	negative	SLC2A6	ENSG00000160326	PDSS2	1	PDSS2	1	0.00975405320534106		WBGene00013074(0);WBGene00010811(0);WBGene00008730(0);WBGene00019550(0);WBGene00019549(0);WBGene00043980(0);WBGene00017382(0);WBGene00019548(0);WBGene00019547(0);WBGene00016431(0);WBGene00010684(0);WBGene00012536(0);WBGene00019207(0)			GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0005765;GO:1902600;GO:0008643;GO:0005764;GO:0005886;GO:0005887;GO:0008645;GO:0006110;GO:0005351;GO:1904659;GO:0005355;GO:0005353;GO:0033300;GO:0015755;GO:0070837;GO:0005215	integral component of membrane;membrane;transmembrane transporter activity;transmembrane transport;lysosomal membrane;proton transmembrane transport;carbohydrate transport;lysosome;plasma membrane;integral component of plasma membrane;hexose transmembrane transport;regulation of glycolytic process;carbohydrate:proton symporter activity;glucose import;glucose transmembrane transport;glucose transmembrane transporter activity;fructose transmembrane transporter activity;dehydroascorbic acid transmembrane transporter activity;fructose transmembrane transport;dehydroascorbic acid transport	Alternative splicing;Glycoprotein;Lysosome;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Sugar transport;Transmembrane;Transmembrane helix;Transport	R-HSA-189200;R-HSA-382551;R-HSA-425407	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
PDSS2	negative	ANKRD33B	ENSG00000164236	PDSS2	1	PDSS2	1	0.00975405320534106					GO:0005515	protein binding	ANK repeat;Coiled coil;Phosphoprotein;Reference proteome;Repeat		
PDSS2	negative	SLFN5	ENSG00000166750	PDSS2	1	PDSS2	1	0.00975405320534106					GO:0005634;GO:0000166;GO:0005524;GO:0030154	nucleus;nucleotide binding;ATP binding;cell differentiation	ATP-binding;Alternative splicing;Differentiation;Isopeptide bond;Nucleotide-binding;Polymorphism;Reference proteome;Ubl conjugation		
PDSS2	negative	FTH1	ENSG00000167996	PDSS2	1	PDSS2	1	0.00975405320534106	WBGene00001501;WBGene00001500	WBGene00001501(0);WBGene00001500(0)		FTH1-related iron overload;HEMOCHROMATOSIS TYPE 5	GO:0005623;GO:0046872;GO:0006879;GO:0008199;GO:0006826;GO:0005634;GO:0016491;GO:0055114;GO:0005515;GO:0006955;GO:0005576;GO:0005737;GO:0005829;GO:0070062;GO:0008285;GO:0043312;GO:1904813;GO:1904724;GO:0005506;GO:0004322;GO:0042802;GO:0048147;GO:0008198;GO:0006880;GO:0008043;GO:0044754;GO:0016020;GO:0016021	ferric iron binding;iron ion transport;cellular iron ion homeostasis;cell;metal ion binding;nucleus;oxidoreductase activity;oxidation-reduction process;protein binding;immune response;iron ion binding;extracellular region;cytoplasm;cytosol;extracellular exosome;negative regulation of cell population proliferation;neutrophil degranulation;ficolin-1-rich granule lumen;tertiary granule lumen;ferroxidase activity;negative regulation of fibroblast proliferation;ferrous iron binding;intracellular sequestering of iron ion;intracellular ferritin complex;autolysosome;membrane;integral component of membrane	3D-structure;Acetylation;Iron;Iron storage;Metal-binding;Oxidoreductase;Phosphoprotein;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-2173782;R-HSA-5653656;R-HSA-382551;R-HSA-199991;R-HSA-6798695;R-HSA-199992;R-HSA-432722;R-HSA-917937;R-HSA-3000480	Innate Immune System;Immune System;Binding and Uptake of Ligands by Scavenger Receptors;Vesicle-mediated transport;Transport of small molecules;Membrane Trafficking;Neutrophil degranulation;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Iron uptake and transport;Scavenging by Class A Receptors
PDSS2	negative	MARCKSL1	ENSG00000175130	PDSS2	1	PDSS2	1	0.00975405320534106					GO:0005737;GO:0016020;GO:0003779;GO:0005886;GO:0005856;GO:0005515;GO:0005516;GO:0070062;GO:0008284	calmodulin binding;cytoplasm;membrane;actin binding;cytoskeleton;plasma membrane;protein binding;extracellular exosome;positive regulation of cell population proliferation	Actin-binding;Calmodulin-binding;Cell membrane;Cytoplasm;Cytoskeleton;Lipoprotein;Membrane;Myristate;Phosphoprotein;Reference proteome		
PDSS2	negative	PJA1	ENSG00000181191	PDSS2	1	PDSS2	1	0.00975405320534106	WBGene00021842				GO:0046872;GO:0016740;GO:0005515;GO:0016567;GO:0061630;GO:0005737;GO:0030163	protein ubiquitination;ubiquitin protein ligase activity;metal ion binding;transferase activity;protein binding;cytoplasm;protein catabolic process	3D-structure;Alternative splicing;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
PDSS2	negative	RAP2B	ENSG00000181467	PDSS2	1	PDSS2	1	0.00975405320534106	WBGene00004308				GO:0016020;GO:0000166;GO:0007165;GO:0003924;GO:0005525;GO:0005829;GO:0005886;GO:0005515;GO:0045121;GO:0032486;GO:0005768;GO:0005923;GO:0070062;GO:0055038;GO:0043312;GO:0035579;GO:0070821;GO:0070527;GO:0019003;GO:0030168;GO:0030336;GO:0044291;GO:0019904;GO:0031954;GO:0061097;GO:0055037	signal transduction;membrane;GTP binding;GTPase activity;Rap protein signal transduction;nucleotide binding;endosome;cytosol;plasma membrane;protein binding;membrane raft;bicellular tight junction;extracellular exosome;recycling endosome membrane;neutrophil degranulation;specific granule membrane;tertiary granule membrane;platelet aggregation;GDP binding;platelet activation;negative regulation of cell migration;cell-cell contact zone;protein domain specific binding;positive regulation of protein autophosphorylation;regulation of protein tyrosine kinase activity;recycling endosome	3D-structure;Endosome;GTP-binding;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Palmitate;Prenylation;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
PDSS2	negative	CASP4	ENSG00000196954	PDSS2	1	PDSS2	1	0.00975405320534106	WBGene00000819;WBGene00000417;WBGene00000820;WBGene00000821	WBGene00000819(0);WBGene00000821(0);WBGene00000820(0);WBGene00000417(0)			GO:0005737;GO:0016020;GO:0005829;GO:0005783;GO:0005789;GO:0016787;GO:0042981;GO:0005739;GO:0005886;GO:0008233;GO:0008234;GO:0006508;GO:0005576;GO:0004197;GO:0006954;GO:0002376;GO:0045087;GO:0005515;GO:0050700;GO:0032991;GO:0006919;GO:0012501;GO:0006915;GO:0070059;GO:0097169;GO:0097199;GO:0050727;GO:1903265;GO:0072557;GO:0072559;GO:0097193;GO:1904646;GO:0061702	regulation of apoptotic process;proteolysis;cysteine-type peptidase activity;cysteine-type endopeptidase activity;cytoplasm;membrane;cytosol;plasma membrane;endoplasmic reticulum;endoplasmic reticulum membrane;hydrolase activity;mitochondrion;peptidase activity;extracellular region;inflammatory response;immune system process;innate immune response;protein binding;CARD domain binding;protein-containing complex;activation of cysteine-type endopeptidase activity involved in apoptotic process;programmed cell death;inflammasome complex;apoptotic process;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;AIM2 inflammasome complex;cysteine-type endopeptidase activity involved in apoptotic signaling pathway;regulation of inflammatory response;positive regulation of tumor necrosis factor-mediated signaling pathway;IPAF inflammasome complex;NLRP3 inflammasome complex;intrinsic apoptotic signaling pathway;cellular response to amyloid-beta	Acetylation;Alternative splicing;Cytoplasm;Endoplasmic reticulum;Hydrolase;Immunity;Inflammasome;Inflammatory response;Innate immunity;Membrane;Mitochondrion;Necrosis;Phosphoprotein;Polymorphism;Protease;Reference proteome;Secreted;Thiol protease;Zymogen	R-HSA-168249;R-HSA-168256;R-HSA-168643;R-HSA-168638	Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;NOD1/2 Signaling Pathway
PDSS2	negative	MAFG	ENSG00000197063	PDSS2	1	PDSS2	1	0.00975405320534106	WBGene00077521	WBGene00077521(0)			GO:0005634;GO:0006355;GO:0003677;GO:0003700;GO:0046982;GO:0005515;GO:0000978;GO:0001228;GO:0001701;GO:0010628;GO:0030534;GO:0030641;GO:0042127;GO:0045604;GO:0045944;GO:0043565;GO:0000981;GO:0005654;GO:0007596	DNA binding;regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;protein heterodimerization activity;cell;protein binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;in utero embryonic development;positive regulation of gene expression;adult behavior;regulation of cellular pH;regulation of cell population proliferation;regulation of epidermal cell differentiation;positive regulation of transcription by RNA polymerase II;sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nucleoplasm;blood coagulation	Acetylation;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-109582;R-HSA-983231	Hemostasis;Factors involved in megakaryocyte development and platelet production
PDSS2	negative	MARCKS	ENSG00000277443	PDSS2	1	PDSS2	1	0.00975405320534106					GO:0005737;GO:0016020;GO:0003779;GO:0005856;GO:0005925;GO:0005516;GO:0005886;GO:0070062;GO:0015629;GO:0051015;GO:0005080;GO:0042802;GO:0051017;GO:0051260;GO:0051764;GO:0005813;GO:0005938;GO:0032432;GO:0042585	calmodulin binding;cytoplasm;membrane;actin binding;cytoskeleton;focal adhesion;plasma membrane;extracellular exosome;actin cytoskeleton;actin filament binding;protein kinase C binding;identical protein binding;actin filament bundle assembly;actin crosslink formation;centrosome;cell cortex;actin filament bundle;germinal vesicle	Actin-binding;Calmodulin-binding;Cytoplasm;Cytoskeleton;Lipoprotein;Membrane;Myristate;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-163685;R-HSA-422356;R-HSA-399997	Metabolism;Integration of energy metabolism;Regulation of insulin secretion;Acetylcholine regulates insulin secretion
